Seagate Technology (STX) 10-K 4 Aug 23 2023 FY Annual report Financial data

Cover

Cover - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 31, 2023	Dec. 31, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-31560
Entity Incorporation, State or Country Code	L2
Entity Tax Identification Number	98-1597419
Entity Address, Address Line One	38/39 Fitzwilliam Square
Entity Address, City or Town	Dublin 2
Entity Address, Country	IE
Entity Address, Postal Zip Code	D02 NX53
City Area Code	353) (1)
Local Phone Number	234-3136
Title of 12(b) Security	Ordinary Shares, par value $0.00001 per share
Trading Symbol	STX
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 10,100
Entity Common Stock, Shares Outstanding		207,393,242
Documents Incorporated by Reference	Portions of the definitive proxy statement to be filed with the Securities and Exchange Commission pursuant to Regulation 14A relating to the registrant’s Annual General Meeting of Shareholders, to be held on October 23, 2023, will be incorporated by reference in this Form 10-K in response to Items 10, 11, 12, 13 and 14 of Part III. The definitive proxy statement will be filed with the SEC no later than 120 days after the registrant's fiscal year ended June 30, 2023.
Entity Registrant Name	Seagate Technology Holdings plc
Entity Central Index Key	0001137789
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	FY

Audit Information

Audit Information	12 Months Ended
	Jun. 30, 2023
Audit Information [Abstract]
Auditor Firm ID	42
Auditor Name	Ernst & Young LLP
Auditor Location	San Jose, California

Legal, Environmental and Other

Legal, Environmental and Other Contingencies	12 Months Ended
	Jun. 30, 2023
Legal, Environmental and Other Contingencies Disclosure [Abstract]
Legal, Environmental and Other Contingencies	Legal, Environmental and Other Contingencies The Company assesses the probability of an unfavorable outcome of all its material litigation, claims or assessments to determine whether a liability had been incurred and whether it is probable that one or more future events will occur confirming the fact of the loss. In the event that an unfavorable outcome is determined to be probable and the amount of the loss can be reasonably estimated, the Company establishes an accrual for the litigation, claim or assessment. In addition, in the event an unfavorable outcome is determined to be less than probable, but reasonably possible, the Company will disclose an estimate of the possible loss or range of such loss; however, when a reasonable estimate cannot be made, the Company will provide disclosure to that effect. Litigation is inherently uncertain and may result in adverse rulings or decisions. Additionally, the Company may enter into settlements or be subject to judgments that may, individually or in the aggregate, have a material adverse effect on its results of operations. Accordingly, actual results could differ materially. Litigation Lambeth Magnetic Structures LLC v. Seagate Technology (US) Holdings, Inc., et al. On April 29, 2016, Lambeth Magnetic Structures LLC filed a complaint against Seagate Technology (US) Holdings, Inc. and Seagate Technology LLC in the U.S. District Court for the Western District of Pennsylvania, alleging infringement of U.S. Patent No. 7,128,988, “Magnetic Material Structures, Devices and Methods,” seeking damages as well as additional relief. The district court entered judgement in favor of Seagate on April 19, 2022. The parties filed post-trial motions with the district court in May 2022. On November 22, 2022, the court denied all pending post-trial motions. Lambeth Magnetic Structures LLC filed a notice of appeal to the Federal Circuit on December 20, 2022. A hearing date has not been set. The Company believes the asserted claims are without merit and intends to vigorously defend this case. Seagate Technology LLC, et al. v. Headway Technologies, Inc., et al. On February 18, 2020, Seagate Technology LLC, Seagate Technology (Thailand) Ltd., Seagate Singapore International Headquarters Pte. Ltd. and Seagate Technology International (collectively, the “Seagate Entities”) filed a complaint in the U.S. District Court for the Northern District of California against defendant suppliers of HDD suspension assemblies. Defendants include NHK Spring Co. Ltd., TDK Corporation, Hutchinson Technology Inc. and several of their subsidiaries and affiliates. The complaint includes federal and state antitrust law claims, as well as a breach of contract claim. The complaint alleges that defendants and their co-conspirators knowingly conspired for more than twelve years not to compete in the supply of suspension assemblies; that defendants misused confidential information that the Seagate Entities had provided pursuant to nondisclosure agreements, in breach of their contractual obligations; and that the Seagate Entities paid artificially high prices on purchases of suspension assemblies. The Seagate Entities seek to recover the overcharges they paid for suspension assemblies, as well as additional relief permitted by law. On March 22, 2022, the Seagate Entities dismissed with prejudice all claims being asserted against Defendants TDK Corporation, Hutchinson Technology Inc. and their subsidiaries and affiliates (collectively “TDK”) relating to the antitrust law claims, the breach of contract claim and other matters described in the complaint. On April 8, 2022, the court entered an Amended Stipulation and Order of Dismissal with Prejudice to dismiss all claims against TDK. On August 2, 2022, NHK Spring Co. Ltd. filed a motion for Partial Summary Judgment Regarding Foreign Commerce and on October 14, 2022, Seagate Entities’ filed their corresponding opposition. On May 15, 2023, the court issued a ruling that Seagate’s antitrust claims can proceed as to suspension assemblies that enter the United States but not as to suspension assembles that do not enter the United States. On July 28, 2023, the judge initiated a reconsideration of this ruling and requested further briefing. A trial date has not been set. UA Local 38 Defined Contribution Pension Plan, et al. v. Seagate Technology Holdings PLC, et al . A putative class action lawsuit alleging violations of the federal securities laws was filed on July 10, 2023, in the U.S. District Court for the Northern District of California against Seagate Technology Holdings plc, Dr. William D. Mosley, and Gianluca Romano. The complaint alleges that it is a securities class action on behalf of all purchasers of Seagate common stock between September 15, 2020 to October 25, 2022 ( the “Class Period”) and asserts claims under Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b5-1. The complaint seeks unspecified monetary damages and other relief. As a second action, Public Employees’ Retirement System of Mississippi v. Seagate Technology Holdings plc, William David Mosley, and Gianluca Romano , was filed on July 26, 2023, asserting similar claims. The Company believes that the asserted claims are without merit and intends to vigorously defend these cases. Environmental Matters The Company’s operations are subject to U.S. and foreign laws and regulations relating to the protection of the environment, including those governing discharges of pollutants into the air and water, the management and disposal of hazardous substances and wastes and the cleanup of contaminated sites. Some of the Company’s operations require environmental permits and controls to prevent and reduce air and water pollution, and these permits are subject to modification, renewal and revocation by issuing authorities. The Company has established environmental management systems and continually updates its environmental policies and standard operating procedures for its operations worldwide. The Company believes that its operations are in material compliance with applicable environmental laws, regulations and permits. The Company budgets for operating and capital costs on an ongoing basis to comply with environmental laws. If additional or more stringent requirements are imposed on the Company in the future, it could incur additional operating costs and capital expenditures. Some environmental laws, such as the Comprehensive Environmental Response Compensation and Liability Act of 1980 (as amended, the “Superfund” law) and its state equivalents, can impose liability for the cost of cleanup of contaminated sites upon any of the current or former site owners or operators or upon parties who sent waste to these sites, regardless of whether the owner or operator owned the site at the time of the release of hazardous substances or the lawfulness of the original disposal activity. The Company has been identified as a responsible or potentially responsible party at several sites. At each of these sites, the Company has an assigned portion of the financial liability based on the type and amount of hazardous substances disposed of by each party at the site and the number of financially viable parties. The Company has fulfilled its responsibilities at some of these sites and remains involved in only a few at this time. While the Company’s ultimate costs in connection with these sites is difficult to predict with complete accuracy, based on its current estimates of cleanup costs and its expected allocation of these costs, the Company does not expect costs in connection with these sites to be material. The Company may be subject to various state, federal and international laws and regulations governing the environment, including those restricting the presence of certain substances in electronic products. For example, the European Union (“EU”) enacted the Restriction of the Use of Certain Hazardous Substances in Electrical and Electronic Equipment (2011/65/EU), which prohibits the use of certain substances, including lead, in certain products, including disk drives and server storage products, put on the market after July 1, 2006. Similar legislation has been or may be enacted in other jurisdictions, including in the U.S., Canada, Mexico, Taiwan, China, Japan and others. The EU REACH Directive (Registration, Evaluation, Authorization, and Restriction of Chemicals, EC 1907/2006) also restricts substances of very high concern in products. If the Company or its suppliers fails to comply with the substance restrictions, recycle requirements or other environmental requirements as they are enacted worldwide, it could have a materially adverse effect on the Company’s business. BIS Settlement On April 18, 2023, the Company’s subsidiaries Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd (collectively, “Seagate”), entered into the Settlement Agreement with BIS that resolves BIS’ allegations regarding Seagate’s sales of hard disk drives to Huawei between August 17, 2020 and September 29, 2021. Under the terms of the Settlement Agreement, Seagate has agreed to pay $300 million to BIS in quarterly installments of $15 million over the course of five years beginning October 31, 2023. Seagate has also agreed to complete three audits of its compliance with the license requirements of Section 734.9 of the U.S. Export Administration Regulations (“EAR”), including one audit by an unaffiliated third-party consultant chosen by Seagate with expertise in U.S. export control laws and two internal audits. The Settlement Agreement also includes a denial order that is suspended and will be waived five years after the date of the order issued under the Settlement Agreement, provided that Seagate has made full and timely payments under the Settlement Agreement and timely completed the audit requirements. While Seagate is in compliance with and upon successful compliance in full with the terms of the Settlement Agreement, BIS has agreed it will not initiate any further administrative proceedings against Seagate in connection with any violation of the EAR arising out of the transactions detailed in the Settlement Agreement. While Seagate believed that it complied with all relevant export control laws at the time it made the hard disk drive sales at issue, Seagate determined that engaging with BIS and settling this matter was in the best interest of the Company, its customers, and its shareholders. In determining to engage with BIS and resolve this matter through a settlement agreement, the Company considered a number of factors, including the risks and cost of protracted litigation involving the U.S. government, as well as the size of the potential penalty and the Company’s desire to focus on current business challenges and long-term business strategy. The Settlement Agreement includes a finding that the Company incorrectly interpreted the regulation at issue to require evaluation of only the last stage of Seagate’s hard disk drive manufacturing process rather than the entire process. As part of this settlement, Seagate has agreed not to contest BIS’ determination that the sales in question did not comply with the U.S. EAR. The Company accrued a charge of $300 million during fiscal year 2023, which is reflected under BIS settlement penalty on its Consolidated Statements of Operations. As of June 30, 2023, $45 million and $255 million were included in Accrued expense and Other non-current liabilities, respectively, on its Consolidated Balance Sheet. Other Matters

Legal, Environmental and Othe_2

Legal, Environmental and Other Contingencies (Details) $ in Millions		12 Months Ended
	Apr. 18, 2023 USD ($) audit	Jun. 30, 2023 USD ($)	Jul. 01, 2022 USD ($)	Jul. 02, 2021 USD ($)
Loss Contingencies [Line Items]
Litigation settlement amount	$ 300
Litigation settlement payments, quarterly installments amount	$ 15
Litigation settlement, number of years of payment	5 years
Litigation settlement, number of audits | audit	3
Litigation settlement, number of third-party audits | audit	1
Litigation settlement, number of internal audits | audit	2
Denial order waiver period	5 years
Loss contingency, loss in period		$ 300	$ 0	$ 0
Accrued Liabilities [Member]
Loss Contingencies [Line Items]
Litigation settlement, amount accrued		45
Other Noncurrent Liabilities
Loss Contingencies [Line Items]
Litigation settlement, amount accrued		$ 255

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Current assets:
Cash and cash equivalents	$ 786	$ 615
Accounts receivable, net	621	1,532
Inventories	1,140	1,565
Other current assets	358	321
Total current assets	2,905	4,033
Property, equipment and leasehold improvements, net	1,706	2,239
Goodwill	1,237	1,237
Other intangible assets, net	0	9
Deferred income taxes	1,117	1,132
Other assets, net	591	294
Total Assets	7,556	8,944
Current liabilities:
Accounts payable	1,603	2,058
Accrued employee compensation	100	252
Accrued warranty	78	65
Current portion of long-term debt	63	584
Accrued expenses	748	596
Total current liabilities	2,592	3,555
Long-term accrued warranty	90	83
Other non-current liabilities	685	135
Long-term debt, less current portion	5,388	5,062
Total Liabilities	8,755	8,835
Seagate Technology plc shareholders' equity:
Preferred shares, $0.00001 par value per share—100,000,000 authorized; no shares issued or outstanding	0	0
Ordinary shares, $0.00001 par value per share—1,250,000,000 authorized; 207,389,381 issued and outstanding at June 30, 2023 and 209,850,169 issued and outstanding at July 1, 2022	0	0
Additional paid-in capital	7,373	7,190
Accumulated other comprehensive income	98	36
Accumulated deficit	(8,670)	(7,117)
Total Shareholders’ (Deficit) Equity	(1,199)	109
Total Liabilities and Shareholders’ (Deficit) Equity	$ 7,556	$ 8,944

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Jul. 01, 2022
Statement of Financial Position [Abstract]
Preferred shares, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred shares, authorized (in shares)	100,000,000	100,000,000
Preferred Stock, Shares Issued	0	0
Preferred stock, shares outstanding (in shares)	0	0
Ordinary shares, par value (in dollars per share)	$ 0.00001	$ 0.00001
Ordinary shares, authorized (in shares)	1,250,000,000	1,250,000,000
Ordinary shares, shares issued (in shares)	207,389,381	209,850,169
Ordinary shares, outstanding (in shares)	207,389,381	209,850,169

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Income Statement [Abstract]
Revenue	$ 7,384	$ 11,661	$ 10,681
Cost of revenue	6,033	8,192	7,764
Product development	797	941	903
Marketing and administrative	491	559	502
Amortization of intangibles	3	11	12
Loss Contingency, Loss in Period	300	0	0
Restructuring and other, net	102	3	8
Total operating expenses	7,726	9,706	9,189
(Loss) income from operations	(342)	1,955	1,492
Interest income	10	2	2
Interest expense	(313)	(249)	(220)
Gain (Loss) on Extinguishment of Debt	190	0
Other, net	(41)	(29)	74
Other expense, net	(154)	(276)	(144)
(Loss) income before income taxes	(496)	1,679	1,348
Provision for income taxes	33	30	34
Net (loss) income	$ (529)	$ 1,649	$ 1,314
Net (loss) income per share:
Basic (in dollars per share)	$ (2.56)	$ 7.50	$ 5.43
Diluted (in dollars per share)	$ (2.56)	$ 7.36	$ 5.36
Number of shares used in per share calculations:
Basic (in shares)	207	220	242
Diluted (in shares)	207	224	245

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Statement of Comprehensive Income [Abstract]
Net income	$ (529)	$ 1,649	$ 1,314
Change in net unrealized gains (losses) on cash flow hedges:
Net unrealized gains arising during the period	65	48	15
(Gains) losses reclassified into earnings	(13)	21	(9)
Net change	52	69	6
Change in unrealized components of post-retirement plans:
Net unrealized gains arising during the period	11	6	1
(Gains) losses reclassified into earnings	(1)	2	3
Net change	(10)	(8)	(4)
Foreign currency translation adjustments	0	0	15
Total other comprehensive income, net of tax	62	77	25
Comprehensive (loss) income	$ (467)	$ 1,726	$ 1,339

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
OPERATING ACTIVITIES
Net income	$ (529)	$ 1,649	$ 1,314
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	513	451	397
Share-based compensation	115	145	112
Net (gain) loss on redemption and repurchase of debt	(204)	0	1
Deferred income taxes	10	(9)	(4)
Other non-cash operating activities, net	(125)	64	(50)
Changes in operating assets and liabilities:
Accounts receivable, net	911	(374)	(42)
Inventories	425	(361)	(64)
Accounts payable	(421)	228	(14)
Accrued employee compensation	(152)	(30)	58
Accrued expenses, income taxes and warranty	101	(26)	(38)
Other assets and liabilities	298	(80)	(44)
Net cash provided by operating activities	942	1,657	1,626
INVESTING ACTIVITIES
Acquisition of property, equipment and leasehold improvements	(316)	(381)	(498)
Proceeds from the sale of assets	534	0	4
Purchases of investments	(1)	(18)	(4)
Proceeds from sale of investments	0	47	29
Maturities of short-term investments	0	0	3
Net cash provided by (used in) investing activities	217	(352)	(466)
FINANCING ACTIVITIES
Redemption and repurchase of debt	(1,578)	(701)	(33)
Dividends to shareholders	(582)	(610)	(649)
Repurchases of ordinary shares	(408)	(1,799)	(2,047)
Taxes paid related to net share settlement of equity awards	(44)	(51)	(33)
Proceeds from issuance of long-term debt	1,600	1,200	1,000
Proceeds from issuance of ordinary shares under employee stock plans	68	68	108
Other financing activities, net	(44)	(6)	(19)
Net cash used in financing activities	(988)	(1,899)	(1,673)
Increase (decrease) in cash, cash equivalents and restricted cash	171	(594)	(513)
Cash, cash equivalents and restricted cash at the beginning of the year	617	1,211	1,724
Cash, cash equivalents and restricted cash at the end of the year	788	617	1,211
Supplemental Disclosure of Cash Flow Information
Cash paid for interest	327	244	184
Cash paid for income taxes, net of refunds	$ 32	$ 33	$ 44

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) shares in Millions, $ in Millions	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit
Starting Balance (in shares) at Jul. 03, 2020		257
Total Seagate Technology plc Shareholders' Equity, Starting Balance at Jul. 03, 2020	$ 1,787	$ 0	$ 6,757	$ (66)	$ (4,904)
Increase (Decrease) in Stockholders' Equity
Net income	1,314				1,314
Other comprehensive loss	25			25
Issuance of ordinary shares under employee stock plans (in shares)		4
Issuance of ordinary shares under employee stock plans	108		108
Repurchases of shares (in shares)		(33)
Repurchases of shares	$ (2,047)				(2,047)
Tax withholding related to vesting of restricted stock units (in shares)	(1)	(1)
Tax withholding related to vesting of restricted share units	$ (33)				(33)
Dividends to shareholders ($2.66 per ordinary share)	(635)				(635)
Share-based compensation	112		112
Ending Balance (in shares) at Jul. 02, 2021		227
Total Seagate Technology plc Shareholders' Equity, Ending Balance at Jul. 02, 2021	$ 631	$ 0	6,977	(41)	(6,305)
Increase (Decrease) in Stockholders' Equity
Common stock, dividends, per share, declared	$ 2.66
Net income	$ 1,649				1,649
Other comprehensive loss	77			77
Issuance of ordinary shares under employee stock plans (in shares)		4
Issuance of ordinary shares under employee stock plans	68		68
Repurchases of shares (in shares)		(20)
Repurchases of shares	$ (1,806)				(1,806)
Tax withholding related to vesting of restricted stock units (in shares)	(1)	(1)
Tax withholding related to vesting of restricted share units	$ (51)				(51)
Dividends to shareholders ($2.66 per ordinary share)	(604)				(604)
Share-based compensation	145		145
Ending Balance (in shares) at Jul. 01, 2022		210
Total Seagate Technology plc Shareholders' Equity, Ending Balance at Jul. 01, 2022	$ 109	$ 0	7,190	36	(7,117)
Increase (Decrease) in Stockholders' Equity
Common stock, dividends, per share, declared	$ 2.77
Net income	$ (529)				(529)
Other comprehensive loss	62			62
Issuance of ordinary shares under employee stock plans (in shares)		3
Issuance of ordinary shares under employee stock plans	68		68
Repurchases of shares (in shares)		(5)
Repurchases of shares	$ (400)				(400)
Tax withholding related to vesting of restricted stock units (in shares)	(1)	(1)
Tax withholding related to vesting of restricted share units	$ (44)				(44)
Dividends to shareholders ($2.66 per ordinary share)	(580)				(580)
Share-based compensation	115		115
Ending Balance (in shares) at Jun. 30, 2023		207
Total Seagate Technology plc Shareholders' Equity, Ending Balance at Jun. 30, 2023	$ (1,199)	$ 0	$ 7,373	$ 98	$ (8,670)
Increase (Decrease) in Stockholders' Equity
Common stock, dividends, per share, declared	$ 2.80

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Organization Seagate Technology Holdings plc (“STX”) and its subsidiaries (collectively, unless the context otherwise indicates, the “Company”) is a leading provider of data storage technology and infrastructure solutions. Its principal products are hard disk drives, commonly referred to as disk drives, hard drives or HDDs. In addition to HDDs, the Company produces a broad range of data storage products including solid state drives (“SSDs”), storage subsystem, as well as a scalable edge-to-cloud mass data platform that includes data transfer shuttles and a storage-as-a-service cloud. On May 18, 2021, Seagate Technology plc, now known as Seagate Technology Unlimited Company (“STUC”), and STX completed a scheme of arrangement pursuant to which STUC’s ordinary shares were acquired by STX and the ordinary shareholders of STUC received, on a one-for-one basis, new ordinary shares of STX (the “Scheme”). As a result of the Scheme, STUC is now a direct, wholly-owned subsidiary of STX, which is the successor issuer to STUC. In connection with the Scheme, STX assumed STUC’s existing obligations in connection with awards granted under STUC’s incentive plans and other similar employee awards and amended such plans and awards as necessary to provide for the issuance of STX’s registered shares rather than the ordinary shares of STUC upon the exercise or vesting of awards . Basis of Presentation and Consolidation The Company’s consolidated financial statements include the accounts of the Company and all its wholly-owned and majority-owned subsidiaries, after elimination of intercompany transactions and balances. The preparation of financial statements in accordance with the United States (“U.S.”) generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company’s consolidated financial statements and accompanying notes. These estimates and assumptions include the impact of the COVID-19 pandemic. Actual results could differ materially from those estimates. The methods, estimates and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results the Company reports in its consolidated financial statements. Fiscal Year The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the Friday closest to June 30. Fiscal years 2023, 2022 and 2021 are comprised of 52 weeks and ended on June 30, 2023, July 1, 2022 and July 2, 2021, respectively. All references to years in these Notes to Consolidated Financial Statements represent fiscal years unless otherwise noted. Fiscal year 2026 will also be comprised of 53 weeks and will end on July 3, 2026. Summary of Significant Accounting Policies Cash and Cash Equivalents. The Company considers all highly liquid investments with a remaining maturity of 90 days or less at the time of purchase to be cash equivalents. The Company’s highly liquid investments are primarily comprised of money market funds, time deposits and certificates of deposits. The Company has classified its marketable debt securities as available-for-sale and they are stated at fair value with unrealized gains and losses included in Accumulated other comprehensive income, which is a component of Shareholders’ (Deficit) Equity. The Company evaluates the available-for-sale debt securities in an unrealized loss position for other-than-temporary impairment. Realized gains and losses are included in Other, net on the Company’s Consolidated Statements of Operations. The cost of securities sold is based on the specific identification method. Other cash equivalents are carried at cost, which approximates fair value. Restricted Cash and Cash Equivalents. Restricted cash and cash equivalents represent cash and cash equivalents that are restricted as to withdrawal or use for other than current operations. Allowance for expected credit loss. The Company maintains an allowance for expected credit loss relating to its accounts receivable based upon expected collectability. This reserve is established based upon historical trends, global macroeconomic conditions, reasonable and supportable forecasts of future conditions and an analysis of specific exposures. The provision for expected credit loss is recorded as a charge to Marketing and administrative expense on the Company’s Consolidated Statements of Operations. Inventories. Inventories are valued at the lower of cost (using the first-in, first-out method) and net realizable value. Net realizable value is based upon the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Adjustments to reduce cost of inventories to its net realizable value are made, if required, for estimated excess or obsolescence determined primarily by future demand forecasts. Property, Equipment and Leasehold Improvements. Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Equipment and buildings are depreciated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated life of the asset or the remaining term of the lease. The costs of additions and substantial improvements to property, equipment and leasehold improvements, which extend the economic life of the underlying assets, are capitalized. The cost of maintenance and repairs to property, equipment and leasehold improvements is expensed as incurred. Goodwill. The Company performs a qualitative assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist, to determine if any events or circumstances exist, such as an adverse change in business climate or a decline in the overall industry that would indicate that it would more likely than not reduce the fair value of a reporting unit below its carrying amount, including goodwill. If it is determined in the qualitative assessment that the fair value of a reporting unit is more likely than not below its carrying amount, including goodwill, then the Company will perform a quantitative impairment test. The quantitative goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Any excess in the carrying value of a reporting unit over its fair value is recognized as an impairment loss, limited to the total amount of goodwill allocated to that reporting unit. Other Long-lived Assets. The Company tests other long-lived assets, including property, equipment and leasehold improvements and other intangible assets subject to amortization, for recoverability whenever events or changes in circumstances indicate that the carrying value of those assets may not be recoverable. The Company performs a recoverability test to assess the recoverability of an asset group. If the recoverability test indicates that the carrying value of the asset group is not recoverable, the Company will estimate the fair value of the asset group and the excess of the carrying value over the fair value is allocated pro rata to derive the adjusted carrying value of assets in the asset group. The adjusted carrying value of each asset in the asset group is not reduced below its fair value. The Company tests other intangible assets not subject to amortization whenever events occur or circumstances change, such as declining financial performance, deterioration in the environment in which the entity operates or deteriorating macroeconomic conditions that have a negative effect on future expected earnings and cash flows that could affect significant inputs used to determine the fair value of the indefinite-lived intangible asset. Assets Held for Sale. The Company classifies its long-lived assets to be sold as held for sale in the period (i) it has approved and committed to a plan to sell the asset, (ii) the asset is available for immediate sale in its present condition, (iii) an active program to locate a buyer and other actions required to sell the asset have been initiated, (iv) the sale of the asset is probable, (v) the asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. The Company initially measures a long-lived asset that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset until the date of sale. Upon designation as an asset held for sale, the Company stops recording depreciation expense on the asset. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale. Leases. The Company determines if an arrangement is a lease or contains a lease at inception. Right-of-use (“ROU”) assets are included in Other assets, net and lease liabilities are included in Accrued expenses and Other non-current liabilities on the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and the corresponding lease liabilities represent its obligation to make lease payments arising from the lease. The Company combines lease and non-lease components for facility leases and does not recognize ROU assets and lease liabilities for leases with an initial term of 12 months or less on the consolidated balance sheets. Lease liabilities are measured at the present value of the remaining lease payments and ROU assets are based on the lease liability, adjusted for lease prepayments, lease incentives received and the lessee’s initial direct costs. For the Company’s leases that do not provide an implicit rate, the net present value of future minimum lease payments is determined using the Company’s estimated incremental borrowing rate based on the information available at the lease commencement date. Additionally, the Company’s lease term may include options to extend or terminate the lease. These options are reflected in the ROU asset and lease liability when it is reasonably certain that the Company will exercise the option. The Company’s lease agreements do not contain any material residual value guarantees. The Company recognizes lease expense on a straight-line basis over the lease term. Variable lease payments not dependent on an index or a rate primarily consist of common area maintenance charges, are expensed as incurred, and are not included in the ROU asset and lease liability calculation. The total operating and variable lease costs were included in operating expenses in the Company’s Consolidated Statements of Operations. Derivative Financial Instruments. The Company records all derivatives on the balance sheet at fair value and establishes criteria for designation and effectiveness of hedging relationships. The Company excludes the change in forward points from the assessment of hedge effectiveness and recognizes the excluded component in Other, net in the Consolidated Statements of Operations. Foreign currency forward exchange contracts not designated as hedge instruments are used to economically hedge the foreign currency exposure on forecasted expenditures in currencies other than U.S. dollar. The Company recognizes the unrealized gains and losses due to the changes in the fair value of these contracts, as well as the related costs in Other, net in the Consolidated Statements of Operations. Warranty. The Company estimates probable product warranty costs at the time revenue is recognized. The Company generally provides warranty on its products for a period of 1 to 5 years. The Company's warranty provision considers estimated product failure rates, trends (including the timing of product returns during the warranty periods), and estimated repair or replacement costs related to product quality issues, if any. The Company also exercises judgement in estimating its ability to sell refurbished products. Revenue Recognition and Sales Incentive Programs. The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, the Company satisfies a performance obligation. Revenue from sales of products is generally recognized upon transfer of control to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products, net of sales taxes. This typically occurs upon shipment from the Company. When applicable, the Company includes shipping charges billed to customers in Revenue and includes the related shipping costs in Cost of revenue on the Company's Consolidated Statements of Operations. The Company records estimated variable consideration at the time of revenue recognition as a reduction to revenue. Variable consideration generally consists of sales incentive programs, such as price protection and volume incentives aimed at increasing customer demand. For original equipment manufacturers (“OEMs”) sales, rebates are typically established by estimating the most likely amount of consideration expected to be received based on an OEM customer’s volume of purchases from the Company or other agreed upon rebate programs. For the distribution and retail channel, these programs typically involve estimating the most likely amount of rebates related to a customer’s level of sales, order size, advertising or point of sale activity as well as the expected value of price protection adjustments based on historical analysis and forecasted pricing environment. Marketing development program costs are accrued and recorded as a reduction to revenue at the same time that the related revenue is recognized. The Company expenses sales commissions as incurred because the amortization period would have been one year or less. These costs are recorded as Marketing and administrative on the Company’s Consolidated Statements of Operations. Restructuring Costs. The timing of recognition for severance costs depends on whether employees are required to render service until they are terminated in order to receive the termination benefits. If employees are required to render service until they are terminated in order to receive the termination benefits, a liability is recognized ratably over the future service period. Otherwise, a liability is recognized when management has committed to a restructuring plan and has communicated those actions to employees. Employee termination benefit costs covered by existing benefit arrangements are recognized when management has committed to a restructuring plan and the severance costs are probable and estimable. Advertising Expense. The cost of advertising is expensed as incurred. Advertising costs were approximately $30 million, $34 million and $29 million in fiscal years 2023, 2022 and 2021, respectively. Share-Based Compensation. The Company accounts for share-based compensation net of estimated forfeitures. Refer to Note 11. Share-Based Compensation for details. Accounting for Income Taxes . The Company records a provision or benefit for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Deferred income tax expense or benefit is recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases as well as net operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance for any tax benefits for which future realization is uncertain. Equity Investments. From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under equity method or the measurement alternative. These investments are included in Other assets, net in the Company's Consolidated Balance Sheets and are adjusted through Other, net in the Consolidated Statement of Operations. Investments are accounted for under the equity method if the Company has the ability to exercise significant influence, but does not have a controlling financial interest. These investments are measured at cost, less any impairment plus the Company's portion of investee’s income or loss. The Company uses the financial statements of investees to determine any adjustments, which are received on a one-quarter lag. For equity investments where the Company does not have the ability to exercise significant influence and there are no readily determinable fair values, the Company has elected to apply the measurement alternative, under which investments are measured at cost, less impairment, and adjusted for qualifying observable price changes on a prospective basis. The Company’s strategic investments are periodically analyzed to determine whether or not there are indicators of impairment by assessing factors such as deterioration of earnings, adverse change in market/industry conditions, the ability to operate as a going concern, and other factors which indicate that the carrying amount of the investment might not be recoverable. In such a case, the decrease in value is recognized in the period the impairment occurs in the Consolidated Statements of Operations. Comprehensive Income. The Company presents comprehensive income in a separate statement. Comprehensive income is comprised of net income and other gains and losses affecting equity that are excluded from net income. Foreign Currency Remeasurement and Translation. The U.S. dollar is the functional currency for the majority of the Company's foreign operations. Monetary assets and liabilities denominated in foreign currencies are remeasured into the functional currency of the subsidiary at the balance sheet date. The gains and losses from the remeasurement of foreign currency denominated balances into the functional currency of the subsidiary are included in Other, net on the Company's Consolidated Statements of Operations. The Company’s subsidiaries that use the U.S. dollar as their functional currency remeasure monetary assets and liabilities at exchange rates in effect at the end of each period, and nonmonetary assets and liabilities at historical rates. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized in foreign currency translation included in Accumulated other comprehensive income, which is a component of Shareholders’ (Deficit) Equity. Government Incentives. The Company enters into government incentive arrangements with domestic and foreign, local, regional and national governments, which vary in size, duration and conditions. The Company receives primarily operating grants, which are recognized as a reduction of expenditures when there is reasonable assurance that the grant will be received and the Company will comply with the conditions specified in the grant agreement. In fiscal year 2023, approximately $13 million of operating grants were recognized as reductions to Cost of revenue and Product development in the Consolidated Statements of Operations. The Company also received advanced cash grants of $13 million, which were reflected within Accrued expenses in the Company's Consolidated Balance Sheets as of June 30, 2023. Concentrations Concentration of Credit Risk. The Company’s customer base is concentrated with a small number of customers. The Company does not generally require collateral or other security to support accounts receivable. To reduce credit risk, the Company performs ongoing credit evaluations on its customers’ financial condition. The Company establishes allowances for expected credit losses based upon factors surrounding the credit risk of customers, global macroeconomic conditions and an analysis of specific exposures. Two customers and one customer accounted for more than 10% of the Company’s accounts receivable as of June 30, 2023 and July 1, 2022, respectively. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, investments and foreign currency forward exchange contracts. The Company mitigates concentrations of credit risk in its financial instruments through diversification, by investing in highly-rated securities and/or major multinational companies. In entering into foreign currency forward exchange contracts, the Company assumes the risk that might arise from the possible inability of counterparties to meet the terms of their contracts. The counterparties to these contracts are major multinational commercial and investment banks, and the Company has not incurred and does not expect any losses as a result of counterparty defaults. Supplier Concentration. Certain of the raw materials, components and equipment used by the Company in the manufacture of its products are available from single-sourced direct and indirect vendors. Shortages could occur in these essential materials and components due to an interruption of supply or increased demand in the industry. If the Company were unable to procure certain materials, components or equipment at all or acceptable prices, it would be required to reduce its manufacturing operations, which could have a material adverse effect on its results of operations. In addition, the Company may make prepayments to certain suppliers or enter into minimum volume commitment agreements. Should these suppliers be unable to deliver on their obligations or experience financial difficulty, the Company may not be able to recover these prepayments. Recently Adopted Accounting Pronouncements In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04 (ASC Topic 848), Reference Rate Reform . This ASU provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. In December 2022, FASB issued ASU 2022-06 (ASC Topic 848) and deferred the sunset date from December 31, 2022 to December 31, 2024. The Company adopted the guidance in the quarter ended September 30, 2022 on a prospective basis and is transitioning from an interest rate based on London Interbank Offered Rate (“LIBOR”) to Secured Overnight Financing Rate (“SOFR”). The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements. In November 2021, the FASB issued ASU 2021-10 (ASC Topic 832), Disclosures by Business Entities about Government Assistance . This ASU requires annual disclosures that increase the transparency of transactions involving government grants, including (1) the type of transactions, (2) the accounting for those transactions and (3) the effect of those transactions on an entity’s financial statements. The Company adopted this guidance for the fiscal year ended June 30, 2023 on a prospective basis. See “Government Incentives” for further details. Recently Issued Accounting Pronouncements In September 2022, the FASB issued ASU 2022-04 (ASC Subtopic 405-50), Disclosure of Supplier Finance Program Obligations . This ASU requires disclosure of key terms of the outstanding supplier finance programs and a roll forward of the related obligations. The Company will adopt this in the first quarter of fiscal year 2024 and provide additional disclosure. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements. In June 2022, the FASB issued ASU 2022-03 (ASC Topic 820), Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions

Balance Sheet Information

Balance Sheet Information	12 Months Ended
	Jun. 30, 2023
Disclosure Text Block Supplement [Abstract]
Balance Sheet Information	Balance Sheet Information Available-for-sale Debt Securities The following table summarizes, by major type, the fair value and amortized cost of the Company’s available-for-sale debt investments as of June 30, 2023 and July 1, 2022: June 30, July 1, (Dollars in millions) Amortized Unrealized Fair Amortized Unrealized Fair Available-for-sale debt securities: Money market funds $ 73 $ — $ 73 $ 60 $ — $ 60 Time deposits and certificates of deposit 1 — 1 1 — 1 Other debt securities 16 — 16 23 — 23 Total $ 90 $ — $ 90 $ 84 $ — $ 84 Included in Cash and cash equivalents $ 72 $ 59 Included in Other current assets 2 2 Included in Other assets, net 16 23 Total $ 90 $ 84 As of June 30, 2023 and July 1, 2022, the Company’s Other current assets included $2 million in restricted cash equivalents held as collateral at banks for various performance obligations. As of June 30, 2023 and July 1, 2022, the Company had no material available-for-sale debt securities that had been in a continuous unrealized loss position for a period greater than 12 months. The Company determined no impairment related to credit losses for available-for-sale debt securities as of June 30, 2023. During fiscal year 2022, the Company recorded a $13 million impairment loss relating to available-for-sale debt securities. The fair value and amortized cost of the Company’s investments classified as available-for-sale debt securities as of June 30, 2023, by remaining contractual maturity were as follows: (Dollars in millions) Amortized Fair Due in less than 1 year $ 74 $ 74 Due in 1 to 5 years 15 15 Due in 6 to 10 years — — Thereafter 1 1 Total $ 90 $ 90 Cash, Cash Equivalents and Restricted Cash The following table provides a summary of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets that reconciles to the corresponding amount in the Consolidated Statements of Cash Flows: (Dollars in millions) June 30, July 1, July 2, Cash and cash equivalents $ 786 $ 615 $ 1,209 Restricted cash included in Other current assets 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 788 $ 617 $ 1,211 Accounts Receivable, net The following table provides details of the accounts receivable, net balance sheet item: (Dollars in millions) June 30, July 1, Accounts receivable $ 625 $ 1,536 Allowances for expected credit losses (4) (4) Account receivable, net $ 621 $ 1,532 Activity in the expected credit losses accounts is as follows: (Dollars in millions) Balance at Beginning of Period Charges (Credit) to Operations Deductions (1) Balance at End of Period Fiscal year ended July 2, 2021 $ 5 — (1) $ 4 Fiscal year ended July 1, 2022 $ 4 — — $ 4 Fiscal year ended June 30, 2023 $ 4 — — $ 4 ______________________________________________ (1) Uncollectible accounts written off, net of recoveries. In connection with the Company’s factoring agreements, from time to time the Company sells trade receivables to third parties for cash proceeds less a discount. During fiscal year 2023, the Company sold trade receivables without recourse for cash proceeds of $876 million, of which $275 million remained subject to servicing by the Company as of June 30, 2023. During fiscal year 2022, the Company sold trade receivables without recourse for cash proceeds of $275 million, of which $200 million remained subject to servicing by the Company as of July 1, 2022. The discounts on trade receivables sold were $11 million for fiscal year 2023 and immaterial for fiscal years 2022 and 2021, respectively. Inventories The following table provides details of the inventory balance sheet item: (Dollars in millions) June 30, July 1, Raw materials and components $ 241 $ 283 Work-in-process 682 716 Finished goods 217 566 Total inventories $ 1,140 $ 1,565 The Company reclassified certain Raw materials and components to Work-in-process as of July 1, 2022 in the table above to conform to the current year’s presentation. The reclassification did not result in any change to the total inventories balance as reported in the Consolidated Balance Sheets and Statements of Cash Flows for all periods presented. Other Current Assets The following table provides details of the other current assets balance sheet item: (Dollars in millions) June 30, July 1, Vendor receivables $ 167 $ 83 Other current assets 191 238 Total $ 358 $ 321 Property, Equipment and Leasehold Improvements, net The components of property, equipment and leasehold improvements, net were as follows: (Dollars in millions) Useful Life in Years June 30, July 1, Land and land improvements $ 21 $ 47 Equipment 3 – 7 8,504 8,473 Buildings and leasehold improvements Up to 30 1,435 1,893 Construction in progress 307 246 10,267 10,659 Less: accumulated depreciation and amortization (8,561) (8,420) Property, equipment and leasehold improvements, net $ 1,706 $ 2,239 Depreciation expense, which includes amortization of leasehold improvements, was $504 million, $431 million and $368 million for fiscal years 2023, 2022 and 2021, respectively. In fiscal year 2023, the Company recognized a charge of $85 million for the accelerated depreciation of certain fixed assets, of which $60 million and $25 million was recorded to Cost of revenue and Operating expense, respectively, in the Consolidated Statement of Operations. In fiscal years 2022 and 2021, the accelerated depreciation charge recognized was immaterial. Interest on borrowings related to eligible capital expenditures is capitalized as part of the cost of the qualified assets and amortized over the estimated useful lives of the assets. During fiscal years 2023, 2022 and 2021, the Company capitalized interest of $8 million, $3 million and $5 million, respectively. Accrued Expenses The following table provides details of the accrued expenses balance sheet item: (Dollars in millions) June 30, July 1, Dividends payable $ 145 $ 147 Other accrued expenses 603 449 Total $ 748 $ 596 Accumulated Other Comprehensive Income (Loss) (“AOCI”) The components of AOCI, net of tax, were as follows: (Dollars in millions) Unrealized Gains/(Losses) on Cash Flow Hedges Unrealized Gains/(Losses) on Post-Retirement Plans Foreign Currency Translation Adjustments Total Balance at July 2, 2021 $ (18) $ (22) $ (1) $ (41) Other comprehensive income before reclassifications 48 6 — 54 Amounts reclassified from AOCI 21 2 — 23 Other comprehensive income 69 8 — 77 Balance at July 1, 2022 51 (14) (1) 36 Other comprehensive income before reclassifications 65 11 — 76 Amounts reclassified from AOCI (13) (1) — (14) Other comprehensive income 52 10 — 62 Balance at June 30, 2023 $ 103 $ (4) $ (1) $ 98

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	12 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The carrying amount of goodwill was $1,237 million as of June 30, 2023 and July 1, 2022. There were no additions to, disposals of, impairments of or translation adjustments to goodwill in fiscal years 2023, 2022 and 2021. Other Intangible Assets Other intangible assets consist primarily of existing technology, customer relationships and trade names acquired in business combinations. Intangibles are amortized on a straight-line basis over the respective estimated useful lives of the assets. Amortization is charged to Operating expenses in the Consolidated Statements of Operations. In fiscal years 2023, 2022 and 2021, amortization expense for other intangible assets was $9 million, $20 million and $29 million, respectively. The carrying value of other intangible assets subject to amortization, excluding fully amortized intangible assets, as of June 30, 2023, is set forth in the following table: (Dollars in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Existing technology $ 10 $ (10) $ — 0.1 Year Total amortizable other intangible assets $ 10 $ (10) $ — 0.1 Year The carrying value of other intangible assets subject to amortization, excluding fully amortized intangible assets, as of July 1, 2022 is set forth in the following table: (Dollars in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Existing technology $ 29 $ (24) $ 5 1.0 Year Customer relationships 71 (68) 3 0.2 Year Other intangible assets 8 (7) 1 0.8 Year Total amortizable other intangible assets $ 108 $ (99) $ 9 0.8 Year

Debt

Debt	12 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Debt	Debt The following table provides details of the Company’s debt as of June 30, 2023 and July 1, 2022: (Dollars in millions) June 30, July 1, Unsecured Senior Notes (1) $1,000 issued on May 22, 2013 at 4.75% due June 1, 2023 (the “2023 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. $ — $ 540 $500 issued on February 3, 2017 at 4.875% due March 1, 2024 (the “2024 Notes”) , interest payable semi-annually on March 1 and September 1 of each year. — 499 $1,000 issued on May 28, 2014 at 4.75% due January 1, 2025 (the “2025 Notes”) , interest payable semi-annually on January 1 and July 1 of each year. 479 479 $700 issued on May 14, 2015 at 4.875% due June 1, 2027 (the “2027 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 504 504 $500 issued on June 18, 2020 at 4.091% due June 1, 2029 (the “June 2029 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 465 466 $500 issued on December 8, 2020 at 3.125% due July 15, 2029 (the “July 2029 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 163 500 $500 issued on May 30, 2023 at 8.25% due December 15, 2029 ( the “December 2029 Notes” ), interest payable semi-annually on June 15 and December 15 of each year. 500 — $500 issued on June 10, 2020 at 4.125% due January 15, 2031 (the “January 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 275 500 $500 issued on December 8, 2020 at 3.375% due July 15, 2031 (the “July 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 72 500 $500 issued on May 30, 2023 at 8.50% due July 15, 2031 ( the “8.50% July 2031 Notes” ), interest payable semi-annually on January 15 and July 15 of each year. 500 — $750 issued on November 30, 2022 at 9.625% due December 1, 2032 (the “2032 Notes”), interest payable semi-annually on June 1 and December 1 of each year. 750 — $500 issued on December 2, 2014 at 5.75% due December 1, 2034 (the “2034 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 489 489 Term Loan $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.125% to 2.375%, ( the “Term Loan A1”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of September 16, 2025. 430 600 $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A2”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. 430 600 $600 borrowed on August 18, 2022 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A3 ”), repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. 430 — 5,487 5,677 Less: unamortized debt issuance costs (36) (31) Debt, net of debt issuance costs 5,451 5,646 Less: current portion of long-term debt (63) (584) Long-term debt, less current portion $ 5,388 $ 5,062 ___________________________________ (1 ) All unsecured senior notes are issued by Seagate HDD Cayman (“Seagate HDD”), and the obligations under these notes are fully and unconditionally guaranteed, on a senior unsecured basis, by Seagate Technology Unlimited Company (“STUC”) and STX . Debt Exchange 2032 Notes. On November 30, 2022, Seagate HDD issued, in a private placement, $750 million in aggregate principal amount of 9.625% Senior Notes due on December 1, 2032, in connection with Seagate HDD’s exchange offers to certain eligible holders of Seagate HDD’s outstanding existing senior notes as set forth below: (Dollars in millions) Existing Notes Principal Amount Outstanding Principal Amount Exchanged July 2031 Notes $ 500 $ 423 July 2029 Notes 500 336 January 2031 Notes 500 205 Total $ 1,500 $ 964 The exchange was accounted for as a debt extinguishment and the Company recorded a net gain of $204 million, which was included in Net gain recognized from early redemption of debt in the Company’s Consolidated Statements of Operations for fiscal year 2023. At any time prior to December 1, 2027, Seagate HDD may redeem the 2032 Notes at its option, in whole or in part, at any time and from time to time, at a “make-whole” redemption price. The “make-whole” redemption price will be equal to the greater of: (1) (a) the sum of the present values at such redemption date of the redemption price of the 2032 Notes that would apply if the new 2032 Notes were redeemed on December 1, 2027 plus the remaining scheduled payments of interest thereon to and including December 1, 2027 discounted to the redemption date on a semi-annual basis at the Treasury Rate plus 50 basis points less (b) interest accrued to the date of redemption, and (2) 100% of the principal amount of the 2032 Notes to be redeemed plus, in either case, accrued and unpaid interest thereon, if any, to, but excluding, the redemption date. At any time on or after December 1, 2027, Seagate HDD may redeem some or all of the 2032 Notes at the prices specified in the Indenture, plus accrued and unpaid interest to, but excluding, the redemption date. In addition, Seagate HDD may redeem with the net cash proceeds from one or more equity offerings up to 40% of the 2032 Notes before December 1, 2025, at a redemption price of 109.625% plus accrued and unpaid interest to, but excluding, the redemption date. December 2029 Notes. On May 30, 2023, Seagate HDD Cayman issued, in a private placement, $500 million in aggregate principal amount of 8.25% Senior Notes which will mature on December 15, 2029. The interest on the December 2029 Notes is payable semi-annually on June 15 and December 15 of each year, commencing on December 15, 2023 . 8.50% July 2031 Notes. On May 30, 2023, Seagate HDD Cayman issued, in a private placement, $500 million in aggregate principal amount of 8.50% Senior Notes which will mature on July 15, 2031. The interest on the July 2031 Notes is payable semi-annually on January 15 and July 15 of each year, commencing on January 15, 2024 . In connection with the issuance of the December 2029 and 8.50% July 2031 Notes, the entire outstanding principal amount of the 2024 Notes and $450 million principal amount of the Term Loans were repaid. The exchange was accounted for as a debt extinguishment and the Company recorded a net loss of $17 million, which was included in Net gain recognized from early redemption of debt in the Company’s Consolidated Statements of Operations for fiscal year 2023. At any time before July 15, 2026, Seagate HDD may redeem the December 2029 or 8.50% July 2031 Notes of either series at its option, in whole or in part, at any time and from time to time, at a “make-whole” redemption price. The “make-whole” redemption price will be equal to the greater of: (1)(a) the sum of the present values at such redemption date of the redemption price of the applicable series of Notes that would apply if such series of Notes were redeemed on July 15, 2026 (at the price specified in the applicable Indenture) plus the remaining scheduled payments of interest thereon to, and including, July 15, 2026 discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) using a discount rate equal to the Treasury Rate (as defined in the applicable Indenture) as of such redemption date; plus 50 basis points less (b) interest accrued to the date of redemption, and (2) 100% of the principal amount of such series of Notes to be redeemed plus, in either case, accrued and unpaid interest thereon, if any, to, but excluding, the redemption date. At any time on or after July 15, 2026, Seagate HDD may, at its option, redeem some or all of the Notes of either series at the prices specified in the applicable Indenture, plus accrued and unpaid interest thereon, if any, to, but excluding, the redemption date. In addition, Seagate HDD may redeem with the net cash proceeds from one or more equity offerings up to 40% of the outstanding principal amount of each series of Notes at any time prior to July 15, 2026, at a redemption price of 108.25%, in the case of the 2029 Notes, and a redemption price of 108.50%, in the case of the 2031 Notes, plus, in each case, accrued and unpaid interest to, but excluding, the redemption date. Debt Repurchases In February 2023, $20 million principal amount of the January 2031 Notes, $5 million principal amount of the June 2029 Notes, and $5 million principal amount of the July 2031 Notes were repurchased for cash at a discount to their principal amounts, plus accrued and unpaid interest. The Company recorded a gain of $3 million on these repurchases during fiscal year 2023, which was included in Net gain recognized from early redemption of debt in the Company’s Consolidated statements of Operations. Credit Agreement The Company’s subsidiary, Seagate HDD Cayman, entered into a credit agreement on February 20, 2019, which was amended on May 28, 2019, September 16, 2019, January 13, 2021, May 18, 2021, October 14, 2021, August 18, 2022, November 8, 2022, May 19, 2023 and June 26, 2023 (the “Credit Agreement”). On August 18, 2022, Seagate Technology Holdings plc and Seagate HDD (the “Borrower”) entered into an amendment to its Credit Agreement (the “Sixth Amendment”), which provided for a new Term Loan facility in the aggregate principal amount of $600 million (“Term Loan A3”). Term Loan A3 was borrowed in full at the closing of the Sixth Amendment. The Sixth Amendment to the Credit Agreement also replaced the LIBOR interest rates plus variable margin for the Term Loans A1 and A2 with the SOFR interest rates plus a variable margin that will be determined based on the corporate credit rating of the Borrower or one of its parent entities. The Sixth Amendment also permits the Borrower to increase the revolving loan commitments or obtain new Term Loans of up to $100 million in aggregate (the “Incremental facility”), subject to the satisfaction of certain terms and conditions. On November 8, 2022, the Borrower entered into the seventh amendment to its Credit Agreement to increase the maximum permitted total leverage ratio the Company must comply with during the covenant relief period that ends on June 28, 2024 and prohibit the Company from pursuing the use of the Incremental Facility during the covenant relief period. The maximum permitted total leverage ratio is 5.0 to 1.0 from the fiscal quarters ending December 30, 2022 to June 30, 2023. For the fiscal quarter ending September 29, 2023, the maximum permitted total leverage ratio is 4.75 to 1.0 and then steps down to 4.5 to 1.0 from the fiscal quarters ending December 29, 2023 to June 28, 2024. The maximum permitted leverage ratio will return to 4.0 to 1.0 for any fiscal quarter ending after June 28, 2024. On May 19, 2023, the Borrower entered into the eight amendment to its Credit Agreement (the “Eighth Amendment”) to replace the total leverage ratio with a new total net leverage ratio during the covenant relief period which terminates on June 27, 2025. The maximum total net leverage ratio is 6.75 to 1.00 beginning with the fiscal quarter ending June 30, 2023, with periodic step downs during the covenant relief period, shifting to a maximum total leverage ratio of 4.0 to 1.0 for any fiscal quarter ending at any time other than during the covenant relief period. The minimum interest coverage ratio is 2.50 to 1.0 beginning with the fiscal quarter ending June 30, 2023, with periodic step downs and step ups during the covenant relief period, returning to a minimum interest coverage ratio of 3.25 to 1.0 for any fiscal quarter ending after June 28, 2024. The Eight Amendment also reduced the Revolving Credit Facility to $1.5 billion. On June 26, 2023, the Borrower entered into the ninth amendment to its Credit Agreement to, among other things, modify the repayment schedules of the Term Loans to reflect the $450 million pay down of the Term Loans. As of June 30, 2023, no borrowings (including Swingline loans) were outstanding and no commitments were utilized for letters of credit issued under the Revolving Credit Facility. STX and certain of its material subsidiaries, including STUC, fully and unconditionally guarantee both the Revolving Credit Facility and the Term Loans. The Credit Agreement includes three financial covenants: (1) interest coverage ratio, (2) leverage ratio and (3) a minimum liquidity amount. The Company was in compliance with the covenants as of June 30, 2023 and expects to be in compliance for the next 12 months. Future Principal Payments on Long-term Debt At June 30, 2023, future principal payments on long-term debt were as follows (in millions): Fiscal Year Amount 2024 $ 63 2025 582 2026 497 2027 612 2028 519 Thereafter 3,245 Total $ 5,518

Income Taxes

Income Taxes	12 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes (Loss) income before income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, U.S. $ 300 $ 145 $ 191 Non-U.S. (796) 1,534 1,157 $ (496) $ 1,679 $ 1,348 The provision for income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Current income tax expense: U.S. $ 6 $ 4 $ — Non-U.S. 17 35 38 Total Current 23 39 38 Deferred income tax expense/(benefit): U.S. 9 3 8 Non-U.S. 1 (12) (12) Total Deferred 10 (9) (4) Provision for income taxes $ 33 $ 30 $ 34 The significant components of the Company’s deferred tax assets and liabilities were as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, Deferred tax assets Accrued warranty $ 38 $ 34 Inventory carrying value adjustments 40 43 Receivable allowances 11 20 Accrued compensation and benefits 43 73 Capitalized research expenses 119 — Depreciation 40 45 Restructuring accruals 14 — Lease liabilities 62 5 Other accruals and deferred items 14 19 Net operating losses 542 671 Tax credit carryforwards 619 650 Other assets 1 1 Gross: Deferred tax assets 1,543 1,561 Less: Valuation allowance (370) (434) Net: Deferred tax assets 1,173 1,127 Deferred tax liabilities Unremitted earnings of certain non-U.S. entities (4) (5) Acquisition-related items (1) (2) Right-of-use assets (62) (5) Other liabilities (2) — Net: Deferred tax liabilities (69) (12) Total net deferred tax assets $ 1,104 $ 1,115 At June 30, 2023, the Company recorded $1.1 billion of net deferred tax assets. The realization of most of these deferred tax assets is primarily dependent on the Company’s ability to generate sufficient U.S. and certain non-Irish taxable income in future periods. Although realization is not assured, the Company’s management believes it is more likely than not that these deferred tax assets will be realized. The amount of deferred tax assets considered realizable, however, may increase or decrease in subsequent periods when the Company re-evaluates the underlying basis for its estimates of future U.S. and certain non-Irish taxable income. The deferred tax asset valuation allowance decreased by $64 million in fiscal year 2023, which primarily relates to the expiration of unutilized tax credit carryforwards. At June 30, 2023, the Company had U.S. and non-U.S. tax net operating loss carryforwards of approximately $3.6 billion and $391 million, respectively, which will expire at various dates beginning in fiscal year 2024, if not utilized. Net operating loss carryforwards of approximately $245 million are scheduled to expire in fiscal year 2024. At June 30, 2023, the Company had U.S. tax credit carryforwards of $739 million, of which $35 million are scheduled to expire at various dates in fiscal year 2024, if not utilized. As of June 30, 2023, approximately $150 million and $60 million of the Company’s total U.S. net operating loss and tax credit carryforwards, respectively, are subject to annual limitations ranging from $1 million to $45 million pursuant to U.S. tax law. For purposes of the reconciliation between the provision for income taxes at the statutory rate and the effective tax rate, the Irish statutory rate of 25% was applied as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, (Benefit) provision at statutory rate $ (124) $ 420 $ 337 Permanent differences 8 5 8 Valuation allowance (18) 7 (2) Effect of rates different than statutory 178 (371) (287) Research credit (18) (26) (27) Other individually immaterial items 7 (5) 5 Provision for income taxes $ 33 $ 30 $ 34 A substantial portion of the Company's operations in Singapore and Thailand operate under various tax incentive programs, which expire in whole or in part at various dates through 2033. Certain tax incentives may be extended if specific conditions are met. The net impact of these tax incentive programs was to decrease the Company’s net loss by approximately $14 million in fiscal year 2023 ($0.07 per share, basic), to increase the Company's net income by approximately $290 million in fiscal year 2022 ($1.29 per share, diluted) and to increase the Company’s net income by approximately $226 million in fiscal year 2021 ($0.92 per share, diluted). The Company analyzes the potential for deferred tax liabilities with respect to the accumulated earnings of foreign subsidiaries on an annual basis. The analysis focuses on the outside basis differences in the stock of the foreign subsidiaries as well as the withholding tax obligations those subsidiaries may have with respect to any distribution. The undistributed earnings for which taxes are not provided are permanently reinvested or can be repatriated without incremental tax liability. As of June 30, 2023 and July 1, 2022, the Company had approximately $116 million and $114 million, respectively, of unrecognized tax benefits excluding interest and penalties. These amounts, if recognized, would impact the effective tax rate subject to certain future valuation allowance offsets. The following table summarizes the activities related to the Company’s gross unrecognized tax benefits: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Balance of unrecognized tax benefits at the beginning of the year $ 114 $ 108 $ 89 Gross increase for tax positions of prior years — 1 7 Gross decrease for tax positions of prior years (4) (1) (1) Gross increase for tax positions of current year 7 6 15 Gross decrease for tax positions of current year (1) — — Settlements — — (1) Lapse of statutes of limitation — — (1) Balance of unrecognized tax benefits at the end of the year $ 116 $ 114 $ 108 It is the Company’s policy to include interest and penalties related to unrecognized tax benefits in the provision for income taxes on the Consolidated Statements of Operations. Interest and penalties recorded on these tax positions were not material to any periods presented in the Consolidated Statement of Operations. As of June 30, 2023, accrued interest and penalties related to unrecognized tax benefits did not materially change compared to fiscal year 2022. During the 12 months beginning July 1, 2023, the Company does not expect a material change to its unrecognized tax benefits as a result of the expiration of certain statutes of limitation.

Leases, Codification Topic 842

Leases, Codification Topic 842	12 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Lessee, Operating Leases	LeasesThe Company is a lessee in several operating leases related to real estate facilities for warehouse, office and lab space. The Company’s lease arrangements comprise operating leases with various expiration dates through 2067. The lease term includes the non-cancelable period of the lease, adjusted for options to extend or terminate the lease when it is reasonably certain that an option will be exercised. During fiscal year 2023, the Company sold and leased back certain properties and recorded a net gain of $156 million within Restructuring and other, net on the Consolidated Statements of Operations. Operating lease costs include short-term lease costs and are shown net of immaterial sublease income. The components of lease costs and other information related to leases were as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Operating lease cost $ 21 $ 16 $ 15 Variable lease cost 3 4 4 Total lease cost $ 24 $ 20 $ 19 Operating cash outflows from operating leases $ 23 $ 20 $ 19 During fiscal year 2023, the Company obtained $353 million ROU assets in exchange for new operating lease liabilities. In fiscal years 2022 and 2021 the ROU assets obtained in exchange for new operating lease liabilities were immaterial. June 30, July 1, July 2, Weighted-average remaining lease term 9.6 years 9.3 years 7.2 years Weighted-average discount rate 8.49 % 6.40 % 6.02 % ROU assets and lease liabilities are included on the Company’s Consolidated Balance Sheet as follows: (Dollars in millions) Balance Sheet Location June 30, July 1, ROU assets Other assets, net $ 396 $ 94 Current lease liabilities Accrued expenses 51 14 Non-current lease liabilities Other non-current liabilities 333 36 At June 30, 2023, future lease payments included in the measurement of lease liabilities were as follows (in millions): Fiscal Year Amount 2024 $ 53 2025 55 2026 55 2027 55 2028 56 Thereafter 290 Total lease payments 564 Less: imputed interest (180) Present value of lease liabilities $ 384

Restructuring and Exit Costs

Restructuring and Exit Costs	12 Months Ended
	Jun. 30, 2023
Restructuring and Related Activities [Abstract]
Restructuring and Exit Costs	Restructuring and Exit Costs During fiscal years 2023, 2022 and 2021, the Company recorded restructuring and other, net of $102 million, $3 million and $8 million, respectively, on the Consolidated Statements of Operations. The Company’s restructuring plans are comprised primarily of charges related to workforce reduction costs, including severance and other one-time termination benefits and facilities and other exit costs. The Company’s significant restructuring plans are described below. October 2022 Plan - On October 24, 2022, the Company committed to an October 2022 restructuring plan (the “October 2022 Plan”) to reduce its cost structure to better align the Company’s operational needs to current economic conditions while continuing to support the long-term business strategy. On March 29, 2023, in light of further deteriorating economic conditions, the Company committed to an expansion of the October 2022 Plan to further reduce its global headcount by approximately 480 employees to a total reduction of approximately 3,480 employees. This expanded plan includes aligning its business plan to near-term market conditions, along with other cost saving measures. The October 2022 Plan was substantially completed by the end of fiscal year 2023. April 2023 Plan - On April 20, 2023, the Company committed to an April 2023 restructuring plan (the “April 2023 Plan”) to further reduce its cost structure in response to changes in macroeconomic and business conditions. The April 2023 Plan is intended to align the Company’s operational needs with the near-term demand environment while continuing to support the long-term business strategy. The April 2023 Plan was substantially completed by the end of fiscal year 2023. The following table summarizes the Company’s restructuring activities under its active restructuring plans for fiscal years 2023, 2022 and 2021: April 2023 Plan October 2022 Plan Other Plans (Dollars in millions) Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Total Accrual balances at July 3, 2020 $ — $ — $ — $ — $ 43 $ 5 $ 48 Restructuring charges — — — — 6 8 14 Cash payments — — — — (47) (6) (53) Adjustments — — — — — (1) (1) Accrual balances at July 2, 2021 — — — — 2 6 8 Restructuring charges — — — — 2 1 3 Cash payments — — — — (4) (2) (6) Adjustments — — — — — — — Accrual balances at July 1, 2022 — — — — — 5 5 Restructuring charges 145 3 104 7 10 — 269 Cash payments (37) (3) (103) (1) (10) (1) (155) Adjustments — — — (1) 1 — — Accrual balances at June 30, 2023 $ 108 $ — $ 1 $ 5 $ 1 $ 4 $ 119 Total costs incurred to date as of June 30, 2023 $ 145 $ 3 $ 104 $ 7 $ 73 $ 24 $ 356 Total expected costs to be incurred as of June 30, 2023 $ — $ — $ — $ — $ — $ 1 $ 1 Of the accrued restructuring balance of $119 million at June 30, 2023, $117 million was included in Accrued expenses and $2 million was included in Other non-current liabilities in the Company’s Consolidated Balance Sheet. The accrued restructuring balance of $5 million at July 1, 2022 was included in Accrued expenses in the Company’s Consolidated Balance Sheet. During fiscal year 2023, the Company sold certain properties and assets and recognized a net gain of $167 million. The net gain was included in Restructuring and other, net in the Company’s Consolidated Statements of Operations. During fiscal year 2021, the Company recognized a gain of $3 million from the sale of a certain property and a gain of $2 million from termination of an operating lease, which were reported in Restructuring and other, net on the Company’s Consolidated Statements of Operations.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company is exposed to foreign currency exchange rate, interest rate and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company has entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. In September 2022, the Company terminated its then existing interest swap agreements relating to Term Loans A1 and A2 and entered into new interest swap agreements with a notional amount of $1.6 billion, to convert the variable interest rate on certain principal amounts of the Term Loans drawn under its Credit Agreement. The Company received cash proceeds of $110 million from the counterparty. The cash proceeds were reported within Net cash provided by operating activities in the Company’s Consolidated Statement of Cash Flows. The Company discontinued the related hedge accounting prospectively and as a result the realized gain of $110 million was accounted and reported in AOCI and is amortized to Interest expense in the Consolidated Statement of Operations over the remaining period of the Term Loans A1 and A2. During fiscal year 2023, $22 million of the gains were amortized to Interest expense in the Company’s Consolidated Statements of Operations. In June 2023, in connection with the $450 million of early repayment of a portion of the outstanding Term Loans principal, the Company terminated $300 million of its then existing interest swap agreements relating to Term Loans A1 and A2 with an immaterial loss. The Company entered into a new interest swap agreement relating to Term Loan A3 with a notional amount of $45 million, to convert the variable interest rate on certain principal amounts of the Term Loans drawn under its Credit Agreement. The Company discontinued the related hedge accounting prospectively and as a result the immaterial realized loss was recorded in Interest expense in the Company’s Consolidated Statement of Operations in fiscal year 2023. As of June 30, 2023, the aggregate notional amount of the Company’s interest-rate swap contracts was $1.3 billion, of which $429 million will mature through September 2025 and $859 million will mature through July 2027. The Company’s accounting policies for these instruments are based on whether the instruments are classified as designated or non-designated hedging instruments. The Company records all derivatives on its Consolidated Balance Sheets at fair value. The changes in the fair value of highly effective designated cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. Derivatives that are not designated as hedging instruments or are not assessed to be highly effective are adjusted to fair value through earnings. The amount of net unrealized gains on cash flow hedges was $12 million and $51 million, respectively, as of June 30, 2023 and as of July 1, 2022. As of June 30, 2023, the amount of existing net gains related to cash flow hedges recorded in AOCI included a net gain of $39 million that is expected to be reclassified to earnings within twelve months. The Company de-designates its cash flow hedges when the forecasted hedged transactions affect earnings or it is probable the forecasted hedged transactions will not occur in the initially identified time period. At such time, the associated gains and losses deferred in AOCI on the Company’s Consolidated Balance Sheets are reclassified into earnings and any subsequent changes in the fair value of such derivative instruments are immediately reflected in earnings. The Company recognized a net gain of $16 million and a net loss of $29 million in Cost of revenue Interest expense Cost of revenue Interest expense Cost of revenue Interest expense Other derivatives not designated as hedging instruments consist of foreign currency forward exchange contracts that the Company uses to hedge the foreign currency exposure on forecasted expenditures denominated in currencies other than the U.S. dollar. The Company also enters into foreign currency forward contracts with contractual maturities of less than one month, which are designed to mitigate the effect of changes in foreign exchange rates on monetary assets and liabilities. The Company recognizes gains and losses on these contracts, as well as the related costs in Other, net on its Consolidated Statements of Operations. The following tables show the total notional value of the Company’s outstanding foreign currency forward exchange contracts as of June 30, 2023 and July 1, 2022. All of the foreign currency forward exchange contracts mature within 12 months. As of June 30, 2023 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 195 $ 161 Thai Baht 129 16 Chinese Renminbi 64 12 British Pound Sterling 57 8 $ 445 $ 197 As of July 1, 2022 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 178 $ 52 Thai Baht 133 35 Chinese Renminbi 92 24 British Pound Sterling 64 15 $ 467 $ 126 The Company is subject to equity market risks due to changes in the fair value of the notional investments selected by its employees as part of its non-qualified deferred compensation plan: the Seagate Deferred Compensation Plan (the “SDCP”). In fiscal year 2014, the Company entered into a Total Return Swap (“TRS”) in order to manage the equity market risks associated with the SDCP’s liabilities. The Company pays a floating rate, based on SOFR plus an interest rate spread, on the notional amount of the TRS. The TRS is designed to substantially offset changes in the SDCP’s liabilities due to changes in the value of the investment options made by employees. As of June 30, 2023, the notional investments underlying the TRS amounted to $108 million. The contract term of the TRS is through January 2024 and is settled on a monthly basis, therefore limiting counterparty performance risk. The Company did not designate the TRS as a hedge. Rather, the Company records all changes in the fair value of the TRS to earnings to offset the market value changes of the SDCP’s liabilities. The following tables show the Company’s derivative instruments measured at gross fair value as reflected in the Consolidated Balance Sheets as of June 30, 2023 and July 1, 2022: As of June 30, 2023 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ 2 Accrued expenses $ (10) Interest rate swap Other current assets 20 Accrued expenses — Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets — Accrued expenses (1) Total return swap Other current assets 1 Accrued expenses — Total derivatives $ 23 $ (11) As of July 1, 2022 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ — Accrued expenses $ (14) Interest rate swap Other current assets 65 Accrued expenses — Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets — Accrued expenses (5) Total return swap Other current assets — Accrued expenses (4) Total derivatives $ 65 $ (23) The following tables show the effect of the Company’s derivative instruments on the Consolidated Statement of Comprehensive Income and Consolidated Statement of Operations for the fiscal year ended June 30, 2023: Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Amount of Gain/(Loss) Recognized in Foreign currency forward exchange contracts Other, net $ (7) Total return swap Operating expenses 6 (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency forward exchange contracts $ (6) Cost of revenue $ 16 Other, net $ (4) Interest rate swap 71 Interest expense (29) Interest expense — The following tables show the effect of the Company’s derivative instruments on the Consolidated Statement of Comprehensive Income and Consolidated Statement of Operations for the fiscal year ended July 1, 2022: Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Amount of Gain/(Loss) Recognized in Foreign currency forward exchange contracts Other, net $ (9) Total return swap Operating expenses (18) (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency forward exchange contracts $ (22) Cost of revenue $ (11) Other, net $ 1 Interest rate swap 70 Interest expense (10) Interest expense —

Fair Value

Fair Value	12 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value	Fair Value Measurement of Fair Value Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy A fair value hierarchy is based on whether the market participant assumptions used in determining fair value are obtained from independent sources (observable inputs) or reflect the Company's own assumptions of market participant valuation (unobservable inputs). A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value are: Level 1 - Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 - Quoted prices for identical assets and liabilities in markets that are inactive; quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; or Level 3 - Prices or valuations that require inputs that are both unobservable and significant to the fair value measurement. The Company considers an active market to be one in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis and views an inactive market as one in which there are few transactions for the asset or liability, the prices are not current, or price quotations vary substantially either over time or among market makers. Where appropriate, the Company’s or the counterparty’s non-performance risk is considered in determining the fair values of liabilities and assets, respectively. Items Measured at Fair Value on a Recurring Basis The following tables present the Company’s assets and liabilities, by financial instrument type and balance sheet line item that are measured at fair value on a recurring basis, excluding accrued interest components, as of: June 30, 2023 July 1, 2022 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (US Dollars in millions) Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Assets: Money market funds $ 72 $ — $ — $ 72 $ 59 $ — $ — $ 59 Total cash equivalents 72 — — 72 59 — — 59 Restricted cash and investments: Money market funds 1 — — 1 1 — — 1 Time deposits and certificates of deposit — 1 — 1 — 1 — 1 Other debt securities — — 16 16 — — 23 23 Derivative assets — 23 — 23 — 65 — 65 Total assets $ 73 $ 24 $ 16 $ 113 $ 60 $ 66 $ 23 $ 149 Liabilities: Derivative liabilities $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23 Total liabilities $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23 June 30, 2023 July 1, 2022 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (US Dollars in millions) Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Assets: Cash and cash equivalents $ 72 $ — $ — $ 72 $ 59 $ — $ — $ 59 Other current assets 1 24 — 25 1 66 — 67 Other assets, net — — 16 16 — — 23 23 Total assets $ 73 $ 24 $ 16 $ 113 $ 60 $ 66 $ 23 $ 149 Liabilities: Accrued expenses $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23 Total liabilities $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23 The Company classifies items in Level 1 if the financial assets consist of securities for which quoted prices are available in an active market. The Company classifies items in Level 2 if the financial asset or liability is valued using observable inputs. The Company uses observable inputs including quoted prices in active markets for similar assets or liabilities. Level 2 assets include: agency bonds, corporate bonds, commercial paper, municipal bonds, U.S. Treasuries, time deposits and certificates of deposit. These debt investments are priced using observable inputs and valuation models which vary by asset class. The Company uses a pricing service to assist in determining the fair value of all of its cash equivalents. For the cash equivalents in the Company’s portfolio, multiple pricing sources are generally available. The pricing service uses inputs from multiple industry standard data providers or other third-party sources and various methodologies, such as weighting and models, to determine the appropriate price at the measurement date. The Company corroborates the prices obtained from the pricing service against other independent sources and, as of June 30, 2023, has not found it necessary to make any adjustments to the prices obtained. The Company’s derivative financial instruments are also classified within Level 2. The Company’s derivative financial instruments consist of foreign currency forward exchange contracts, interest rate swaps and the TRS. The Company recognizes derivative financial instruments in its consolidated financial statements at fair value. The Company determines the fair value of these instruments by considering the estimated amount it would pay or receive to terminate these agreements at the reporting date. Items Measured at Fair Value on a Non-Recurring Basis From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under the equity method or the measurement alternative. Investments under the measurement alternative are recorded at cost, less impairment and adjusted for qualifying observable price changes on a prospective basis. If measured at fair value in the Consolidated Balance Sheets, these investments would generally be classified in Level 3 of the fair value hierarchy. For the investments that are accounted for under the equity method, the Company recorded a net loss of $4 million in fiscal year 2023, and a net gain of $8 million and $48 million in fiscal years 2022 and 2021, respectively. The adjusted carrying value of the investments accounted under the equity method amounted to $55 million and $61 million as of June 30, 2023 and July 1, 2022 respectively. For the investments that are accounted under the measurement alternative, the Company recorded a net loss of $5 million in fiscal year 2023, which included $9 million related to downward adjustments to write down the carrying amount of certain investments to their fair value. For fiscal years 2022 and 2021, the Company recorded a net gain of $4 million and $51 million, respectively. In fiscal year 2021, the Company recorded downward adjustment of $12 million to write down the carrying amount of certain investments to their fair value. As of June 30, 2023 and July 1, 2022, the carrying value of the Company’s strategic investments under the measurement alter native was $88 million and $88 million, respectively. The Company’s debt is carried at amortized cost. The estimated fair value of the Company’s debt is derived using the closing price of the same debt instruments as of the date of valuation, which takes into account the yield curve, interest rates and other observable inputs. Accordingly, these fair value measurements are categorized as Level 2. The following table presents the fair value and amortized cost of the Company’s debt in order of maturity: June 30, 2023 July 1, 2022 (Dollars in millions) Carrying Estimated Carrying Estimated 4.750% Senior Notes due June 2023 $ — $ — $ 540 $ 538 4.875% Senior Notes due March 2024 — — 499 494 4.750% Senior Notes due January 2025 479 472 479 471 4.875% Senior Notes due June 2027 504 484 504 483 4.091% Senior Notes due June 2029 465 436 466 427 3.125% Senior Notes due July 2029 163 126 500 396 8.250% Senior Notes due December 2029 500 522 — — 4.125% Senior Notes due January 2031 275 227 500 410 3.375% Senior Notes due July 2031 72 53 500 393 8.500% Senior Notes due July 2031 500 524 — — 9.625% Senior Notes due December 2032 750 830 — — 5.750% Senior Notes due December 2034 489 438 489 433 SOFR Based Term Loan A1 due September 2025 430 426 600 588 SOFR Based Term Loan A2 due July 2027 430 420 600 586 SOFR Based Term Loan A3 due July 2027 430 413 — — $ 5,487 $ 5,371 $ 5,677 $ 5,219 Less: unamortized debt issuance costs (36) — (31) — Debt, net of debt issuance costs $ 5,451 $ 5,371 $ 5,646 $ 5,219 Less: current portion of debt, net of debt issuance costs (63) (62) (584) (582) Long-term debt, less current portion, net of debt issuance costs $ 5,388 $ 5,309 $ 5,062 $ 4,637

Shareholders' Equity

Shareholders' Equity	12 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Shareholders' Equity	Shareholders’ (Deficit) Equity Share Capital The Company’s authorized share capital is $13,500 and consists of 1,250,000,000 ordinary shares, par value $0.00001, of which 207,389,381 shares were outstanding as of June 30, 2023, and 100,000,000 preferred shares, par value $0.00001, of which none were issued or outstanding as of June 30, 2023. Ordinary shares - Holders of ordinary shares are entitled to receive dividends when and as declared by the Company’s board of directors (the “Board of Directors”). Upon any liquidation, dissolution, or winding up of the Company, after required payments are made to holders of preferred shares, any remaining assets of the Company will be distributed ratably to holders of the preferred and ordinary shares. Holders of shares are entitled to one vote per share on all matters upon which the ordinary shares are entitled to vote, including the election of directors. Preferred shares - The Company may issue preferred shares in one or more series, up to the authorized amount, without shareholder approval. The Board of Directors is authorized to establish from time to time the number of shares to be included in each series, and to fix the rights, preferences and privileges of the shares of each wholly unissued series and any of its qualifications, limitations or restrictions. The Board of Directors can also increase or decrease the number of shares of a series, but not below the number of shares of that series then outstanding, without any further vote or action by the shareholders. The Board of Directors may authorize the issuance of preferred shares with voting or conversion rights that could harm the voting power or other rights of the holders of the ordinary shares. The issuance of preferred shares, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of the Company and might harm the market price of its ordinary shares and the voting and other rights of the holders of ordinary shares. Repurchases of Equity Securities All repurchases are effected as redemptions in accordance with the Company’s Constitution. As of June 30, 2023, $1.9 billion remained available for repurchase under the existing repurchase authorization limit approved by the Board of Directors. The following table sets forth information with respect to repurchases of the Company’s ordinary shares during fiscal years 2023, 2022 and 2021: (In millions) Number of Shares Repurchased Dollar Value of Shares Repurchased Cumulative repurchased through July 3, 2020 392 $ 12,386 Repurchased in fiscal year 2021 (1) 34 2,081 Cumulative repurchased through July 2, 2021 426 14,467 Repurchased in fiscal year 2022 (1) 21 1,857 Cumulative repurchased through July 1, 2022 447 16,324 Repurchased in fiscal year 2023 (1) 6 444 Cumulative repurchased through June 30, 2023 453 $ 16,768 ___________________________________________________ (1) For fiscal years 2023, 2022 and 2021, includes net share settlements of $44 million, $51 million and $33 million for 1 million, 1 million and 1 million shares, respectively, in connection with tax withholding related to vesting of restricted share units .

Share-based Compensation

Share-based Compensation	12 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Compensation	Share-Based Compensation Share-Based Compensation Plans The Company’s share-based compensation plans have been established to promote the Company’s long-term growth and financial success by providing incentives to its employees, directors and consultants through grants of share-based awards. The provisions of the Company's share-based benefit plans, which allow for the grant of various types of equity-based awards, are also intended to provide greater flexibility to maintain the Company's competitive ability to attract, retain and motivate participants for the benefit of the Company and its shareholders. Seagate Technology Holdings plc 2022 Equity Incentive Plan (the “2022 EIP”) : On October 20, 2021, (the “Approval Date”), shareholders of the Company approved the adoption of the 2022 EIP in replacement of Seagate Technology Holdings plc 2012 Equity Inventive Plan (the “2012 EIP”), which was retired as of the Approval Date. The 2022 EIP provides for the grant of various types of awards including restricted share units (“RSUs”), options, performance-based share units (“PSUs”) and share appreciation rights. The maximum number of shares that may be delivered to the participants under the 2022 EIP shall not exceed (i) 14.1 million ordinary shares, plus (ii) any shares subject to any outstanding share awards granted under the 2012 EIP that, on or after the Approval Date expire, are cancelled or otherwise terminate, in whole or in part, without having been exercised or redeemed in full, or are settled in cash ((i) and (ii) together being the “Share Reserve”). The maximum aggregate number of shares that may be issued pursuant to RSUs or PSUs (collectively, “Full-Value Share Awards”) shall not exceed 12.3 million ordinary shares. Any shares that are subject to the 2022 EIP will be counted against the Share Reserve as one share for every one share granted. As of June 30, 2023, there were 9.9 million ordinary shares available for issuance of Full-Value Share Awards under the 2022 EIP. Dot Hill Systems 2009 Equity Incentive Plan (the “DHEIP”) . Effective May 18, 2021, Seagate Technology Holdings plc assumed the Dot Hill Systems 2009 Equity Incentive Plan, which was acquired by STUC effective October 6, 2015. The Company assumed the remaining authorized but unused share reserve of approximately 2.0 million shares, based on the conversion ratio, from the DHEIP on the acquisition date. Effective April 24, 2019, the Company terminated the DHEIP and thus, no further grants will be made under the DHEIP. Outstanding awards granted under the DHEIP will remain subject to the terms of the DHEIP. Seagate Technology Holdings plc Employee Stock Purchase Plan (the “ESPP”). There are 60.0 million ordinary shares authorized to be issued under the ESPP. The ESPP consists of a six-month offering period with a maximum issuance of 1.5 million ordinary shares per offering period. The ESPP permits eligible employees to purchase ordinary shares through payroll deductions generally at 85% of the fair market value of the ordinary shares. As of June 30, 2023, there were approximately 6.6 million ordinary shares available for issuance under the ESPP. Equity Awards RSUs generally vest over a period of four years, with 25% vest on the first anniversary of the vesting commencement date and the remaining 75% vest ratably each quarter over the next 36 months, subject to continuous employment with the Company through the vesting date. Options generally vest as follows: 25% of the awards will vest on the first anniversary of the vesting commencement date and the remaining 75% will vest ratably each month thereafter over the next 36 months, subject to continuous employment with the Company through the vesting date. Options granted under the 2022 EIP and 2012 EIP have an exercise price equal to the fair market value of the Company’s ordinary shares on the grant date. Fair market value is defined as the closing price of the Company's ordinary shares on NASDAQ on the grant date. The Company granted PSUs to its senior executive officers under the 2022 EIP and 2012 EIP where vesting is subject to both the continued employment of the participant by the Company and the achievement of certain financial and operational performance goals established by the Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”). A single PSU represents the right to receive a single ordinary share of the Company. During fiscal years 2023, 2022 and 2021, the Company granted 0.3 million, 0.3 million and 0.3 million PSUs, respectively, where performance is measured based on a three-year average return on invested capital (“ROIC”) goal and a relative total shareholder return (“TSR”) goal, which is based on the Company’s ordinary shares measured against a benchmark TSR of a peer group over the same three-year period (the “TSR/ROIC” awards). For fiscal years 2023 and 2022, the PSUs granted to certain executive officers contain two ESG modifiers that will increase or decrease the PSU achievement level based on the Company’s performance against both a social goal of increasing gender diversity in leadership positions and an environmental goal of greenhouse gas reduction. These awards vest after the end of the performance period of three years from the grant date. A percentage of these units may vest only if at least the minimum ROIC goal is met regardless of whether the TSR goal is met. The number of share units to vest will range from 0% to 200% of the targeted units. In evaluating the fair value of these units, the Company used a Monte Carlo simulation on the grant date, taking the market-based TSR goal into consideration. Compensation expense related to these units is only recorded in a period if it is probable that the ROIC goal will be met, and it is to be recorded at the expected level of achievement. The Company also granted 0.1 million and 0.1 million PSUs during fiscal years 2021 and 2020, respectively, to certain of its executive officers which are subject to a performance goal related to the Company's adjusted earnings per share (“AEPS”). These awards have a maximum seven-year vesting period, with 25% annual vesting starting on the first anniversary of the grant date. If the AEPS goal is not achieved, vesting is delayed to a following year in which the AEPS goal is achieved. Any unvested awards from prior years may vest cumulatively in a future year within the seven-year vesting period if the annual AEPS goal is achieved during a subsequent year. If the AEPS goal has not been met by the end of the seven-year period, any unvested shares will be forfeited. Determining Fair Value of Seagate Technology Share Plans Valuation and amortization method - The Company estimates the fair value of granted share options, RSUs and PSUs subject to an AEPS condition granted using the Black-Scholes-Merton valuation model and a single share award approach. This fair value is then amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period or the remaining service (vesting) period. Expected Term - Expected term represents the period that the Company’s share-based awards are expected to be outstanding and was determined based on historical experience of similar awards, giving consideration to the contractual terms of the share-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of its share-based awards. Expected Volatility - The Company uses a combination of the implied volatility of its traded options and historical volatility of its share price. Expected Dividend - The Black-Scholes-Merton valuation model calls for a single expected dividend yield as an input. The dividend yield is determined by dividing the expected per share dividend during the coming year by the grant date share price. The expected dividend assumption is based on the Company’s current expectations about its anticipated dividend policy. Also, because the expected dividend yield should reflect marketplace participants’ expectations, the Company does not incorporate changes in dividends anticipated by management unless those changes have been communicated to or otherwise are anticipated by marketplace participants. Risk-Free Interest Rate - The Company bases the risk-free interest rate used in the Black-Scholes-Merton valuation model on the implied yield currently available on U.S. Treasury zero-coupon issues with an equivalent remaining term. Where the expected term of the Company's share-based awards do not correspond with the terms for which interest rates are quoted, the Company performed a straight-line interpolation to determine the rate from the available term maturities. The fair value of the Company’s shares related to options and RSUs granted to employees, shares issued from the ESPP and PSUs subject to TSR/ROIC or AEPS conditions for fiscal years 2023, 2022 and 2021 were estimated using the following assumptions: Fiscal Years 2023 2022 2021 Options Expected term (in years) 4.2 4.2 4.2 Volatility 37 % 38 % 37 - 38 % Weighted-average volatility 37 % 38 % 38 % Expected dividend rate 3.7 % 2.8 % 3.2 - 5.2 % Weighted-average expected dividend rate 3.7 % 2.8 % 4.7 % Risk-free interest rate 3.5 % 0.6 % 0.2 - 0.7 % Weighted-average fair value $ 17.28 $ 21.02 $ 10.77 RSUs Expected term (in years) 1 - 2.2 1 - 2.5 1 - 2.5 Expected dividend rate 3.2 - 5.5 % 2.4 - 3.4 % 2.5 - 5.4 % Weighted-average expected dividend rate 3.8 % 2.8 % 4.6 % Weighted-average fair value $ 62.82 $ 82.40 $ 50.64 ESPP Expected term (in years) 0.5 0.5 0.5 Volatility 39 - 40 % 36 - 39 % 39 - 44 % Weighted-average volatility 39 % 37 % 42 % Expected dividend rate 3.5 - 4.0 % 2.6 - 3.0 % 4.0 - 5.8 % Weighted-average expected dividend rate 3.8 % 2.8 % 5.1 % Risk-free interest rate 2.9 - 4.7 % 0.1 - 0.5 % 0.1 % Weighted-average fair value $ 19.36 $ 24.38 $ 13.77 PSUs subject to TSR/ROIC conditions Expected term (in years) 3.0 3.0 3.0 Volatility 40 % 39 % 38 % Weighted-average volatility 40 % 39 % 38 % Expected dividend rate 4.1 % 3.1 % 5.6 % Weighted-average expected dividend rate 4.1 % 3.1 % 5.6 % Risk-free interest rate 3.6 % 0.4 % 0.2 % Weighted-average fair value $ 64.38 $ 86.01 $ 43.20 PSUs subject to an AEPS condition Expected term (in years) 0 0 2.5 Expected dividend rate — — 3.2 - 5.2 % Weighted-average expected dividend rate — — 4.9 % Weighted-average fair value — — $ 45.50 Share-Based Compensation Expense The Company recorded $115 million, $145 million and $112 million of share-based compensation during fiscal years 2023, 2022 and 2021, respectively. Management has made an estimate of expected forfeitures and is recognizing compensation costs only for those equity awards expected to vest. When estimating forfeitures, the Company considers voluntary termination behavior as well as the historical analysis of actual forfeited awards. Share Option Activity The Company issues new ordinary shares upon exercise of share options. The following is a summary of option activities: Options Number of Shares (In millions) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (In years) Aggregate Intrinsic Value (Dollars in millions) Outstanding at July 1, 2022 1.6 $ 49.26 3.6 $ 36 Granted 0.2 $ 68.83 Exercised (0.2) $ 41.47 Forfeited (0.1) $ 72.13 Outstanding at June 30, 2023 1.5 $ 51.96 2.9 $ 21 Vested and expected to vest at June 30, 2023 1.5 $ 51.78 2.8 $ 21 Exercisable at June 30, 2023 1.1 $ 46.60 2.0 $ 20 The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted price of the Company’s ordinary shares for the options that were in-the-money at June 30, 2023. During fiscal years 2023, 2022 and 2021, the aggregate intrinsic value of options exercised under the Company’s share option plans was $5 million, $11 million and $31 million, respectively, determined as of the date of option exercise. The aggregate fair value of options vested during fiscal years 2023, 2022 and 2021 was approximately $4 million, $4 million and $4 million, respectively. At June 30, 2023, the total compensation cost related to options granted to employees but not yet recognized was approximately $5 million, net of approximately $2 million of estimated forfeitures. This cost is being amortized on a straight-line basis over a weighted-average remaining term of approximately 2.5 years and will be adjusted for subsequent changes in estimated forfeitures. Unvested Awards Activity The following is a summary of unvested award activities which do not contain a performance condition: Unvested Awards Number of Shares (In millions) Weighted-Average Grant-Date Fair Value Unvested at July 1, 2022 4.8 $ 58.86 Granted 1.8 $ 62.82 Forfeited (1.0) $ 61.86 Vested (1.9) $ 54.79 Unvested at June 30, 2023 3.7 $ 62.07 At June 30, 2023, the total compensation cost related to unvested awards granted to employees but not yet recognized was approximately $156 million, net of estimated forfeitures of approximately $29 million. This cost is being amortized on a straight-line basis over a weighted-average remaining term of 2.1 years and will be adjusted for subsequent changes in estimated forfeitures. The aggregate fair value of unvested awards vested during fiscal years 2023, 2022 and 2021 were approximately $105 million, $96 million and $75 million, respectively. Performance Awards The following is a summary of unvested award activities which contain a performance condition: Performance Awards Number of Shares (In millions) Weighted-Average Grant-Date Fair Value Performance units at July 1, 2022 0.9 $ 59.72 Granted 0.4 $ 60.72 Forfeited (0.2) $ 64.46 Vested (0.4) $ 51.30 Performance units at June 30, 2023 0.7 $ 64.29 At June 30, 2023, the total compensation cost related to performance awards granted to employees but not yet recognized was approximately $8 million, net of estimated forfeitures of approximately $2 million. This cost is being amortized on a straight-line basis over a weighted-average remaining term of 1.2 years. The aggregate fair value of performance awards vested during fiscal years 2023, 2022 and 2021 were approximately $16 million, $4 million and $8 million, respectively. ESPP During fiscal years 2023, 2022 and 2021, the aggregate intrinsic value of shares purchased under the Company's ESPP was approximately $10 million, $29 million and $27 million, respectively. At June 30, 2023, the total compensation cost related to options to purchase the Company's ordinary shares under the ESPP but not yet recognized was approximately $1.5 million. This cost will be amortized on a straight-line basis over a weighted-average period of approximately one month. During fiscal year 2023, the Company issued 0.9 million ordinary shares with a weighted-average exercise price of $62.36 per share. Tax-Deferred Savings Plan The Company has a tax-deferred savings plan, the Seagate 401(k) Plan (the "401(k) plan"), for the benefit of qualified employees. The 401(k) plan is designed to provide employees with an accumulation of funds at retirement. Qualified employees may elect to make contributions to the 401(k) plan on a bi-weekly basis. Pursuant to the 401(k) plan, the Company matches 50% of employee contributions, up to 6% of compensation, subject to maximum annual contributions of $6,000 per participating employee. During fiscal years 2023, 2022 and 2021, the Company made matching contributions of $15 million, $15 million and $15 million, respectively. Deferred Compensation Plan The Company has adopted the SDCP for the benefit of eligible employees. The plan is designed to permit certain discretionary employer contributions, in excess of the tax limits applicable to the 401(k) plan, and to permit employee deferrals in excess of certain tax limits. During fiscal year 2014, the Company entered into a TRS in order to manage the equity market risks associated with the SDCP liabilities. See Note 8. Derivative Financial Instruments contained in this report for additional information about the TRS.

Guarantees

Guarantees	12 Months Ended
	Jun. 30, 2023
Guarantees [Abstract]
Guarantees	Guarantees Indemnifications of Officers and Directors Seagate Technology, an exempted company incorporated with limited liability under the laws of the Cayman Islands (“Seagate-Cayman”) and wholly-owned subsidiary of STX, from time to time enters into indemnification agreements with the directors, officers, employees and agents of STX or any of its subsidiaries (each, an “Indemnitee”). The indemnification agreements provide indemnification in addition to any of Indemnitee’s indemnification rights under any relevant Articles of Association (or similar constitutional document), applicable law or otherwise, and indemnifies an Indemnitee for certain expenses (including attorneys’ fees), judgments, fines and settlement amounts actually and reasonably incurred by him or her in any action or proceeding, including any action by or in the right of STX or any of its subsidiaries, arising out of his or her service as a director, officer, employee or agent of STX or any of its subsidiaries or of any other entity to which he or she provides services at the Company’s request. However, Indemnitees are not indemnified under the indemnification agreements for (i) any fraud or dishonesty in the performance of Indemnitee’s duty to STX or the applicable subsidiary or (ii) Indemnitee’s conscious, intentional or willful failure to act honestly, lawfully and in good faith with a view to the best interests of the Company. In addition, the indemnification agreements provide that Seagate-Cayman will advance expenses incurred by an Indemnitee in connection with enforcement of the indemnification agreement or with the investigation, settlement or appeal of any action or proceeding against him or her as to which he or she could be indemnified. The nature of these indemnification obligations prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay on behalf of its officers and directors. Historically, the Company has not made any significant indemnification payments under such indemnification agreements and no amount has been accrued in the Company’s consolidated financial statements with respect to these indemnification obligations. Indemnification Obligations The Company from time to time enters into agreements with customers, suppliers, partners and others in the ordinary course of business that provide indemnification for certain matters including, but not limited to, intellectual property infringement claims, environmental claims and breach of agreement claims. The nature of the Company’s indemnification obligations prevents the Company from making a reasonable estimate of the maximum potential amount it could be required to pay. Historically, the Company has not made any significant indemnification payments under such agreements and no amount has been accrued in the Company’s consolidated financial statements with respect to these indemnification obligations. Product Warranty The Company estimates probable product warranty costs at the time revenue is recognized. The Company generally warrants its products for a period of 1 to 5 years. The Company uses estimated repair or replacement costs and uses statistical modeling to estimate product warranty return rates in order to determine its warranty obligation. As of June 30, 2023, the Company’s reserve for product warranty was $168 million compared to $148 million as of July 1, 2022. The increase of $20 million was primarily driven by an increase in the Company’s warranty return rate as compared to prior year and higher cost of repair, partially offset by continued decline in total number of units under warranty. Changes in the Company’s product warranty liability during the fiscal years ended June 30, 2023, July 1, 2022 and July 2, 2021 were as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Balance, beginning of period $ 148 $ 136 $ 151 Warranties issued 55 79 76 Repairs and replacements (92) (88) (81) Changes in liability for pre-existing warranties, including expirations 57 21 (10) Balance, end of period $ 168 $ 148 $ 136

Earnings Per Share

Earnings Per Share	12 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Earnings Per Share	(Loss) Earnings Per Share Basic earnings per share is computed by dividing income available to shareholders by the weighted-average number of shares outstanding during the period. Diluted earnings per share is computed by dividing income available to shareholders by the weighted-average number of shares outstanding during the period and the number of additional shares that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding options, unvested RSUs and PSUs and shares to be purchased under the ESPP. The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in fair market value of the Company’s share price can result in a greater dilutive effect from potentially dilutive securities. The following table sets forth the computation of basic and diluted net (loss) income per share attributable to the shareholders of the Company: Fiscal Years Ended (In millions, except per share data) June 30, July 1, July 2, Numerator: Net (loss) income $ (529) $ 1,649 $ 1,314 Number of shares used in per share calculations: Total shares for purposes of calculating basic net (loss) income per share 207 220 242 Weighted-average effect of dilutive securities: Employee equity award plans — 4 3 Total shares for purposes of calculating diluted net (loss) income per share 207 224 245 Net (loss) income per share Basic $ (2.56) $ 7.50 $ 5.43 Diluted (2.56) 7.36 5.36 During fiscal year 2023, the Company recorded a net loss, and as such, all potentially dilutive securities related to the employee equity award plans have been excluded for those periods as including them would be anti-dilutive. The weighted average anti-dilutive shares that were excluded from the computation of diluted net (loss) income per share were 7 million for the fiscal year ended June 30, 2023, and were not material for the fiscal years ended July 1, 2022 and July 2, 2021.

Commitments

Commitments	12 Months Ended
	Jun. 30, 2023
Commitments Disclosure [Abstract]
Commitments	Commitments Unconditional Long-Term Purchase Obligations. As of June 30, 2023, the Company had unconditional long-term purchase obligations of approximately $2.8 billion, primarily related to purchases of inventory components. The Company expects the commitment to total $297 million, $991 million, $981 million and $489 million, respectively, for fiscal years 2025, 2026, 2027, and 2028. During fiscal year 2023, the Company recorded order cancellation fees of $108 million to terminate certain purchase commitments related to purchase of inventory components and equipment, which was reflected under Cost of revenue on its Consolidated Statements of Operations. As of June 30, 2023, $68 million remained unpaid and is expected to be paid within one year. Unconditional Long-Term Capital Expenditures . As of June 30, 2023, the Company had unconditional long-term commitment of approximately $101 million, primarily related to purchases of equipment. The Company expects the capital expenditures to total $35 million, $39 million and $27 million, respectively, for fiscal years 2025, 2026, and 2027.

Business Segment and Geographic

Business Segment and Geographic Information	12 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Business Segment and Geographic Information	Business Segment and Geographic Information The Company’s manufacturing operations are based on technology platforms that are used to produce various data storage and systems solutions that serve multiple applications and markets. The Company has determined that its Chief Operating Decision Maker, the Chief Executive Officer, evaluates performance of the Company and makes decisions regarding investments in the Company’s technology platforms and manufacturing infrastructure based on the Company’s consolidated results. As a result, the Company has concluded that its manufacture and distribution of storage solutions constitutes one reporting segment. In fiscal years 2023, 2022 and 2021, one customer accounted for approximately 10%, 10% and 11% of consolidated revenue, respectively. The following table summarizes the Company’s operations by country: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Revenue from external customers (1) : Singapore $ 3,271 $ 5,322 $ 5,180 United States 3,053 4,694 3,656 The Netherlands 1,046 1,627 1,825 Other 14 18 20 Consolidated $ 7,384 $ 11,661 $ 10,681 Long-lived assets: United States $ 667 $ 670 $ 612 Thailand 606 679 682 Singapore 460 557 570 Other 369 426 411 Consolidated $ 2,102 $ 2,332 $ 2,275 ___________________________________ (1) Revenue is attributed to countries based on the bill from location.

Revenue

Revenue	12 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The following table provides information about disaggregated revenue by sales channel and geographical region for the Company’s single reportable segment: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Revenues by Channel OEMs $ 5,448 $ 8,742 $ 7,403 Distributors 1,119 1,676 1,854 Retailers 817 1,243 1,424 Total $ 7,384 $ 11,661 $ 10,681 Revenues by Geography (1) Asia Pacific $ 3,285 $ 5,340 $ 5,198 Americas 3,053 4,694 3,656 EMEA 1,046 1,627 1,827 Total $ 7,384 $ 11,661 $ 10,681 ____________________________________________________

Subsequent Events

Subsequent Events	12 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events Dividend Declared On July 26, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.70 per share, which will be payable on October 10, 2023 to shareholders of record as of the close of business on September 26, 2023.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Pay vs Performance Disclosure
Net income	$ (529)	$ 1,649	$ 1,314

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Jun. 30, 2023 shares	Jun. 30, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		The table below summarizes the material terms of trading arrangements adopted by any of our executive officers or directors during the June 2023 quarter. All of the trading arrangements listed below are intended to satisfy the affirmative defense of Rule 10b5-1(c). Name Title Date of Adoption End Date¹ Aggregate number of ordinary shares to be sold pursuant to the trading agreement Dr. William D. Mosley Chief Executive Officer 6/1/2023 9/11/2024 452,048 Gianluca Romano EVP and Chief Financial Officer 5/26/2023 12/15/2023 40,177 Ban Seng Teh EVP, Chief Commercial Officer 6/7/2023 6/7/2024 20,000 Katherine E. Schuelke SVP, Chief Legal Officer and Corporate Secretary 5/31/2023 9/29/2023 Net shares issued upon vesting of an aggregate 18,937 restricted stock units and performance stock units plus 262 ordinary shares. ___________________________________ ¹ Each plan will expire on the earlier of the end date and the completion of all transactions under the trading arrangement.
Rule 10b5-1 Arrangement Adopted	true
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Dr. William D. Mosley [Member]
Trading Arrangements, by Individual
Name	Dr. William D. Mosley
Title	Chief Executive Officer
Adoption Date	6/1/2023
Termination Date	9/11/2024
Arrangement Duration	468 days
Aggregate Available	452,048	452,048
Gianluca Romano [Member]
Trading Arrangements, by Individual
Name	Gianluca Romano
Title	EVP and Chief Financial Officer
Adoption Date	5/26/2023
Termination Date	12/15/2023
Arrangement Duration	203 days
Aggregate Available	40,177	40,177
Ban Seng Teh [Member]
Trading Arrangements, by Individual
Name	Ban Seng Teh
Title	EVP, Chief Commercial Officer
Adoption Date	6/7/2023
Termination Date	6/7/2024
Arrangement Duration	366 days
Aggregate Available	20,000	20,000
Katherine E. Schuelke [Member]
Trading Arrangements, by Individual
Name	Katherine E. Schuelke
Title	SVP, Chief Legal Officer and Corporate Secretary
Adoption Date	5/31/2023
Termination Date	9/29/2023
Arrangement Duration	121 days
RSUs and PSUs [Member] | Katherine E. Schuelke [Member]
Trading Arrangements, by Individual
Aggregate Available	18,937	18,937
Ordinary Shares [Member] | Katherine E. Schuelke [Member]
Trading Arrangements, by Individual
Aggregate Available	262	262

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2023
Significant Accounting Policies
Basis of Presentation and Consolidation	Basis of Presentation and ConsolidationThe Company’s consolidated financial statements include the accounts of the Company and all its wholly-owned and majority-owned subsidiaries, after elimination of intercompany transactions and balances.
Fiscal Period	The Company operates and reports financial results on a fiscal year of 52 or 53 weeks ending on the Friday closest to June 30. Fiscal years 2023, 2022 and 2021 are comprised of 52 weeks and ended on June 30, 2023, July 1, 2022 and July 2, 2021, respectively. All references to years in these Notes to Consolidated Financial Statements represent fiscal years unless otherwise noted. Fiscal year 2026 will also be comprised of 53 weeks and will end on July 3, 2026.
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Cash and Cash Equivalents. The Company considers all highly liquid investments with a remaining maturity of 90 days or less at the time of purchase to be cash equivalents. The Company’s highly liquid investments are primarily comprised of money market funds, time deposits and certificates of deposits. The Company has classified its marketable debt securities as available-for-sale and they are stated at fair value with unrealized gains and losses included in Accumulated other comprehensive income, which is a component of Shareholders’ (Deficit) Equity. The Company evaluates the available-for-sale debt securities in an unrealized loss position for other-than-temporary impairment. Realized gains and losses are included in Other, net on the Company’s Consolidated Statements of Operations. The cost of securities sold is based on the specific identification method. Other cash equivalents are carried at cost, which approximates fair value. Restricted Cash and Cash Equivalents. Restricted cash and cash equivalents represent cash and cash equivalents that are restricted as to withdrawal or use for other than current operations.
Allowance For Expected Credit Loss	Allowance for expected credit loss. The Company maintains an allowance for expected credit loss relating to its accounts receivable based upon expected collectability. This reserve is established based upon historical trends, global macroeconomic conditions, reasonable and supportable forecasts of future conditions and an analysis of specific exposures. The provision for expected credit loss is recorded as a charge to Marketing and administrative expense on the Company’s Consolidated Statements of Operations.
Inventory	Inventories. Inventories are valued at the lower of cost (using the first-in, first-out method) and net realizable value. Net realizable value is based upon the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. Adjustments to reduce cost of inventories to its net realizable value are made, if required, for estimated excess or obsolescence determined primarily by future demand forecasts.
Property, Equipment and Leasehold Improvements	Property, Equipment and Leasehold Improvements. Property, equipment and leasehold improvements are stated at cost less accumulated depreciation and amortization. Equipment and buildings are depreciated using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized using the straight-line method over the shorter of the estimated life of the asset or the remaining term of the lease. The costs of additions and substantial improvements to property, equipment and leasehold improvements, which extend the economic life of the underlying assets, are capitalized. The cost of maintenance and repairs to property, equipment and leasehold improvements is expensed as incurred.
Assessment of Goodwill and Other Long-Lived Assets for Impairment	Goodwill. The Company performs a qualitative assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist, to determine if any events or circumstances exist, such as an adverse change in business climate or a decline in the overall industry that would indicate that it would more likely than not reduce the fair value of a reporting unit below its carrying amount, including goodwill. If it is determined in the qualitative assessment that the fair value of a reporting unit is more likely than not below its carrying amount, including goodwill, then the Company will perform a quantitative impairment test. The quantitative goodwill impairment test is performed by comparing the fair value of a reporting unit with its carrying amount. Any excess in the carrying value of a reporting unit over its fair value is recognized as an impairment loss, limited to the total amount of goodwill allocated to that reporting unit. Other Long-lived Assets. The Company tests other long-lived assets, including property, equipment and leasehold improvements and other intangible assets subject to amortization, for recoverability whenever events or changes in circumstances indicate that the carrying value of those assets may not be recoverable. The Company performs a recoverability test to assess the recoverability of an asset group. If the recoverability test indicates that the carrying value of the asset group is not recoverable, the Company will estimate the fair value of the asset group and the excess of the carrying value over the fair value is allocated pro rata to derive the adjusted carrying value of assets in the asset group. The adjusted carrying value of each asset in the asset group is not reduced below its fair value. The Company tests other intangible assets not subject to amortization whenever events occur or circumstances change, such as declining financial performance, deterioration in the environment in which the entity operates or deteriorating macroeconomic conditions that have a negative effect on future expected earnings and cash flows that could affect significant inputs used to determine the fair value of the indefinite-lived intangible asset.
Assets Held For Sale	Assets Held for Sale. The Company classifies its long-lived assets to be sold as held for sale in the period (i) it has approved and committed to a plan to sell the asset, (ii) the asset is available for immediate sale in its present condition, (iii) an active program to locate a buyer and other actions required to sell the asset have been initiated, (iv) the sale of the asset is probable, (v) the asset is being actively marketed for sale at a price that is reasonable in relation to its current fair value and (vi) it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn. The Company initially measures a long-lived asset that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held for sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset until the date of sale. Upon designation as an asset held for sale, the Company stops recording depreciation expense on the asset. The Company assesses the fair value of a long-lived asset less any costs to sell at each reporting period and until the asset is no longer classified as held for sale.
Leases	Leases. The Company determines if an arrangement is a lease or contains a lease at inception. Right-of-use (“ROU”) assets are included in Other assets, net and lease liabilities are included in Accrued expenses and Other non-current liabilities on the Company’s Consolidated Balance Sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term and the corresponding lease liabilities represent its obligation to make lease payments arising from the lease. The Company combines lease and non-lease components for facility leases and does not recognize ROU assets and lease liabilities for leases with an initial term of 12 months or less on the consolidated balance sheets. Lease liabilities are measured at the present value of the remaining lease payments and ROU assets are based on the lease liability, adjusted for lease prepayments, lease incentives received and the lessee’s initial direct costs. For the Company’s leases that do not provide an implicit rate, the net present value of future minimum lease payments is determined using the Company’s estimated incremental borrowing rate based on the information available at the lease commencement date. Additionally, the Company’s lease term may include options to extend or terminate the lease. These options are reflected in the ROU asset and lease liability when it is reasonably certain that the Company will exercise the option. The Company’s lease agreements do not contain any material residual value guarantees.
Derivative Financial Instruments	Derivative Financial Instruments. The Company records all derivatives on the balance sheet at fair value and establishes criteria for designation and effectiveness of hedging relationships. The Company excludes the change in forward points from the assessment of hedge effectiveness and recognizes the excluded component in Other, net in the Consolidated Statements of Operations. Foreign currency forward exchange contracts not designated as hedge instruments are used to economically hedge the foreign currency exposure on forecasted expenditures in currencies other than U.S. dollar. The Company recognizes the unrealized gains and losses due to the changes in the fair value of these contracts, as well as the related costs in Other, net in the Consolidated Statements of Operations. The Company is exposed to foreign currency exchange rate, interest rate and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company has entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. In September 2022, the Company terminated its then existing interest swap agreements relating to Term Loans A1 and A2 and entered into new interest swap agreements with a notional amount of $1.6 billion, to convert the variable interest rate on certain principal amounts of the Term Loans drawn under its Credit Agreement. The Company received cash proceeds of $110 million from the counterparty. The cash proceeds were reported within Net cash provided by operating activities in the Company’s Consolidated Statement of Cash Flows. The Company discontinued the related hedge accounting prospectively and as a result the realized gain of $110 million was accounted and reported in AOCI and is amortized to Interest expense in the Consolidated Statement of Operations over the remaining period of the Term Loans A1 and A2. During fiscal year 2023, $22 million of the gains were amortized to Interest expense in the Company’s Consolidated Statements of Operations. In June 2023, in connection with the $450 million of early repayment of a portion of the outstanding Term Loans principal, the Company terminated $300 million of its then existing interest swap agreements relating to Term Loans A1 and A2 with an immaterial loss. The Company entered into a new interest swap agreement relating to Term Loan A3 with a notional amount of $45 million, to convert the variable interest rate on certain principal amounts of the Term Loans drawn under its Credit Agreement. The Company discontinued the related hedge accounting prospectively and as a result the immaterial realized loss was recorded in Interest expense in the Company’s Consolidated Statement of Operations in fiscal year 2023. As of June 30, 2023, the aggregate notional amount of the Company’s interest-rate swap contracts was $1.3 billion, of which $429 million will mature through September 2025 and $859 million will mature through July 2027. The Company’s accounting policies for these instruments are based on whether the instruments are classified as designated or non-designated hedging instruments. The Company records all derivatives on its Consolidated Balance Sheets at fair value. The changes in the fair value of highly effective designated cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. Derivatives that are not designated as hedging instruments or are not assessed to be highly effective are adjusted to fair value through earnings. The amount of net unrealized gains on cash flow hedges was $12 million and $51 million, respectively, as of June 30, 2023 and as of July 1, 2022. As of June 30, 2023, the amount of existing net gains related to cash flow hedges recorded in AOCI included a net gain of $39 million that is expected to be reclassified to earnings within twelve months.
Establishment of Warranty Accruals	Warranty. The Company estimates probable product warranty costs at the time revenue is recognized. The Company generally provides warranty on its products for a period of 1 to 5 years. The Company's warranty provision considers estimated product failure rates, trends (including the timing of product returns during the warranty periods), and estimated repair or replacement costs related to product quality issues, if any. The Company also exercises judgement in estimating its ability to sell refurbished products.
Revenue Recognition, Sales Returns and Allowances, and Sales Incentive Programs	Revenue Recognition and Sales Incentive Programs. The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, the Company satisfies a performance obligation. Revenue from sales of products is generally recognized upon transfer of control to customers in an amount that reflects the consideration the Company expects to receive in exchange for those products, net of sales taxes. This typically occurs upon shipment from the Company. When applicable, the Company includes shipping charges billed to customers in Revenue and includes the related shipping costs in Cost of revenue on the Company's Consolidated Statements of Operations. The Company records estimated variable consideration at the time of revenue recognition as a reduction to revenue. Variable consideration generally consists of sales incentive programs, such as price protection and volume incentives aimed at increasing customer demand. For original equipment manufacturers (“OEMs”) sales, rebates are typically established by estimating the most likely amount of consideration expected to be received based on an OEM customer’s volume of purchases from the Company or other agreed upon rebate programs. For the distribution and retail channel, these programs typically involve estimating the most likely amount of rebates related to a customer’s level of sales, order size, advertising or point of sale activity as well as the expected value of price protection adjustments based on historical analysis and forecasted pricing environment. Marketing development program costs are accrued and recorded as a reduction to revenue at the same time that the related revenue is recognized.
Restructuring Costs	Restructuring Costs. The timing of recognition for severance costs depends on whether employees are required to render service until they are terminated in order to receive the termination benefits. If employees are required to render service until they are terminated in order to receive the termination benefits, a liability is recognized ratably over the future service period. Otherwise, a liability is recognized when management has committed to a restructuring plan and has communicated those actions to employees. Employee termination benefit costs covered by existing benefit arrangements are recognized when management has committed to a restructuring plan and the severance costs are probable and estimable.
Advertising Expense	Advertising Expense. The cost of advertising is expensed as incurred. Advertising costs were approximately $30 million, $34 million and $29 million in fiscal years 2023, 2022 and 2021, respectively.
Stock-Based Compensation	Share-Based Compensation. The Company accounts for share-based compensation net of estimated forfeitures. Refer to Note 11. Share-Based Compensation for details.
Accounting for Income Taxes	Accounting for Income Taxes. The Company records a provision or benefit for income taxes for the anticipated tax consequences of the reported results of operations using the asset and liability method. Deferred income tax expense or benefit is recognized by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases as well as net operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance for any tax benefits for which future realization is uncertain
Financial Instruments Remeasurement	Equity Investments. From time to time, the Company enters into certain strategic investments for the promotion of business and strategic objectives, which are accounted for either under equity method or the measurement alternative. These investments are included in Other assets, net in the Company's Consolidated Balance Sheets and are adjusted through Other, net in the Consolidated Statement of Operations. Investments are accounted for under the equity method if the Company has the ability to exercise significant influence, but does not have a controlling financial interest. These investments are measured at cost, less any impairment plus the Company's portion of investee’s income or loss. The Company uses the financial statements of investees to determine any adjustments, which are received on a one-quarter lag. For equity investments where the Company does not have the ability to exercise significant influence and there are no readily determinable fair values, the Company has elected to apply the measurement alternative, under which investments are measured at cost, less impairment, and adjusted for qualifying observable price changes on a prospective basis. The Company’s strategic investments are periodically analyzed to determine whether or not there are indicators of impairment by assessing factors such as deterioration of earnings, adverse change in market/industry conditions, the ability to operate as a going concern, and other factors which indicate that the carrying amount of the investment might not be recoverable. In such a case, the decrease in value is recognized in the period the impairment occurs in the Consolidated Statements of Operations.
Comprehensive Income	Comprehensive Income. The Company presents comprehensive income in a separate statement. Comprehensive income is comprised of net income and other gains and losses affecting equity that are excluded from net income.
Foreign Currency Remeasurement and Translation	Foreign Currency Remeasurement and Translation. The U.S. dollar is the functional currency for the majority of the Company's foreign operations. Monetary assets and liabilities denominated in foreign currencies are remeasured into the functional currency of the subsidiary at the balance sheet date. The gains and losses from the remeasurement of foreign currency denominated balances into the functional currency of the subsidiary are included in Other, net on the Company's Consolidated Statements of Operations. The Company’s subsidiaries that use the U.S. dollar as their functional currency remeasure monetary assets and liabilities at exchange rates in effect at the end of each period, and nonmonetary assets and liabilities at historical rates. The Company translates the assets and liabilities of its non-U.S. dollar functional currency subsidiaries into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses for these subsidiaries are translated using rates that approximate those in effect during the period. Gains and losses from these translations are recognized in foreign currency translation included in Accumulated other comprehensive income, which is a component of Shareholders’ (Deficit) Equity. Government Incentives. The Company enters into government incentive arrangements with domestic and foreign, local, regional and national governments, which vary in size, duration and conditions. The Company receives primarily operating grants, which are recognized as a reduction of expenditures when there is reasonable assurance that the grant will be received and the Company will comply with the conditions specified in the grant agreement. In fiscal year 2023, approximately $13 million of operating grants were recognized as reductions to Cost of revenue and Product development in the Consolidated Statements of Operations. The Company also received advanced cash grants of $13 million, which were reflected within Accrued expenses in the Company's Consolidated Balance Sheets as of June 30, 2023.
Concentration of Credit Risk	Concentration of Credit Risk. The Company’s customer base is concentrated with a small number of customers. The Company does not generally require collateral or other security to support accounts receivable. To reduce credit risk, the Company performs ongoing credit evaluations on its customers’ financial condition. The Company establishes allowances for expected credit losses based upon factors surrounding the credit risk of customers, global macroeconomic conditions and an analysis of specific exposures. Two customers and one customer accounted for more than 10% of the Company’s accounts receivable as of June 30, 2023 and July 1, 2022, respectively. Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash equivalents, investments and foreign currency forward exchange contracts. The Company mitigates concentrations of credit risk in its financial instruments through diversification, by investing in highly-rated securities and/or major multinational companies. In entering into foreign currency forward exchange contracts, the Company assumes the risk that might arise from the possible inability of counterparties to meet the terms of their contracts. The counterparties to these contracts are major multinational commercial and investment banks, and the Company has not incurred and does not expect any losses as a result of counterparty defaults.
Concentration Risk, Supplier	Supplier Concentration. Certain of the raw materials, components and equipment used by the Company in the manufacture of its products are available from single-sourced direct and indirect vendors. Shortages could occur in these essential materials and components due to an interruption of supply or increased demand in the industry. If the Company were unable to procure certain materials, components or equipment at all or acceptable prices, it would be required to reduce its manufacturing operations, which could have a material adverse effect on its results of operations. In addition, the Company may make prepayments to certain suppliers or enter into minimum volume commitment agreements. Should these suppliers be unable to deliver on their obligations or experience financial difficulty, the Company may not be able to recover these prepayments.
Recent Accounting Pronouncements	Recently Adopted Accounting Pronouncements In March 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-04 (ASC Topic 848), Reference Rate Reform . This ASU provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. In December 2022, FASB issued ASU 2022-06 (ASC Topic 848) and deferred the sunset date from December 31, 2022 to December 31, 2024. The Company adopted the guidance in the quarter ended September 30, 2022 on a prospective basis and is transitioning from an interest rate based on London Interbank Offered Rate (“LIBOR”) to Secured Overnight Financing Rate (“SOFR”). The adoption of this ASU did not have a material impact on the Company’s consolidated financial statements. In November 2021, the FASB issued ASU 2021-10 (ASC Topic 832), Disclosures by Business Entities about Government Assistance . This ASU requires annual disclosures that increase the transparency of transactions involving government grants, including (1) the type of transactions, (2) the accounting for those transactions and (3) the effect of those transactions on an entity’s financial statements. The Company adopted this guidance for the fiscal year ended June 30, 2023 on a prospective basis. See “Government Incentives” for further details. Recently Issued Accounting Pronouncements In September 2022, the FASB issued ASU 2022-04 (ASC Subtopic 405-50), Disclosure of Supplier Finance Program Obligations . This ASU requires disclosure of key terms of the outstanding supplier finance programs and a roll forward of the related obligations. The Company will adopt this in the first quarter of fiscal year 2024 and provide additional disclosure. The Company does not expect the adoption of this ASU to have a material impact on its consolidated financial statements. In June 2022, the FASB issued ASU 2022-03 (ASC Topic 820), Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions
Fair Value, Policy	Measurement of Fair Value Fair value is defined as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact and it considers assumptions that market participants would use when pricing the asset or liability. Fair Value Hierarchy A fair value hierarchy is based on whether the market participant assumptions used in determining fair value are obtained from independent sources (observable inputs) or reflect the Company's own assumptions of market participant valuation (unobservable inputs). A financial instrument's categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The three levels of inputs that may be used to measure fair value are: Level 1 - Quoted prices in active markets that are unadjusted and accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 - Quoted prices for identical assets and liabilities in markets that are inactive; quoted prices for similar assets and liabilities in active markets or financial instruments for which significant inputs are observable, either directly or indirectly; or Level 3 - Prices or valuations that require inputs that are both unobservable and significant to the fair value measurement. The Company considers an active market to be one in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis and views an inactive market as one in which there are few transactions for the asset or liability, the prices are not current, or price quotations vary substantially either over time or among market makers. Where appropriate, the Company’s or the counterparty’s non-performance risk is considered in determining the fair values of liabilities and assets, respectively.

Derivative Instruments and Hedg

Derivative Instruments and Hedging Activities (Policies)	12 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments. The Company records all derivatives on the balance sheet at fair value and establishes criteria for designation and effectiveness of hedging relationships. The Company excludes the change in forward points from the assessment of hedge effectiveness and recognizes the excluded component in Other, net in the Consolidated Statements of Operations. Foreign currency forward exchange contracts not designated as hedge instruments are used to economically hedge the foreign currency exposure on forecasted expenditures in currencies other than U.S. dollar. The Company recognizes the unrealized gains and losses due to the changes in the fair value of these contracts, as well as the related costs in Other, net in the Consolidated Statements of Operations. The Company is exposed to foreign currency exchange rate, interest rate and to a lesser extent, equity market risks relating to its ongoing business operations. From time to time, the Company enters into cash flow hedges in the form of foreign currency forward exchange contracts in order to manage the foreign currency exchange rate risk on forecasted expenses and investments denominated in foreign currencies. The Company has entered into certain interest rate swap agreements to convert the variable interest rate on its Term Loans to fixed interest rates. The objective of the interest rate swap agreements is to eliminate the variability of interest payment cash flows associated with the variable interest rate under the Term Loans. The Company designated the interest rate swaps as cash flow hedges. In September 2022, the Company terminated its then existing interest swap agreements relating to Term Loans A1 and A2 and entered into new interest swap agreements with a notional amount of $1.6 billion, to convert the variable interest rate on certain principal amounts of the Term Loans drawn under its Credit Agreement. The Company received cash proceeds of $110 million from the counterparty. The cash proceeds were reported within Net cash provided by operating activities in the Company’s Consolidated Statement of Cash Flows. The Company discontinued the related hedge accounting prospectively and as a result the realized gain of $110 million was accounted and reported in AOCI and is amortized to Interest expense in the Consolidated Statement of Operations over the remaining period of the Term Loans A1 and A2. During fiscal year 2023, $22 million of the gains were amortized to Interest expense in the Company’s Consolidated Statements of Operations. In June 2023, in connection with the $450 million of early repayment of a portion of the outstanding Term Loans principal, the Company terminated $300 million of its then existing interest swap agreements relating to Term Loans A1 and A2 with an immaterial loss. The Company entered into a new interest swap agreement relating to Term Loan A3 with a notional amount of $45 million, to convert the variable interest rate on certain principal amounts of the Term Loans drawn under its Credit Agreement. The Company discontinued the related hedge accounting prospectively and as a result the immaterial realized loss was recorded in Interest expense in the Company’s Consolidated Statement of Operations in fiscal year 2023. As of June 30, 2023, the aggregate notional amount of the Company’s interest-rate swap contracts was $1.3 billion, of which $429 million will mature through September 2025 and $859 million will mature through July 2027. The Company’s accounting policies for these instruments are based on whether the instruments are classified as designated or non-designated hedging instruments. The Company records all derivatives on its Consolidated Balance Sheets at fair value. The changes in the fair value of highly effective designated cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. Derivatives that are not designated as hedging instruments or are not assessed to be highly effective are adjusted to fair value through earnings. The amount of net unrealized gains on cash flow hedges was $12 million and $51 million, respectively, as of June 30, 2023 and as of July 1, 2022. As of June 30, 2023, the amount of existing net gains related to cash flow hedges recorded in AOCI included a net gain of $39 million that is expected to be reclassified to earnings within twelve months.

Balance Sheet Information (Tabl

Balance Sheet Information (Tables)	12 Months Ended
	Jun. 30, 2023
Disclosure Text Block Supplement [Abstract]
Summary of Debt Securities, Available-for-sale	The following table summarizes, by major type, the fair value and amortized cost of the Company’s available-for-sale debt investments as of June 30, 2023 and July 1, 2022: June 30, July 1, (Dollars in millions) Amortized Unrealized Fair Amortized Unrealized Fair Available-for-sale debt securities: Money market funds $ 73 $ — $ 73 $ 60 $ — $ 60 Time deposits and certificates of deposit 1 — 1 1 — 1 Other debt securities 16 — 16 23 — 23 Total $ 90 $ — $ 90 $ 84 $ — $ 84 Included in Cash and cash equivalents $ 72 $ 59 Included in Other current assets 2 2 Included in Other assets, net 16 23 Total $ 90 $ 84
Fair value and amortized cost of available-for-sale securities by contractual maturity	June 30, 2023, by remaining contractual maturity were as follows: (Dollars in millions) Amortized Fair Due in less than 1 year $ 74 $ 74 Due in 1 to 5 years 15 15 Due in 6 to 10 years — — Thereafter 1 1 Total $ 90 $ 90
Cash, Cash Equivalent, and Restricted Cash	The following table provides a summary of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets that reconciles to the corresponding amount in the Consolidated Statements of Cash Flows: (Dollars in millions) June 30, July 1, July 2, Cash and cash equivalents $ 786 $ 615 $ 1,209 Restricted cash included in Other current assets 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 788 $ 617 $ 1,211
Schedule of Cash and Cash Equivalents	The following table provides a summary of cash, cash equivalents and restricted cash reported within the Consolidated Balance Sheets that reconciles to the corresponding amount in the Consolidated Statements of Cash Flows: (Dollars in millions) June 30, July 1, July 2, Cash and cash equivalents $ 786 $ 615 $ 1,209 Restricted cash included in Other current assets 2 2 2 Total cash, cash equivalents and restricted cash shown in the Statements of Cash Flows $ 788 $ 617 $ 1,211
Accounts Receivable, net	The following table provides details of the accounts receivable, net balance sheet item: (Dollars in millions) June 30, July 1, Accounts receivable $ 625 $ 1,536 Allowances for expected credit losses (4) (4) Account receivable, net $ 621 $ 1,532
Accounts Receivable, Allowance for Credit Loss	Activity in the expected credit losses accounts is as follows: (Dollars in millions) Balance at Beginning of Period Charges (Credit) to Operations Deductions (1) Balance at End of Period Fiscal year ended July 2, 2021 $ 5 — (1) $ 4 Fiscal year ended July 1, 2022 $ 4 — — $ 4 Fiscal year ended June 30, 2023 $ 4 — — $ 4 ______________________________________________ (1) Uncollectible accounts written off, net of recoveries.
Inventories	The following table provides details of the inventory balance sheet item: (Dollars in millions) June 30, July 1, Raw materials and components $ 241 $ 283 Work-in-process 682 716 Finished goods 217 566 Total inventories $ 1,140 $ 1,565 The Company reclassified certain Raw materials and components to Work-in-process as of July 1, 2022 in the table above to conform to the current year’s presentation. The reclassification did not result in any change to the total inventories balance as reported in the Consolidated Balance Sheets and Statements of Cash Flows for all periods presented.
Schedule of Other Current Assets	The following table provides details of the other current assets balance sheet item: (Dollars in millions) June 30, July 1, Vendor receivables $ 167 $ 83 Other current assets 191 238 Total $ 358 $ 321
Property, Equipment and Leasehold Improvements, net	The components of property, equipment and leasehold improvements, net were as follows: (Dollars in millions) Useful Life in Years June 30, July 1, Land and land improvements $ 21 $ 47 Equipment 3 – 7 8,504 8,473 Buildings and leasehold improvements Up to 30 1,435 1,893 Construction in progress 307 246 10,267 10,659 Less: accumulated depreciation and amortization (8,561) (8,420) Property, equipment and leasehold improvements, net $ 1,706 $ 2,239
Accrued Expenses	The following table provides details of the accrued expenses balance sheet item: (Dollars in millions) June 30, July 1, Dividends payable $ 145 $ 147 Other accrued expenses 603 449 Total $ 748 $ 596
Accumulated Other Comprehensive Income (Loss)	The components of AOCI, net of tax, were as follows: (Dollars in millions) Unrealized Gains/(Losses) on Cash Flow Hedges Unrealized Gains/(Losses) on Post-Retirement Plans Foreign Currency Translation Adjustments Total Balance at July 2, 2021 $ (18) $ (22) $ (1) $ (41) Other comprehensive income before reclassifications 48 6 — 54 Amounts reclassified from AOCI 21 2 — 23 Other comprehensive income 69 8 — 77 Balance at July 1, 2022 51 (14) (1) 36 Other comprehensive income before reclassifications 65 11 — 76 Amounts reclassified from AOCI (13) (1) — (14) Other comprehensive income 52 10 — 62 Balance at June 30, 2023 $ 103 $ (4) $ (1) $ 98

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Expected amortization expense for acquisition-related intangible assets	The carrying value of other intangible assets subject to amortization, excluding fully amortized intangible assets, as of June 30, 2023, is set forth in the following table: (Dollars in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Existing technology $ 10 $ (10) $ — 0.1 Year Total amortizable other intangible assets $ 10 $ (10) $ — 0.1 Year The carrying value of other intangible assets subject to amortization, excluding fully amortized intangible assets, as of July 1, 2022 is set forth in the following table: (Dollars in millions) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Existing technology $ 29 $ (24) $ 5 1.0 Year Customer relationships 71 (68) 3 0.2 Year Other intangible assets 8 (7) 1 0.8 Year Total amortizable other intangible assets $ 108 $ (99) $ 9 0.8 Year

Debt (Tables)

Debt (Tables)	12 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The following table provides details of the Company’s debt as of June 30, 2023 and July 1, 2022: (Dollars in millions) June 30, July 1, Unsecured Senior Notes (1) $1,000 issued on May 22, 2013 at 4.75% due June 1, 2023 (the “2023 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. $ — $ 540 $500 issued on February 3, 2017 at 4.875% due March 1, 2024 (the “2024 Notes”) , interest payable semi-annually on March 1 and September 1 of each year. — 499 $1,000 issued on May 28, 2014 at 4.75% due January 1, 2025 (the “2025 Notes”) , interest payable semi-annually on January 1 and July 1 of each year. 479 479 $700 issued on May 14, 2015 at 4.875% due June 1, 2027 (the “2027 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 504 504 $500 issued on June 18, 2020 at 4.091% due June 1, 2029 (the “June 2029 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 465 466 $500 issued on December 8, 2020 at 3.125% due July 15, 2029 (the “July 2029 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 163 500 $500 issued on May 30, 2023 at 8.25% due December 15, 2029 ( the “December 2029 Notes” ), interest payable semi-annually on June 15 and December 15 of each year. 500 — $500 issued on June 10, 2020 at 4.125% due January 15, 2031 (the “January 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 275 500 $500 issued on December 8, 2020 at 3.375% due July 15, 2031 (the “July 2031 Notes”) , interest payable semi-annually on January 15 and July 15 of each year. 72 500 $500 issued on May 30, 2023 at 8.50% due July 15, 2031 ( the “8.50% July 2031 Notes” ), interest payable semi-annually on January 15 and July 15 of each year. 500 — $750 issued on November 30, 2022 at 9.625% due December 1, 2032 (the “2032 Notes”), interest payable semi-annually on June 1 and December 1 of each year. 750 — $500 issued on December 2, 2014 at 5.75% due December 1, 2034 (the “2034 Notes”) , interest payable semi-annually on June 1 and December 1 of each year. 489 489 Term Loan $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.125% to 2.375%, ( the “Term Loan A1”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of September 16, 2025. 430 600 $600 borrowed on October 14, 2021 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A2”) , repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. 430 600 $600 borrowed on August 18, 2022 at SOFR plus a variable margin ranging from 1.25% to 2.5%, ( the “Term Loan A3 ”), repayable in quarterly installments beginning on December 31, 2022, with a final maturity date of July 30, 2027. 430 — 5,487 5,677 Less: unamortized debt issuance costs (36) (31) Debt, net of debt issuance costs 5,451 5,646 Less: current portion of long-term debt (63) (584) Long-term debt, less current portion $ 5,388 $ 5,062 ___________________________________ (1 ) All unsecured senior notes are issued by Seagate HDD Cayman (“Seagate HDD”), and the obligations under these notes are fully and unconditionally guaranteed, on a senior unsecured basis, by Seagate Technology Unlimited Company (“STUC”) and STX .
Future principal payments on long-term debt	At June 30, 2023, future principal payments on long-term debt were as follows (in millions): Fiscal Year Amount 2024 $ 63 2025 582 2026 497 2027 612 2028 519 Thereafter 3,245 Total $ 5,518

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Schedule of Income Before Income Tax Expense (Benefit)	(Loss) income before income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, U.S. $ 300 $ 145 $ 191 Non-U.S. (796) 1,534 1,157 $ (496) $ 1,679 $ 1,348
Schedule of Provision For (Benefits From) Income Taxes	The provision for income taxes consisted of the following: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Current income tax expense: U.S. $ 6 $ 4 $ — Non-U.S. 17 35 38 Total Current 23 39 38 Deferred income tax expense/(benefit): U.S. 9 3 8 Non-U.S. 1 (12) (12) Total Deferred 10 (9) (4) Provision for income taxes $ 33 $ 30 $ 34
Schedule of Deferred Tax Assets and Liabilities	The significant components of the Company’s deferred tax assets and liabilities were as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, Deferred tax assets Accrued warranty $ 38 $ 34 Inventory carrying value adjustments 40 43 Receivable allowances 11 20 Accrued compensation and benefits 43 73 Capitalized research expenses 119 — Depreciation 40 45 Restructuring accruals 14 — Lease liabilities 62 5 Other accruals and deferred items 14 19 Net operating losses 542 671 Tax credit carryforwards 619 650 Other assets 1 1 Gross: Deferred tax assets 1,543 1,561 Less: Valuation allowance (370) (434) Net: Deferred tax assets 1,173 1,127 Deferred tax liabilities Unremitted earnings of certain non-U.S. entities (4) (5) Acquisition-related items (1) (2) Right-of-use assets (62) (5) Other liabilities (2) — Net: Deferred tax liabilities (69) (12) Total net deferred tax assets $ 1,104 $ 1,115
Schedule of Reconciliation Between the Provision for Income Taxes at the Statutory Rate and the Effective Tax Rate	For purposes of the reconciliation between the provision for income taxes at the statutory rate and the effective tax rate, the Irish statutory rate of 25% was applied as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, (Benefit) provision at statutory rate $ (124) $ 420 $ 337 Permanent differences 8 5 8 Valuation allowance (18) 7 (2) Effect of rates different than statutory 178 (371) (287) Research credit (18) (26) (27) Other individually immaterial items 7 (5) 5 Provision for income taxes $ 33 $ 30 $ 34
Schedule of Gross Unrecognized Tax Benefits	The following table summarizes the activities related to the Company’s gross unrecognized tax benefits: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Balance of unrecognized tax benefits at the beginning of the year $ 114 $ 108 $ 89 Gross increase for tax positions of prior years — 1 7 Gross decrease for tax positions of prior years (4) (1) (1) Gross increase for tax positions of current year 7 6 15 Gross decrease for tax positions of current year (1) — — Settlements — — (1) Lapse of statutes of limitation — — (1) Balance of unrecognized tax benefits at the end of the year $ 116 $ 114 $ 108

Leases, Codification Topic 842

Leases, Codification Topic 842 (Tables)	12 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Lease, Cost	Operating lease costs include short-term lease costs and are shown net of immaterial sublease income. The components of lease costs and other information related to leases were as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Operating lease cost $ 21 $ 16 $ 15 Variable lease cost 3 4 4 Total lease cost $ 24 $ 20 $ 19 Operating cash outflows from operating leases $ 23 $ 20 $ 19 During fiscal year 2023, the Company obtained $353 million ROU assets in exchange for new operating lease liabilities. In fiscal years 2022 and 2021 the ROU assets obtained in exchange for new operating lease liabilities were immaterial. June 30, July 1, July 2, Weighted-average remaining lease term 9.6 years 9.3 years 7.2 years Weighted-average discount rate 8.49 % 6.40 % 6.02 % ROU assets and lease liabilities are included on the Company’s Consolidated Balance Sheet as follows: (Dollars in millions) Balance Sheet Location June 30, July 1, ROU assets Other assets, net $ 396 $ 94 Current lease liabilities Accrued expenses 51 14 Non-current lease liabilities Other non-current liabilities 333 36
Lessee, Operating Lease, Liability, Maturity	At June 30, 2023, future lease payments included in the measurement of lease liabilities were as follows (in millions): Fiscal Year Amount 2024 $ 53 2025 55 2026 55 2027 55 2028 56 Thereafter 290 Total lease payments 564 Less: imputed interest (180) Present value of lease liabilities $ 384

Restructuring and Exit Costs (T

Restructuring and Exit Costs (Tables)	12 Months Ended
	Jun. 30, 2023
Restructuring and Related Activities [Abstract]
Schedule of Restructuring Reserve by Cost Type	The following table summarizes the Company’s restructuring activities under its active restructuring plans for fiscal years 2023, 2022 and 2021: April 2023 Plan October 2022 Plan Other Plans (Dollars in millions) Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Workforce Reduction Costs Facilities and Other Exit Costs Total Accrual balances at July 3, 2020 $ — $ — $ — $ — $ 43 $ 5 $ 48 Restructuring charges — — — — 6 8 14 Cash payments — — — — (47) (6) (53) Adjustments — — — — — (1) (1) Accrual balances at July 2, 2021 — — — — 2 6 8 Restructuring charges — — — — 2 1 3 Cash payments — — — — (4) (2) (6) Adjustments — — — — — — — Accrual balances at July 1, 2022 — — — — — 5 5 Restructuring charges 145 3 104 7 10 — 269 Cash payments (37) (3) (103) (1) (10) (1) (155) Adjustments — — — (1) 1 — — Accrual balances at June 30, 2023 $ 108 $ — $ 1 $ 5 $ 1 $ 4 $ 119 Total costs incurred to date as of June 30, 2023 $ 145 $ 3 $ 104 $ 7 $ 73 $ 24 $ 356 Total expected costs to be incurred as of June 30, 2023 $ — $ — $ — $ — $ — $ 1 $ 1

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	12 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of notional value of outstanding foreign currency forward exchange contracts	The following tables show the total notional value of the Company’s outstanding foreign currency forward exchange contracts as of June 30, 2023 and July 1, 2022. All of the foreign currency forward exchange contracts mature within 12 months. As of June 30, 2023 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 195 $ 161 Thai Baht 129 16 Chinese Renminbi 64 12 British Pound Sterling 57 8 $ 445 $ 197 As of July 1, 2022 (Dollars in millions) Contracts Designated as Hedges Contracts Not Designated as Hedges Singapore Dollar $ 178 $ 52 Thai Baht 133 35 Chinese Renminbi 92 24 British Pound Sterling 64 15 $ 467 $ 126
Schedule of gross fair value of derivative instruments	The following tables show the Company’s derivative instruments measured at gross fair value as reflected in the Consolidated Balance Sheets as of June 30, 2023 and July 1, 2022: As of June 30, 2023 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ 2 Accrued expenses $ (10) Interest rate swap Other current assets 20 Accrued expenses — Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets — Accrued expenses (1) Total return swap Other current assets 1 Accrued expenses — Total derivatives $ 23 $ (11) As of July 1, 2022 Derivative Assets Derivative Liabilities (Dollars in millions) Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedging instruments: Foreign currency forward exchange contracts Other current assets $ — Accrued expenses $ (14) Interest rate swap Other current assets 65 Accrued expenses — Derivatives not designated as hedging instruments: Foreign currency forward exchange contracts Other current assets — Accrued expenses (5) Total return swap Other current assets — Accrued expenses (4) Total derivatives $ 65 $ (23)
Schedule of the effect of derivative instruments on Other comprehensive income (loss) OCI and the Consolidated Statement of Operations	The following tables show the effect of the Company’s derivative instruments on the Consolidated Statement of Comprehensive Income and Consolidated Statement of Operations for the fiscal year ended June 30, 2023: Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Amount of Gain/(Loss) Recognized in Foreign currency forward exchange contracts Other, net $ (7) Total return swap Operating expenses 6 (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency forward exchange contracts $ (6) Cost of revenue $ 16 Other, net $ (4) Interest rate swap 71 Interest expense (29) Interest expense — The following tables show the effect of the Company’s derivative instruments on the Consolidated Statement of Comprehensive Income and Consolidated Statement of Operations for the fiscal year ended July 1, 2022: Derivatives Not Designated as Hedging Instruments Location of Gain/(Loss) Recognized in Amount of Gain/(Loss) Recognized in Foreign currency forward exchange contracts Other, net $ (9) Total return swap Operating expenses (18) (Dollars in millions) Derivatives Designated as Hedging Instruments Amount of Gain/(Loss) Recognized in OCI on Derivatives (Effective Portion) Location of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Amount of Gain/(Loss) Reclassified from Accumulated OCI into Income (Effective Portion) Location of Gain/(Loss) Recognized in Income on Derivatives (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amount of Gain/(Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing) Foreign currency forward exchange contracts $ (22) Cost of revenue $ (11) Other, net $ 1 Interest rate swap 70 Interest expense (10) Interest expense —

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following tables present the Company’s assets and liabilities, by financial instrument type and balance sheet line item that are measured at fair value on a recurring basis, excluding accrued interest components, as of: June 30, 2023 July 1, 2022 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (US Dollars in millions) Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Assets: Money market funds $ 72 $ — $ — $ 72 $ 59 $ — $ — $ 59 Total cash equivalents 72 — — 72 59 — — 59 Restricted cash and investments: Money market funds 1 — — 1 1 — — 1 Time deposits and certificates of deposit — 1 — 1 — 1 — 1 Other debt securities — — 16 16 — — 23 23 Derivative assets — 23 — 23 — 65 — 65 Total assets $ 73 $ 24 $ 16 $ 113 $ 60 $ 66 $ 23 $ 149 Liabilities: Derivative liabilities $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23 Total liabilities $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23
Schedule of Fair Value, by Balance Sheet Grouping, Measured on Recurring Basis	June 30, 2023 July 1, 2022 Fair Value Measurements at Reporting Date Using Fair Value Measurements at Reporting Date Using (US Dollars in millions) Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Quoted Prices in Active Markets for Identical Instruments Significant Other Observable Inputs Significant Unobservable Inputs Total Assets: Cash and cash equivalents $ 72 $ — $ — $ 72 $ 59 $ — $ — $ 59 Other current assets 1 24 — 25 1 66 — 67 Other assets, net — — 16 16 — — 23 23 Total assets $ 73 $ 24 $ 16 $ 113 $ 60 $ 66 $ 23 $ 149 Liabilities: Accrued expenses $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23 Total liabilities $ — $ 11 $ — $ 11 $ — $ 23 $ — $ 23
Schedule of Carrying Values and Estimated Fair Values of Debt Instruments	The Company’s debt is carried at amortized cost. The estimated fair value of the Company’s debt is derived using the closing price of the same debt instruments as of the date of valuation, which takes into account the yield curve, interest rates and other observable inputs. Accordingly, these fair value measurements are categorized as Level 2. The following table presents the fair value and amortized cost of the Company’s debt in order of maturity: June 30, 2023 July 1, 2022 (Dollars in millions) Carrying Estimated Carrying Estimated 4.750% Senior Notes due June 2023 $ — $ — $ 540 $ 538 4.875% Senior Notes due March 2024 — — 499 494 4.750% Senior Notes due January 2025 479 472 479 471 4.875% Senior Notes due June 2027 504 484 504 483 4.091% Senior Notes due June 2029 465 436 466 427 3.125% Senior Notes due July 2029 163 126 500 396 8.250% Senior Notes due December 2029 500 522 — — 4.125% Senior Notes due January 2031 275 227 500 410 3.375% Senior Notes due July 2031 72 53 500 393 8.500% Senior Notes due July 2031 500 524 — — 9.625% Senior Notes due December 2032 750 830 — — 5.750% Senior Notes due December 2034 489 438 489 433 SOFR Based Term Loan A1 due September 2025 430 426 600 588 SOFR Based Term Loan A2 due July 2027 430 420 600 586 SOFR Based Term Loan A3 due July 2027 430 413 — — $ 5,487 $ 5,371 $ 5,677 $ 5,219 Less: unamortized debt issuance costs (36) — (31) — Debt, net of debt issuance costs $ 5,451 $ 5,371 $ 5,646 $ 5,219 Less: current portion of debt, net of debt issuance costs (63) (62) (584) (582) Long-term debt, less current portion, net of debt issuance costs $ 5,388 $ 5,309 $ 5,062 $ 4,637

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	12 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Schedule of Share Repurchases	The following table sets forth information with respect to repurchases of the Company’s ordinary shares during fiscal years 2023, 2022 and 2021: (In millions) Number of Shares Repurchased Dollar Value of Shares Repurchased Cumulative repurchased through July 3, 2020 392 $ 12,386 Repurchased in fiscal year 2021 (1) 34 2,081 Cumulative repurchased through July 2, 2021 426 14,467 Repurchased in fiscal year 2022 (1) 21 1,857 Cumulative repurchased through July 1, 2022 447 16,324 Repurchased in fiscal year 2023 (1) 6 444 Cumulative repurchased through June 30, 2023 453 $ 16,768 ___________________________________________________ (1) For fiscal years 2023, 2022 and 2021, includes net share settlements of $44 million, $51 million and $33 million for 1 million, 1 million and 1 million shares, respectively, in connection with tax withholding related to vesting of restricted share units .

Share-based Compensation (Table

Share-based Compensation (Tables)	12 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Weighted-average assumptions used to determine the fair value	The fair value of the Company’s shares related to options and RSUs granted to employees, shares issued from the ESPP and PSUs subject to TSR/ROIC or AEPS conditions for fiscal years 2023, 2022 and 2021 were estimated using the following assumptions: Fiscal Years 2023 2022 2021 Options Expected term (in years) 4.2 4.2 4.2 Volatility 37 % 38 % 37 - 38 % Weighted-average volatility 37 % 38 % 38 % Expected dividend rate 3.7 % 2.8 % 3.2 - 5.2 % Weighted-average expected dividend rate 3.7 % 2.8 % 4.7 % Risk-free interest rate 3.5 % 0.6 % 0.2 - 0.7 % Weighted-average fair value $ 17.28 $ 21.02 $ 10.77 RSUs Expected term (in years) 1 - 2.2 1 - 2.5 1 - 2.5 Expected dividend rate 3.2 - 5.5 % 2.4 - 3.4 % 2.5 - 5.4 % Weighted-average expected dividend rate 3.8 % 2.8 % 4.6 % Weighted-average fair value $ 62.82 $ 82.40 $ 50.64 ESPP Expected term (in years) 0.5 0.5 0.5 Volatility 39 - 40 % 36 - 39 % 39 - 44 % Weighted-average volatility 39 % 37 % 42 % Expected dividend rate 3.5 - 4.0 % 2.6 - 3.0 % 4.0 - 5.8 % Weighted-average expected dividend rate 3.8 % 2.8 % 5.1 % Risk-free interest rate 2.9 - 4.7 % 0.1 - 0.5 % 0.1 % Weighted-average fair value $ 19.36 $ 24.38 $ 13.77 PSUs subject to TSR/ROIC conditions Expected term (in years) 3.0 3.0 3.0 Volatility 40 % 39 % 38 % Weighted-average volatility 40 % 39 % 38 % Expected dividend rate 4.1 % 3.1 % 5.6 % Weighted-average expected dividend rate 4.1 % 3.1 % 5.6 % Risk-free interest rate 3.6 % 0.4 % 0.2 % Weighted-average fair value $ 64.38 $ 86.01 $ 43.20 PSUs subject to an AEPS condition Expected term (in years) 0 0 2.5 Expected dividend rate — — 3.2 - 5.2 % Weighted-average expected dividend rate — — 4.9 % Weighted-average fair value — — $ 45.50
Stock option activity	The Company issues new ordinary shares upon exercise of share options. The following is a summary of option activities: Options Number of Shares (In millions) Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (In years) Aggregate Intrinsic Value (Dollars in millions) Outstanding at July 1, 2022 1.6 $ 49.26 3.6 $ 36 Granted 0.2 $ 68.83 Exercised (0.2) $ 41.47 Forfeited (0.1) $ 72.13 Outstanding at June 30, 2023 1.5 $ 51.96 2.9 $ 21 Vested and expected to vest at June 30, 2023 1.5 $ 51.78 2.8 $ 21 Exercisable at June 30, 2023 1.1 $ 46.60 2.0 $ 20
Nonvested share activity	The following is a summary of unvested award activities which do not contain a performance condition: Unvested Awards Number of Shares (In millions) Weighted-Average Grant-Date Fair Value Unvested at July 1, 2022 4.8 $ 58.86 Granted 1.8 $ 62.82 Forfeited (1.0) $ 61.86 Vested (1.9) $ 54.79 Unvested at June 30, 2023 3.7 $ 62.07
Performance award activity	The following is a summary of unvested award activities which contain a performance condition: Performance Awards Number of Shares (In millions) Weighted-Average Grant-Date Fair Value Performance units at July 1, 2022 0.9 $ 59.72 Granted 0.4 $ 60.72 Forfeited (0.2) $ 64.46 Vested (0.4) $ 51.30 Performance units at June 30, 2023 0.7 $ 64.29

Guarantees (Tables)

Guarantees (Tables)	12 Months Ended
	Jun. 30, 2023
Guarantees [Abstract]
Schedule of Product Warranty Liability	Changes in the Company’s product warranty liability during the fiscal years ended June 30, 2023, July 1, 2022 and July 2, 2021 were as follows: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Balance, beginning of period $ 148 $ 136 $ 151 Warranties issued 55 79 76 Repairs and replacements (92) (88) (81) Changes in liability for pre-existing warranties, including expirations 57 21 (10) Balance, end of period $ 168 $ 148 $ 136

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted net income (loss) per share	The following table sets forth the computation of basic and diluted net (loss) income per share attributable to the shareholders of the Company: Fiscal Years Ended (In millions, except per share data) June 30, July 1, July 2, Numerator: Net (loss) income $ (529) $ 1,649 $ 1,314 Number of shares used in per share calculations: Total shares for purposes of calculating basic net (loss) income per share 207 220 242 Weighted-average effect of dilutive securities: Employee equity award plans — 4 3 Total shares for purposes of calculating diluted net (loss) income per share 207 224 245 Net (loss) income per share Basic $ (2.56) $ 7.50 $ 5.43 Diluted (2.56) 7.36 5.36

Business Segment and Geograph_2

Business Segment and Geographic Information (Tables)	12 Months Ended
	Jun. 30, 2023
Segment Reporting [Abstract]
Summary of Operations by Geographic Area	The following table summarizes the Company’s operations by country: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Revenue from external customers (1) : Singapore $ 3,271 $ 5,322 $ 5,180 United States 3,053 4,694 3,656 The Netherlands 1,046 1,627 1,825 Other 14 18 20 Consolidated $ 7,384 $ 11,661 $ 10,681 Long-lived assets: United States $ 667 $ 670 $ 612 Thailand 606 679 682 Singapore 460 557 570 Other 369 426 411 Consolidated $ 2,102 $ 2,332 $ 2,275 ___________________________________ (1) Revenue is attributed to countries based on the bill from location.

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table provides information about disaggregated revenue by sales channel and geographical region for the Company’s single reportable segment: Fiscal Years Ended (Dollars in millions) June 30, July 1, July 2, Revenues by Channel OEMs $ 5,448 $ 8,742 $ 7,403 Distributors 1,119 1,676 1,854 Retailers 817 1,243 1,424 Total $ 7,384 $ 11,661 $ 10,681 Revenues by Geography (1) Asia Pacific $ 3,285 $ 5,340 $ 5,198 Americas 3,053 4,694 3,656 EMEA 1,046 1,627 1,827 Total $ 7,384 $ 11,661 $ 10,681 ____________________________________________________

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Schedule of Fiscal Years [Line Items]
Net income	$ (529)	$ 1,649	$ 1,314
Diluted (in dollars per share)	$ (2.56)	$ 7.36	$ 5.36
Advertising Expense
Advertising costs	$ 30	$ 34	$ 29
Government grants recognized in period	$ 13
Minimum
Establishment of Warranty Accruals
Product warranty period term (in years)	1 year
Maximum
Establishment of Warranty Accruals
Product warranty period term (in years)	5 years

Balance Sheet Information (Summ

Balance Sheet Information (Summary of fair value and amortized cost of investments, by major type) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 90	$ 84
Unrealized Gain/(Loss)	0	0
Fair Value	90	84
Money market funds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	73	60
Unrealized Gain/(Loss)	0	0
Fair Value	73	60
Time deposits and certificates of deposit
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1	1
Unrealized Gain/(Loss)	0	0
Fair Value	1	1
Debt Securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	16	23
Unrealized Gain/(Loss)	0	0
Fair Value	16	23
Cash and Cash Equivalents
Debt Securities, Available-for-sale [Line Items]
Fair Value	72	59
Other Current Assets
Debt Securities, Available-for-sale [Line Items]
Fair Value	2	2
Other Assets
Debt Securities, Available-for-sale [Line Items]
Fair Value	$ 16	$ 23

Balance Sheet Information (Narr

Balance Sheet Information (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Property, Equipment and Leasehold Improvements, net
Restricted cash and cash equivalents, current	$ 2	$ 2	$ 2
Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale	0	0
Debt Securities, Available-for-Sale, Allowance for Credit Loss	0	13
Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount	876	275
Continuing Involvement with Continued to be Recognized Transferred Financial Assets, Amount Outstanding	275	200
Discount on trade receivables sold	11	0	0
Depreciation Expense	504	431	368
Accelerated depreciation charge	85	0	0
Capitalized Interest	8	$ 3	$ 5
Cost of Sales
Property, Equipment and Leasehold Improvements, net
Accelerated depreciation charge	60
Operating Expense
Property, Equipment and Leasehold Improvements, net
Accelerated depreciation charge	$ 25

Balance Sheet Information (Fair

Balance Sheet Information (Fair value and amortized cost of available-for-sale securities by contractual maturity) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Amortized Cost
Amortized cost, due in less than 1 year	$ 74
Amortized cost, due in 1 to 5 years	15
Amortized cost, due in 5 to 10 years	0
Amortized cost, thereafter	1
Amortized Cost	90	$ 84
Fair Value
Fair value, due in less than 1 year	74
Fair value, due in 1 to 5 years	15
Fair value, due in 5 to 10 years	0
Fair value, thereafter	1
Fair value, Total	$ 90	$ 84

Balance Sheet Information (Cash

Balance Sheet Information (Cash, Cash Equivalents, and Restricted Cash) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021	Jul. 03, 2020
Investments, Debt and Equity Securities [Abstract]
Cash and cash equivalents	$ 786	$ 615	$ 1,209
Restricted cash included in Other current assets	2	2	2
Total cash, cash equivalents, and restricted cash shown in the Statements of Cash Flows	$ 788	$ 617	$ 1,211	$ 1,724

Balance Sheet Information (Acco

Balance Sheet Information (Accounts Receivable, net) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Accounts Receivable, Gross, Current	$ 625	$ 1,536
Allowance for Doubtful Accounts Receivable, Current	(4)	(4)
Accounts receivable, net	621	1,532
Continuing Involvement with Continued to be Recognized Transferred Financial Assets, Amount Outstanding	$ 275	$ 200

Balance Sheet Information (Allo

Balance Sheet Information (Allowance for Doubtful Accounts Rollforward) (Details) - Allowance for doubtful accounts - USD ($) $ in Millions		12 Months Ended
		Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period		$ 4	$ 4	$ 5
Charges to Operations		0	0	0
Deductions	[1]	0	0	(1)
Balance at End of Period		$ 4	$ 4	$ 4
[1] (1) Uncollectible accounts written off, net of recoveries.

Balance Sheet Information (Inve

Balance Sheet Information (Inventories) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Inventory, Net [Abstract]
Raw materials and components	$ 241	$ 283
Work-in-process	682	716
Finished goods	217	566
Total Inventory	$ 1,140	$ 1,565

Balance Sheet Information (Othe

Balance Sheet Information (Other Current Assets) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Schedule of Investments [Abstract]
Vendor receivables	$ 167	$ 83
Other current assets	191	238
Total	$ 358	$ 321

Balance Sheet Information (Prop

Balance Sheet Information (Property, Equipment and Leasehold Improvements, net) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 10,267	$ 10,659
Less: accumulated depreciation and amortization	(8,561)	(8,420)
Total property, equipment and leasehold improvements, net	1,706	2,239
Land
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	21	47
Equipment
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 8,504	8,473
Equipment | Minimum
Property, Equipment and Leasehold Improvements, net
Useful life in years	3 years
Equipment | Maximum
Property, Equipment and Leasehold Improvements, net
Useful life in years	7 years
Buildings and leasehold improvements
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 1,435	1,893
Buildings and leasehold improvements | Maximum
Property, Equipment and Leasehold Improvements, net
Useful life in years	30 years
Construction in progress
Property, Equipment and Leasehold Improvements, net
Property, equipment and leasehold improvements	$ 307	$ 246

Balance Sheet Information (Accr

Balance Sheet Information (Accrued Expenses) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Payables and Accruals [Abstract]
Dividends Payable, Current	$ 145	$ 147
Other accrued expenses	603	449
Accrued expenses, total	$ 748	$ 596

Balance Sheet Information (Accu

Balance Sheet Information (Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	$ 109	$ 631	$ 1,787
Change in net unrealized gain (loss) on available-for-sale debt securities	65	48	15
Less: reclassification for amounts included in net income	(13)	21	(9)
(Gains) losses reclassified into earnings	52	69	6
Net unrealized gains arising during the period	11	6	1
(Gains) losses reclassified into earnings	(1)	2	3
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	10	8	4
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax		0
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, Net of Tax	0	0
Foreign currency translation adjustments	0	0	15
Other comprehensive income	62	77	25
Total Seagate Technology plc Shareholders' Equity, Ending Balance	(1,199)	109	631
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	36	(41)	(66)
Other comprehensive income before reclassifications	76	54
Amounts reclassified from AOCI	(14)	23
Other comprehensive income	62	77
Total Seagate Technology plc Shareholders' Equity, Ending Balance	98	36	(41)
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	51	(18)
Total Seagate Technology plc Shareholders' Equity, Ending Balance	103	51	(18)
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	(14)	(22)
Total Seagate Technology plc Shareholders' Equity, Ending Balance	(4)	(14)	(22)
Accumulated Foreign Currency Adjustment Attributable to Parent
Accumulated Other Comprehensive Income (Loss) [Roll Forward]
Total Seagate Technology plc Shareholders' Equity, Starting Balance	(1)	(1)
Total Seagate Technology plc Shareholders' Equity, Ending Balance	$ (1)	$ (1)	$ (1)

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 1,237	$ 1,237
Goodwill, Impaired, Accumulated Impairment Loss	0	0	$ 0
Goodwill, Translation and Purchase Accounting Adjustments	0	0	0
Disposal Group, Including Discontinued Operation, Goodwill	0	0	0
Amortization of Intangible Assets	$ 9	$ 20	$ 29

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets (Carrying value of intangible assets) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 10	$ 108
Accumulated Amortization	(10)	(99)
Finite-Lived Intangible Assets, Net	$ 0	$ 9
Weighted Average Remaining Useful Life (in years)	1 month 6 days	9 months 18 days
Technology-Based Intangible Assets
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 10	$ 29
Accumulated Amortization	(10)	(24)
Finite-Lived Intangible Assets, Net	$ 0	$ 5
Finite-Lived Intangible Assets, Remaining Amortization Period	1 month 6 days	1 year
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 71
Accumulated Amortization		(68)
Finite-Lived Intangible Assets, Net		$ 3
Weighted Average Remaining Useful Life (in years)		2 months 12 days
Other intangible assets
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		$ 8
Accumulated Amortization		(7)
Finite-Lived Intangible Assets, Net		$ 1
Weighted Average Remaining Useful Life (in years)		9 months 18 days

Debt - Long-term Debt (Details)

Debt - Long-term Debt (Details) - USD ($)

12 Months Ended

Oct. 14, 2021

Jun. 30, 2023

Jul. 01, 2022

Jul. 03, 2020

May 30, 2023

Mar. 31, 2023

Nov. 30, 2022

Aug. 18, 2022

Dec. 08, 2020

Jun. 18, 2020

Jun. 10, 2020

Feb. 03, 2017

May 14, 2015

Dec. 02, 2014

May 28, 2014

May 22, 2013

Debt Instrument [Line Items]

Stated interest rate (as a percent)

8.50%

9.625%

Basis spread on variable rate (basis points)

5,000%

Debt, net of debt issuance costs

$ 964,000,000

Current portion of long-term debt

$ (63,000,000)

(584,000,000)

Long-term debt, less current portion

5,388,000,000

5,062,000,000

Gain (Loss) on Extinguishment of Debt

$ 190,000,000

0

$ 0

Percentage of principal amount redeemed

40%

Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 5,487,000,000

5,677,000,000

Long-Term Debt, Gross

5,487,000,000

5,677,000,000

Debt Issuance Costs, Net

(36,000,000)

(31,000,000)

Debt, net of debt issuance costs

5,451,000,000

5,646,000,000

Current portion of long-term debt

(63,000,000)

(584,000,000)

Long-term debt, less current portion

5,388,000,000

5,062,000,000

4.750% Senior Notes due June 2023 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 0

540,000,000

Stated interest rate (as a percent)

4.75%

4.875% Senior Notes due March 2024 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 0

499,000,000

Stated interest rate (as a percent)

4.875%

4.750% Senior Notes due January 2025 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 479,000,000

479,000,000

Stated interest rate (as a percent)

4.75%

4.875% Senior Notes due June 2027 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 504,000,000

504,000,000

Stated interest rate (as a percent)

4.875%

4.091% Senior Notes due June 2029 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 465,000,000

466,000,000

Stated interest rate (as a percent)

4.091%

3.125% Senior Notes due July 2029

Debt Instrument [Line Items]

Debt, net of debt issuance costs

336,000,000

3.125% Senior Notes due July 2029 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 163,000,000

500,000,000

Stated interest rate (as a percent)

3.125%

4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Debt, net of debt issuance costs

205,000,000

4.125% Senior Notes due January 2031 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 275,000,000

500,000,000

Stated interest rate (as a percent)

4.125%

3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Debt, net of debt issuance costs

$ 423,000,000

3.375% Senior Notes due July 2031 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 72,000,000

500,000,000

Stated interest rate (as a percent)

3.375%

5.750% Senior Notes due December 2034 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 489,000,000

489,000,000

Term Loan A1 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

430,000,000

600,000,000

Term Loan A2 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

430,000,000

600,000,000

SOFR Based Term Loan A3 due July 2027 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

430,000,000

0

8.250% Senior Notes due December 2029 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 500,000,000

0

Stated interest rate (as a percent)

8.25%

8.500% Senior Notes due July 2031 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 500,000,000

0

Stated interest rate (as a percent)

8.50%

9.625% Senior Notes due December 2032 | Debt Instrument, Redemption, Period One

Debt Instrument [Line Items]

Percentage of principal amount redeemed

100%

9.625% Senior Notes due December 2032 | Reported Value Measurement

Debt Instrument [Line Items]

Current and noncurrent debt including short-term borrowings

$ 750,000,000

0

Stated interest rate (as a percent)

9.625%

Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,500,000,000

Senior Notes | 4.750% Senior Notes due June 2023

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Senior Notes | 4.875% Senior Notes due March 2024

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.875%

Senior Notes | 4.750% Senior Notes due January 2025

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Senior Notes | 4.875% Senior Notes due June 2027

Debt Instrument [Line Items]

Aggregate principal amount

$ 700,000,000

Stated interest rate (as a percent)

4.875%

Senior Notes | 4.091% Senior Notes due June 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.091%

Senior Notes | 3.125% Senior Notes due July 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

3.125%

Senior Notes | 4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.125%

Senior Notes | 3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

8.50%

3.375%

Senior Notes | 5.750% Senior Notes due December 2034

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

5.75%

Senior Notes | 8.250% Senior Notes due December 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

8.25%

Senior Notes | 8.500% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Senior Notes | 9.625% Senior Notes due December 2032

Debt Instrument [Line Items]

Aggregate principal amount

$ 750,000,000

Gain (Loss) on Extinguishment of Debt

$ 204,000,000

Term Loan A1 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Minimum | Term Loan A1

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.125%

Minimum | Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.25%

Maximum | Term Loan A1

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.375%

Maximum | Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.50%

Debt - Narrative (Details)

Debt - Narrative (Details)

1 Months Ended

12 Months Ended

Oct. 14, 2021 USD ($)

Jun. 30, 2023 USD ($)

Jun. 30, 2023 USD ($)

Jul. 01, 2022 USD ($)

Jul. 02, 2021 USD ($)

Jul. 03, 2020 USD ($)

May 30, 2023 USD ($)

May 19, 2023 USD ($)

Feb. 28, 2023 USD ($)

Nov. 30, 2022 USD ($)

Aug. 18, 2022 USD ($)

Dec. 08, 2020 USD ($)

Jun. 18, 2020 USD ($)

Jun. 10, 2020 USD ($)

May 14, 2015 USD ($)

May 28, 2014 USD ($)

May 22, 2013 USD ($)

Debt Instrument [Line Items]

Stated interest rate (as a percent)

8.50%

9.625%

Gain (Loss) on Extinguishment of Debt

$ 190,000,000

$ 0

$ 0

Basis spread on variable rate (basis points)

5,000%

Percentage of principal amount redeemed

40%

Net (gain) loss on redemption and repurchase of debt

$ 204,000,000

0

$ (1,000,000)

Net Gain on Debt Exchange

Debt Instrument [Line Items]

Net (gain) loss on redemption and repurchase of debt

$ 3,000,000

Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

4.091% Senior Notes due June 2029

Debt Instrument [Line Items]

Debt instrument, repurchase amount

$ 5,000,000

9.625% Senior Notes due December 2032 | Debt Instrument, Redemption, Period One

Debt Instrument [Line Items]

Percentage of principal amount redeemed

100%

4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Debt instrument, repurchase amount

20,000,000

3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Debt instrument, repurchase amount

$ 5,000,000

Senior Notes 8.25 Percent Due December 2029 and Senior Notes 8.50 Percent Due July 2031

Debt Instrument [Line Items]

Gain (Loss) on Extinguishment of Debt

$ 17,000,000

Senior Notes 8.25 Percent Due December 2029 and Senior Notes 8.50 Percent Due July 2031 | Debt Instrument, Redemption, Period One

Debt Instrument [Line Items]

Percentage of principal amount redeemed

100%

Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,500,000,000

Senior Notes | 4.750% Senior Notes due June 2023

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Senior Notes | 4.750% Senior Notes due January 2025

Debt Instrument [Line Items]

Aggregate principal amount

$ 1,000,000,000

Stated interest rate (as a percent)

4.75%

Senior Notes | 4.091% Senior Notes due June 2029

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.091%

Senior Notes | 4.875% Senior Notes due June 2027

Debt Instrument [Line Items]

Aggregate principal amount

$ 700,000,000

Stated interest rate (as a percent)

4.875%

Senior Notes | 9.625% Senior Notes due December 2032

Debt Instrument [Line Items]

Aggregate principal amount

$ 750,000,000

Gain (Loss) on Extinguishment of Debt

$ 204,000,000

Senior Notes | 4.125% Senior Notes due January 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

4.125%

Senior Notes | 3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Stated interest rate (as a percent)

8.50%

3.375%

Senior Notes | 8.500% Senior Notes due July 2031

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Term Loan A1 | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.125%

Term Loan A1 | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.375%

Term Loan A1 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Term Loan A2 | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 600,000,000

Term Loan A2 | Medium-term Notes | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

1.25%

Term Loan A2 | Medium-term Notes | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

2.50%

Term Loan A3 | Medium-term Notes

Debt Instrument [Line Items]

Increase to line of credit or conversion to term loan, amount

$ 100,000,000

8.250% Senior Notes due December 2029

Debt Instrument [Line Items]

Percentage of principal amount redeemed

108.25%

3.375% Senior Notes due July 2031

Debt Instrument [Line Items]

Percentage of principal amount redeemed

108.50%

Senior Notes 8.25 Percent Due December 2029 and Senior Notes 8.50 Percent Due July 2031

Debt Instrument [Line Items]

Basis spread on variable rate (basis points)

5,000%

Term Loans [Member]

Debt Instrument [Line Items]

Debt repayments

$ 450,000,000

$ 450,000,000

9.625% Senior Notes due December 2032

Debt Instrument [Line Items]

Percentage of principal amount redeemed

109.625%

Seventh Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period One

Debt Instrument [Line Items]

Leverage ratio, maximum

5

5

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

1

Seventh Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Two

Debt Instrument [Line Items]

Leverage ratio, maximum

4.75

4.75

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

1

Seventh Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Three

Debt Instrument [Line Items]

Leverage ratio, maximum

4.5

4.5

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

1

Seventh Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Four

Debt Instrument [Line Items]

Leverage ratio, maximum

4

4

Eighth Amendment to Credit Agreement | Medium-term Notes

Debt Instrument [Line Items]

Line of credit facility, maximum borrowing capacity

$ 1,500,000,000

Eighth Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period One

Debt Instrument [Line Items]

Leverage ratio, maximum

6.75

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

Eighth Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Two

Debt Instrument [Line Items]

Leverage ratio, maximum

4

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

Eighth Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Three

Debt Instrument [Line Items]

Leverage ratio, maximum

2.50

Debt Instrument, Covenant, Leverage Ratio, Minimum

1

Eighth Amendment to Credit Agreement | Medium-term Notes | Debt Instrument, Leverage, Period Four

Debt Instrument [Line Items]

Leverage ratio, maximum

3.25

Debt (Future principal payments

Debt (Future principal payments on long-term debt) (Details) $ in Millions	Jun. 30, 2023 USD ($)
Debt Disclosure [Abstract]
2024	$ 63
2025	582
2026	497
2027	612
2028	519
Thereafter	3,245
Total future principal payments on short-term and long-term debt	$ 5,518

Income Taxes (Income (Loss) Bef

Income Taxes (Income (Loss) Before Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Income Tax Disclosure [Abstract]
U.S.	$ 300	$ 145	$ 191
Non-U.S.	(796)	1,534	1,157
(Loss) income before income taxes	$ (496)	$ 1,679	$ 1,348

Income Taxes (Schedule of Provi

Income Taxes (Schedule of Provision for (Benefit From) Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Current income tax expense:
U.S.	$ 6	$ 4	$ 0
Non-U.S.	17	35	38
Total Current	23	39	38
Deferred income tax expense/(benefit):
U.S.	9	3	8
Non-U.S.	1	(12)	(12)
Total Deferred	10	(9)	(4)
Provision for income taxes	$ 33	$ 30	$ 34

Income Taxes (Schedule of Defer

Income Taxes (Schedule of Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Deferred tax assets
Accrued warranty	$ 38	$ 34
Inventory carrying value adjustments	40	43
Receivable allowances	11	20
Accrued compensation and benefits	43	73
Capitalized research expenses	119	0
Depreciation	40	45
Restructuring accruals	14	0
Lease liabilities	62	5
Other accruals and deferred items	14	19
Net operating losses	542	671
Tax credit carryforwards	619	650
Other assets	1	1
Gross: Deferred tax assets	1,543	1,561
Less: Valuation allowance	(370)	(434)
Net: Deferred tax assets	1,173	1,127
Deferred tax liabilities
Unremitted earnings of certain non-U.S. entities	(4)	(5)
Acquisition-related items	(1)	(2)
Right-of-use assets	(62)	(5)
Other liabilities	(2)	0
Net: Deferred tax liabilities	69	12
Total net deferred tax assets	$ 1,104	$ 1,115

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021	Jul. 03, 2020
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Total net deferred tax assets	$ 1,104	$ 1,115
Increase (decrease) in valuation allowance	64
Operating loss carryforwards, subject to expiration	245
Tax credit carryforward subject to expiration	35
NOL subject to annual limitation on use	150
Tax credit carryforwards subject to annual limitation on use	$ 60
Domestic federal statutory rate (as a percent)	25%
Income tax holiday, aggregate dollar amount	$ 14	$ 290	$ 226
Income tax holiday tax incentive income tax benefits per share (in dollars per share)	$ 0.07	$ 1.29	$ 0.92
Total gross unrecognized tax benefits excluding interest and penalties	$ 116	$ 114	$ 108	$ 89
Minimum
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Aggregate annual limitation on use of NOL and tax credit carryforwards pursuant to U.S. tax law	1
Maximum
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Aggregate annual limitation on use of NOL and tax credit carryforwards pursuant to U.S. tax law	45
U.S. Federal
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Net operating loss carryforwards	3,600
Tax credit carryforwards	739
Non-U.S.
Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items]
Net operating loss carryforwards	$ 391

Income Taxes (Schedule of Recon

Income Taxes (Schedule of Reconciliation Between Income at Statutory Rate and Effective Rate) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Income Tax Disclosure [Abstract]
(Benefit) provision at statutory rate	$ (124)	$ 420	$ 337
Permanent differences	8	5	8
Valuation allowance	(18)	7	(2)
Effect of rates different than statutory	178	(371)	(287)
Research credit	(18)	(26)	(27)
Other individually immaterial items	7	(5)	5
Provision for income taxes	$ 33	$ 30	$ 34

Income Taxes (Schedule of Gross

Income Taxes (Schedule of Gross Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Income Tax Disclosure [Abstract]
Balance of unrecognized tax benefits at the beginning of the year	$ 114	$ 108	$ 89
Gross increase for tax positions of prior years	0	1	7
Gross decrease for tax positions of prior years	(4)	(1)	(1)
Gross increase for tax positions of current year	7	6	15
Gross decrease for tax positions of current year	(1)	0	0
Settlements	0	0	(1)
Lapse of statutes of limitation	0	0	(1)
Balance of unrecognized tax benefits at the end of the year	$ 116	$ 114	$ 108

Leases, Codification Topic 84_2

Leases, Codification Topic 842 (Narrative) (Details) $ in Millions	12 Months Ended
	Jun. 30, 2023 USD ($)
Leases [Abstract]
Gain on sale-leaseback transactions	$ 156
ROU assets obtained	$ 353

Leases, Codification Topic 84_3

Leases, Codification Topic 842 (Operating Lease Costs) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Leases [Abstract]
Operating Lease, Cost	$ 21	$ 16	$ 15
Variable Lease, Cost	3	4	4
Lease, Cost	24	20	19
Operating Lease, Payments	$ 23	$ 20	$ 19

Leases, Codification Topic 84_4

Leases, Codification Topic 842 (Weighted-Average, ROU Assets, and Lease Liabilities) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Leases [Abstract]
Operating Lease, Weighted Average Remaining Lease Term	9 years 7 months 6 days	9 years 3 months 18 days	7 years 2 months 12 days
Operating Lease, Weighted Average Discount Rate, Percent	8.49%	6.40%	6.02%
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets, net	Other assets, net
Operating lease, ROU asset	$ 396	$ 94
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued expenses	Accrued expenses
Operating Lease, Liability, Current	$ 51	$ 14
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other non-current liabilities	Other non-current liabilities
Operating Lease, Liability, Noncurrent	$ 333	$ 36

Leases, Codification Topic 84_5

Leases, Codification Topic 842 (Future Minimum Lease Payments) (Details) $ in Millions	Jun. 30, 2023 USD ($)
Leases [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year One	$ 53
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two	55
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three	55
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four	55
Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five	56
Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five	290
Lessee, Operating Lease, Liability, to be Paid	564
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	(180)
Operating lease liability	$ 384

Restructuring and Exit Costs (N

Restructuring and Exit Costs (Narrative) (Details) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 30, 2022 numberOfEmployees	Jun. 30, 2023 USD ($) numberOfEmployees	Jul. 01, 2022 USD ($)	Jul. 02, 2021 USD ($)	Jul. 03, 2020 USD ($)
Restructuring Reserve [Line Items]
Restructuring and other, net		$ 102	$ 3	$ 8
Restructuring and related cost, number of positions eliminated | numberOfEmployees	480
Total number of positions eliminated | numberOfEmployees		3,480
Restructuring Reserve		$ 119	5	8	$ 48
Gain on sale of assets		167
Gain (loss) on assets held for sale				(3)
Gain (Loss) on Termination of Lease				(2)
Workforce Restructuring Charges
Restructuring Reserve [Line Items]
Restructuring and other, net		269	$ 3	$ 14
Accrued Liabilities [Member] | Workforce Restructuring Charges
Restructuring Reserve [Line Items]
Restructuring Reserve		$ 117

Restructuring and Exit Costs (S

Restructuring and Exit Costs (Schedule of Restructuring Reserve by Type of Cost) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021	Jul. 03, 2020
Restructuring Reserve [Roll Forward]
Restructuring Reserve	$ 119	$ 5	$ 8	$ 48
Restructuring and other, net	102	3	8
Payments for Restructuring	(155)	(6)	(53)
Restructuring Reserve, Accrual Adjustment	0	0	(1)
Restructuring and Related Cost, Incurred Cost	356
Restructuring and Related Cost, Expected Cost	$ 1
Restructuring, Incurred Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Restructuring and other, net
Employee Severance | April 2023 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	$ 108	0	0	0
Restructuring and other, net	145	0	0
Payments for Restructuring	(37)	0	0
Restructuring Reserve, Accrual Adjustment	0	0	0
Restructuring and Related Cost, Incurred Cost	145
Restructuring and Related Cost, Expected Cost	0
Employee Severance | October 2022 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	1	0	0	0
Restructuring and other, net	104	0	0
Payments for Restructuring	(103)	0	0
Restructuring Reserve, Accrual Adjustment	0	0	0
Restructuring and Related Cost, Incurred Cost	104
Restructuring and Related Cost, Expected Cost	0
Employee Severance | Other Plans
Restructuring Reserve [Roll Forward]
Restructuring Reserve	1	0	2	43
Restructuring and other, net	10	2	6
Payments for Restructuring	(10)	(4)	(47)
Restructuring Reserve, Accrual Adjustment	1	0	0
Restructuring and Related Cost, Incurred Cost	73
Restructuring and Related Cost, Expected Cost	0
Facility Closing | April 2023 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	0	0	0	0
Restructuring and other, net	3	0	0
Payments for Restructuring	(3)	0	0
Restructuring Reserve, Accrual Adjustment	0	0	0
Restructuring and Related Cost, Incurred Cost	3
Restructuring and Related Cost, Expected Cost	0
Facility Closing | October 2022 Plan
Restructuring Reserve [Roll Forward]
Restructuring Reserve	5	0	0	0
Restructuring and other, net	7	0	0
Payments for Restructuring	(1)	0	0
Restructuring Reserve, Accrual Adjustment	(1)	0	0
Restructuring and Related Cost, Incurred Cost	7
Restructuring and Related Cost, Expected Cost	0
Facility Closing | Other Plans
Restructuring Reserve [Roll Forward]
Restructuring Reserve	4	5	6	$ 5
Restructuring and other, net	0	1	8
Payments for Restructuring	(1)	(2)	(6)
Restructuring Reserve, Accrual Adjustment	0	0	(1)
Restructuring and Related Cost, Incurred Cost	24
Restructuring and Related Cost, Expected Cost	1
Workforce Restructuring Charges
Restructuring Reserve [Roll Forward]
Restructuring and other, net	269	$ 3	$ 14
Workforce Restructuring Charges | Accrued Liabilities [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve	117
Workforce Restructuring Charges | Other Noncurrent Liabilities
Restructuring Reserve [Roll Forward]
Restructuring Reserve	$ 2

Derivative Financial Instrume_3

Derivative Financial Instruments (Narrative) (Details) - USD ($)	1 Months Ended		12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Derivative Financial Instruments
Proceeds from counterparty		$ 110,000,000
Derivative Instrument, Loss Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]			Interest Expense		Interest Expense
Term Loans [Member]
Derivative Financial Instruments
Debt repayments	$ 450,000,000		$ 450,000,000
Cost of Sales
Derivative Financial Instruments
Derivative Instrument, Loss Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]				Cost of revenue
Interest Expense
Derivative Financial Instruments
Derivative Instrument, Loss Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]				Interest Expense
Cash Flow Hedging
Derivative Financial Instruments
Unrealized Gain (Loss) on Cash Flow Hedging Instruments			12,000,000	$ 51,000,000
Cash Flow Hedge Gain (Loss) To Be Reclassified During Next 12 Months	39,000,000		39,000,000
Gain on hedge designation cash flow hedge			16,000,000		$ 14,000,000
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion			29,000,000		$ 7,000,000
Cash Flow Hedging | Cost of Sales
Derivative Financial Instruments
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion				11,000,000
Cash Flow Hedging | Interest Expense
Derivative Financial Instruments
Derivative Instruments, Loss Reclassified from Accumulated OCI into Income, Effective Portion				$ 10,000,000
Term Loan
Derivative Financial Instruments
Derivative, notional amount	1,300,000,000	1,600,000,000	1,300,000,000
Term Loan A1 | Derivative Instrument Maturity, Tranche One
Derivative Financial Instruments
Derivative, notional amount	429,000,000		429,000,000
Term Loan A1 | Derivative Instrument Maturity, Tranche Two
Derivative Financial Instruments
Derivative, notional amount	859,000,000		859,000,000
Total Return Swap | Not Designated as Hedging Instrument
Derivative Financial Instruments
Derivative notional amount	108,000,000		108,000,000
Interest Rate Swap
Derivative Financial Instruments
Gain recognized on derivatives		$ 110,000,000
Term Loan A3
Derivative Financial Instruments
Derivative, notional amount	45,000,000		45,000,000
Term Loans A1 and A2
Derivative Financial Instruments
Derivative, notional amount	$ 300,000,000		$ 300,000,000

Derivative Financial Instrume_4

Derivative Financial Instruments (Schedule of notional value of outstanding foreign currency forward exchange contracts) (Details) - Foreign currency forward exchange contracts - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Derivatives designated as hedging instruments
Derivative Financial Instruments
Derivative notional amount	$ 445	$ 467
Derivatives designated as hedging instruments | Singapore, Dollars
Derivative Financial Instruments
Derivative notional amount	195	178
Derivatives designated as hedging instruments | Thailand, Baht
Derivative Financial Instruments
Derivative notional amount	129	133
Derivatives designated as hedging instruments | China, Yuan Renminbi
Derivative Financial Instruments
Derivative notional amount	64	92
Derivatives designated as hedging instruments | United Kingdom, Pounds
Derivative Financial Instruments
Derivative notional amount	57	64
Not Designated as Hedging Instrument
Derivative Financial Instruments
Derivative notional amount	197	126
Not Designated as Hedging Instrument | Singapore, Dollars
Derivative Financial Instruments
Derivative notional amount	161	52
Not Designated as Hedging Instrument | Thailand, Baht
Derivative Financial Instruments
Derivative notional amount	16	35
Not Designated as Hedging Instrument | China, Yuan Renminbi
Derivative Financial Instruments
Derivative notional amount	12	24
Not Designated as Hedging Instrument | United Kingdom, Pounds
Derivative Financial Instruments
Derivative notional amount	$ 8	$ 15

Derivative Financial Instrume_5

Derivative Financial Instruments (Schedule of gross fair value of derivative instruments) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	$ 23	$ 65
Liability derivatives, Accrued expenses	(11)	(23)
Derivatives designated as hedging instruments | Foreign currency forward exchange contracts | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	2	0
Derivatives designated as hedging instruments | Foreign currency forward exchange contracts | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses	(10)	(14)
Derivatives designated as hedging instruments | Interest Rate Swap | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	20	65
Derivatives designated as hedging instruments | Interest Rate Swap | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses	0	0
Not Designated as Hedging Instrument | Foreign currency forward exchange contracts | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	0	0
Not Designated as Hedging Instrument | Foreign currency forward exchange contracts | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses	(1)	(5)
Not Designated as Hedging Instrument | Total Return Swap | Other Current Assets
Fair Values of Derivative Instruments
Asset Derivatives, Other current assets	1	0
Not Designated as Hedging Instrument | Total Return Swap | Accrued Expenses
Fair Values of Derivative Instruments
Liability derivatives, Accrued expenses	$ 0	$ (4)

Derivative Financial Instrume_6

Derivative Financial Instruments (Schedule of the effect of derivative instruments on Other comprehensive income (loss) and the Consolidated Statement of Operations) (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Sep. 30, 2022	Jun. 30, 2023	Jul. 01, 2022
Interest Rate Swap
Derivatives Instruments, Gain (Loss)
Gain recognized on derivatives	$ 110
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax		$ 22
Other nonoperating income, net | Foreign currency forward exchange contracts
Derivatives Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in Income on Derivatives		(7)	$ (9)
Gain recognized on derivatives		(6)	(22)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax		16	(11)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Ineffective Portion, Net		(4)	1
Operating Expense | Total Return Swap
Derivatives Instruments, Gain (Loss)
Amount of Gain/(Loss) Recognized in Income on Derivatives		6	(18)
Operating Expense | Interest Rate Swap
Derivatives Instruments, Gain (Loss)
Gain recognized on derivatives		71	70
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax		(29)	(10)
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Ineffective Portion, Net		$ 0	$ 0

Fair Value (Narrative) (Details

Fair Value (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Assets and liabilities measured at fair value on a recurring basis
Income (Loss) from Equity Method Investments	$ (4)	$ 8	$ 48
Equity Method Investments	55	61
Net gains (losses) from investment under measurement alternative	(5)	4	$ 51
Equity Securities without Readily Determinable Fair Value, Amount	$ 88	$ 88
Derivative Instrument, Gain Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Cost of revenue		Cost of revenue
Derivative Instrument, Loss Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]	Interest Expense		Interest Expense
Other nonoperating income, net | Equity Securities
Assets and liabilities measured at fair value on a recurring basis
Downward adjustments	$ 9		$ 12
Cost of Sales
Assets and liabilities measured at fair value on a recurring basis
Derivative Instrument, Loss Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]		Cost of revenue
Interest Expense
Assets and liabilities measured at fair value on a recurring basis
Derivative Instrument, Loss Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]		Interest Expense

Fair Value (Schedule of Fair Va

Fair Value (Schedule of Fair Value, by Balance Sheet Grouping, Measured on Recurring Basis) (Details) - USD ($) $ in Millions	Jun. 30, 2023	Jul. 01, 2022
Assets:
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other current assets	Other current assets
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued expenses	Accrued expenses
Recurring basis
Assets:
Cash and cash equivalents and short-term investments	$ 72	$ 59
Cash and cash equivalents	72	59
Other current assets	25	67
Other assets, net	16	23
Total assets	113	149
Liabilities:
Accrued Liabilities, Fair Value Disclosure	11	23
Financial and Nonfinancial Liabilities, Fair Value Disclosure	11	23
Recurring basis | Derivative Financial Instruments, Assets
Assets:
Derivative asset	23	65
Recurring basis | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	11	23
Recurring basis | Money market funds
Assets:
Cash and cash equivalents and short-term investments	72	59
Restricted Cash and Investments, Current	1	1
Recurring basis | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	1	1
Recurring basis | Debt Securities
Assets:
Restricted Cash and Investments, Current	16	23
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1)
Assets:
Cash and cash equivalents and short-term investments	72	59
Cash and cash equivalents	72	59
Other current assets	1	1
Other assets, net	0	0
Total assets	73	60
Liabilities:
Accrued Liabilities, Fair Value Disclosure	0	0
Financial and Nonfinancial Liabilities, Fair Value Disclosure	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Derivative Financial Instruments, Assets
Assets:
Derivative asset	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Money market funds
Assets:
Cash and cash equivalents and short-term investments	72	59
Restricted Cash and Investments, Current	1	1
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Quoted Prices in Active Markets for Identical Instruments (Level 1) | Debt Securities
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Other Observable Inputs (Level 2)
Assets:
Cash and cash equivalents and short-term investments	0	0
Cash and cash equivalents	0	0
Other current assets	24	66
Other assets, net	0	0
Total assets	24	66
Liabilities:
Accrued Liabilities, Fair Value Disclosure	11	23
Financial and Nonfinancial Liabilities, Fair Value Disclosure	11	23
Recurring basis | Significant Other Observable Inputs (Level 2) | Derivative Financial Instruments, Assets
Assets:
Derivative asset	23	65
Recurring basis | Significant Other Observable Inputs (Level 2) | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	11	23
Recurring basis | Significant Other Observable Inputs (Level 2) | Money market funds
Assets:
Cash and cash equivalents and short-term investments	0	0
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Other Observable Inputs (Level 2) | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	1	1
Recurring basis | Significant Other Observable Inputs (Level 2) | Debt Securities
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Unobservable Inputs (Level 3)
Assets:
Cash and cash equivalents and short-term investments	0	0
Cash and cash equivalents	0	0
Other current assets	0	0
Other assets, net	16	23
Total assets	16	23
Liabilities:
Accrued Liabilities, Fair Value Disclosure	0	0
Financial and Nonfinancial Liabilities, Fair Value Disclosure	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Derivative Financial Instruments, Assets
Assets:
Derivative asset	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Derivative Financial Instruments, Liabilities
Liabilities:
Derivative Liability	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Money market funds
Assets:
Cash and cash equivalents and short-term investments	0	0
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Time deposits and certificates of deposit
Assets:
Restricted Cash and Investments, Current	0	0
Recurring basis | Significant Unobservable Inputs (Level 3) | Debt Securities
Assets:
Restricted Cash and Investments, Current	$ 16	$ 23

Fair Value (Schedule of Carryin

Fair Value (Schedule of Carrying Values and Estimated Fair Values of Debt Instruments) (Details) - USD ($) $ in Millions	Jun. 30, 2023	May 30, 2023	Mar. 31, 2023	Nov. 30, 2022	Jul. 01, 2022
Debt Fair Value Disclosures
Debt, net of debt issuance costs					$ 964
Less: current portion of debt, net of debt issuance costs	$ (63)				(584)
Long-term debt, less current portion, net of debt issuance costs	5,388				5,062
Stated interest rate (as a percent)		8.50%		9.625%
3.125% Senior Notes due July 2029
Debt Fair Value Disclosures
Debt, net of debt issuance costs					336
4.125% Senior Notes due January 2031
Debt Fair Value Disclosures
Debt, net of debt issuance costs					205
3.375% Senior Notes due July 2031
Debt Fair Value Disclosures
Debt, net of debt issuance costs			$ 423
Carrying Amount
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	5,487				5,677
Debt issuance costs	(36)				(31)
Debt, net of debt issuance costs	5,451				5,646
Less: current portion of debt, net of debt issuance costs	(63)				(584)
Long-term debt, less current portion, net of debt issuance costs	5,388				5,062
Carrying Amount | 4.750% Senior Notes due June 2023
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 0				540
Stated interest rate (as a percent)	4.75%
Carrying Amount | 4.875% Senior Notes due March 2024
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 0				499
Stated interest rate (as a percent)	4.875%
Carrying Amount | 4.750% Senior Notes due January 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 479				479
Stated interest rate (as a percent)	4.75%
Carrying Amount | 4.875% Senior Notes due June 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 504				504
Stated interest rate (as a percent)	4.875%
Carrying Amount | 4.091% Senior Notes due June 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 465				466
Stated interest rate (as a percent)	4.091%
Carrying Amount | 3.125% Senior Notes due July 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 163				500
Stated interest rate (as a percent)	3.125%
Carrying Amount | 8.250% Senior Notes due December 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 500				0
Stated interest rate (as a percent)	8.25%
Carrying Amount | 4.125% Senior Notes due January 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 275				500
Stated interest rate (as a percent)	4.125%
Carrying Amount | 3.375% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 72				500
Stated interest rate (as a percent)	3.375%
Carrying Amount | 8.500% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 500				0
Stated interest rate (as a percent)	8.50%
Carrying Amount | 9.625% Senior Notes due December 2032
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 750				0
Stated interest rate (as a percent)	9.625%
Carrying Amount | 5.750% Senior Notes due December 2034
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 489				489
Carrying Amount | SOFR Based Term Loan A1 due September 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	430				600
Carrying Amount | SOFR Based Term Loan A2 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	430				600
Carrying Amount | SOFR Based Term Loan A3 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 430				0
Carrying Amount | Senior Notes 5.750 Percent due December 2034
Debt Fair Value Disclosures
Stated interest rate (as a percent)	5.75%
Estimate of Fair Value Measurement
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 5,371				5,219
Debt issuance costs	0				0
Debt, net of debt issuance costs	5,371				5,219
Less: current portion of debt, net of debt issuance costs	(62)				(582)
Long-term debt, less current portion, net of debt issuance costs	5,309				4,637
Estimate of Fair Value Measurement | 4.750% Senior Notes due June 2023
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	0				538
Estimate of Fair Value Measurement | 4.875% Senior Notes due March 2024
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	0				494
Estimate of Fair Value Measurement | 4.750% Senior Notes due January 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	472				471
Estimate of Fair Value Measurement | 4.875% Senior Notes due June 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	484				483
Estimate of Fair Value Measurement | 4.091% Senior Notes due June 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	436				427
Estimate of Fair Value Measurement | 3.125% Senior Notes due July 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	126				396
Estimate of Fair Value Measurement | 8.250% Senior Notes due December 2029
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	522				0
Estimate of Fair Value Measurement | 4.125% Senior Notes due January 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	227				410
Estimate of Fair Value Measurement | 3.375% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	53				393
Estimate of Fair Value Measurement | 8.500% Senior Notes due July 2031
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	524				0
Estimate of Fair Value Measurement | 9.625% Senior Notes due December 2032
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	830				0
Estimate of Fair Value Measurement | 5.750% Senior Notes due December 2034
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	438				433
Estimate of Fair Value Measurement | SOFR Based Term Loan A1 due September 2025
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	426				588
Estimate of Fair Value Measurement | SOFR Based Term Loan A2 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	420				586
Estimate of Fair Value Measurement | SOFR Based Term Loan A3 due July 2027
Debt Fair Value Disclosures
Current and noncurrent debt including short-term borrowings	$ 413				$ 0

Shareholders' Equity (Narrative

Shareholders' Equity (Narrative) (Details)	12 Months Ended
	Jun. 30, 2023 USD ($) $ / shares shares	Jul. 01, 2022 $ / shares shares
Equity [Abstract]
Authorized Share Capital Common and Preferred Stock Value | $	$ 13,500
Ordinary shares, authorized (in shares)	1,250,000,000	1,250,000,000
Ordinary shares, par value (in dollars per share) | $ / shares	$ 0.00001	$ 0.00001
Ordinary shares, outstanding (in shares)	207,389,381	209,850,169
Preferred shares, authorized (in shares)	100,000,000	100,000,000
Preferred shares, par value (in dollars per share) | $ / shares	$ 0.00001	$ 0.00001
Preferred Stock, Shares Issued	0	0
Preferred stock, shares outstanding (in shares)	0	0
Ordinary shares, voting rights	one vote per share
Preferred Stock Minimum Number of Series	1
Stock Repurchase Program, Remaining Authorized Repurchase Amount | $	$ 1,900,000,000

Shareholders' Equity (Schedule

Shareholders' Equity (Schedule of Share Repurchases) (Details) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022		Jul. 02, 2021
Repurchases of Equity Securities, Number of Shares Repurchased
Number of shares repurchased, cumulative, beginning of the period (in shares)	447	426		392
Number of shares repurchased, during the period (in shares)	6	21	[1]	34	[1]
Number of shares repurchased, cumulative, end of the period (in shares)	453	447		426
Repurchases of Equity Securities, Dollar Value of Shares Repurchased
Dollar value of shares repurchased, cumulative, beginning of the period	$ 16,324	$ 14,467		$ 12,386
Dollar value of shares repurchased during the period	444	1,857	[1]	2,081	[1]
Dollar value of shares repurchased, cumulative, end of the period	16,768	16,324		14,467
Settlement in connection with tax withholding	$ 44	$ 51		$ 33
Settlement of shares in connection with tax withholding (in shares)	1	1		1
[1] For fiscal years 2023, 2022 and 2021, includes net share settlements of $44 million, $51 million and $33 million for 1 million, 1 million and 1 million shares, respectively, in connection with tax withholding related to vesting of restricted share units .

Share-based Compensation (Narra

Share-based Compensation (Narrative) (Details)	12 Months Ended
	Jun. 30, 2023 USD ($) mo $ / shares shares	Jul. 01, 2022 USD ($) shares	Jul. 02, 2021 USD ($) shares	Oct. 20, 2021 shares	Oct. 06, 2015 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	$ 115,000,000	$ 145,000,000	$ 112,000,000
Percentage match of employee contribution under 401(k) plan (as a percent)	50%
Maximum contribution match by the employer as a percentage of employee compensation (as a percent)	6%
Maximum amount of contribution per employee made by the employer per year	$ 6,000
Matching contributions	$ 15,000,000	15,000,000	15,000,000
Stock Compensation Plan | STX 2012 EIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant | shares	9,900,000
Stock Compensation Plan | Equity Incentive Plan Dot Hill 2009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized | shares					2,000,000
Stock Compensation Plan | Nonvested Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value of nonvested shares vested	$ 4,000,000	4,000,000
Stock Compensation Plan | Performance Awards Market Condition
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value of nonvested shares vested	$ 16,000,000	4,000,000	8,000,000
Stock Compensation Plan | Equity Incentive Plan 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized | shares				14,100,000
Employee Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares available for grant | shares	6,600,000
Number of shares authorized | shares	60,000,000
Offering period for Stock Purchase Plan (in months)	6 months
Maximum number of shares per offering period | shares	1,500,000
Employee purchase price, percentage of fair market value of ordinary shares	85%
Aggregate intrinsic value of options exercised	$ 10,000,000	29,000,000	27,000,000
Unrecognized compensation cost	$ 1,500,000
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	1 month
Number of shares, granted | shares	900,000
Per share weighted average price of shares purchased | $ / shares	$ 62.36
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement, Vesting Period Maximum	4 years
Unrecognized compensation cost of estimated forfeitures	$ 29,000,000
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	2 years 1 month 6 days
Restricted Stock Units (RSUs) | Nonvested Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 156,000,000
Restricted Stock Units (RSUs) | Performance Awards Market Condition
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value of nonvested shares vested	105,000,000	96,000,000	75,000,000
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate intrinsic value of options exercised	5,000,000	$ 11,000,000	31,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value			$ 4,000,000
Unrecognized compensation cost	5,000,000
Value of stock options, share based compensation, not yet recognized	$ 2,000,000
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	2 years 6 months
Number of shares, granted | shares	200,000
Employee Stock Option | Share-based Compensation Award, Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of options to be vested on first anniversary of vesting commencement date (as a percent)	25%
Employee Stock Option | Share-based Compensation Award, Tranche Two through Four
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of options to be vested on first anniversary of vesting commencement date (as a percent)	75%
Employee Stock Option | Full Value Share Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining award vesting period (in months) | mo	36
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost of estimated forfeitures	$ 2,000,000
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	1 year 2 months 12 days
Performance Shares | TSR/ROIC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares	300,000	300,000	300,000
Performance period (in years)	3 years
Minimum percentage of targeted stock units to vest (as a percent)	0%
Maximum percentage of targeted stock units to vest (as a percent)	200%
Performance Shares | AEPS
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of options to be vested on first anniversary of vesting commencement date (as a percent)	25%
Award vesting period	7 years
Performance Shares | AEPS | Senior Executive Officers
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted | shares		100,000	100,000
Performance Shares | Performance Awards Market Condition
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost	$ 8,000,000
Restricted Stock Units and Performance Share Units | Equity Incentive Plan 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized | shares				12,300,000

Share-based Compensation (Weigh

Share-based Compensation (Weighted-average assumptions used to determine the fair value) (Details) - $ / shares	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	4 years 2 months 12 days	4 years 2 months 12 days	4 years 2 months 12 days
Volatility, low end of the range			37%
Volatility, high end of the range	37%	38%	38%
Weighted-average volatility	37%	38%	38%
Weighted-average expected dividend rate	3.70%	2.80%	4.70%
Risk-free interest rate, minimum			0.20%
Risk-free interest rate, maximum	3.50%	0.60%	0.70%
Weighted average fair value	$ 17.28	$ 21.02	$ 10.77
Employee Stock Option | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend rate			3.20%
Employee Stock Option | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend rate	3.70%	2.80%	5.20%
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average expected dividend rate	3.80%	2.80%	4.60%
Weighted average fair value	$ 62.82	$ 82.40	$ 50.64
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	1 year	1 year	1 year
Expected dividend rate	3.20%	2.40%	2.50%
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years 2 months 12 days	2 years 6 months	2 years 6 months
Expected dividend rate	5.50%	3.40%	5.40%
Employee Stock | ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months	6 months
Volatility, low end of the range	39%	36%	39%
Volatility, high end of the range	40%	39%	44%
Weighted-average volatility	39%	37%	42%
Weighted-average expected dividend rate	3.80%	2.80%	5.10%
Risk-free interest rate, minimum	2.90%	0.10%	0.10%
Risk-free interest rate, maximum	4.70%	0.50%
Weighted average fair value	$ 19.36	$ 24.38	$ 13.77
Employee Stock | ESPP | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend rate	3.50%	2.60%	4%
Employee Stock | ESPP | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend rate	4%	3%	5.80%
Performance Shares | TSR/ROIC
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	3 years	3 years	3 years
Volatility	40%	39%	38%
Weighted-average volatility	40%	39%	38%
Expected dividend rate	4.10%	3.10%	5.60%
Weighted-average expected dividend rate	4.10%	3.10%	5.60%
Risk-free interest rate	3.60%	0.40%	0.20%
Weighted average fair value	$ 64.38	$ 86.01	$ 43.20
Performance Shares | AEPS [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	0 years	0 years	2 years 6 months
Expected dividend rate	0%	0%
Weighted-average expected dividend rate	0%	0%	4.90%
Weighted average fair value	$ 0	$ 0	$ 45.50
Performance Shares | AEPS [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend rate			3.20%
Performance Shares | AEPS [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend rate			5.20%

Share-based Compensation (Stock

Share-based Compensation (Stock option activity) (Details) - Employee Stock Option - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Number of shares, outstanding at the beginning of the period	1.6
Number of shares, granted	0.2
Number of shares, exercised	(0.2)
Number of shares, forfeited	(0.1)
Number of shares, outstanding at the end of the period	1.5	1.6
Number of shares, vested and expected to vest	1.5
Number of shares, exercisable	1.1
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-average exercise price, outstanding at the beginning of the period (in dollars per share)	$ 49.26
Weighted-average exercise price, granted (in dollars per share)	68.83
Weighted average exercise price option issued (in dollars per share)	41.47
Weighted-average exercise price, forfeitures (in dollars per share)	72.13
Weighted-average exercise price, outstanding at the end of the period (in dollars per share)	51.96	$ 49.26
Weighted-average exercise price, vested and expected to vest (in dollars per share)	51.78
Weighted-average exercise price, exercisable (in dollars per share)	$ 46.60
Weighted-average remaining contractual term, outstanding at the beginning of the period (in years)	2 years 10 months 24 days	3 years 7 months 6 days
Weighted-average remaining contractual term, vested and expected to vest (in years)	2 years 9 months 18 days
Weighted-average remaining contractual term, exercisable (in years)	2 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 21	$ 36
Aggregate intrinsic value, vested and expected to vest	21
Aggregate intrinsic value, exercisable	$ 20

Share-based Compensation (Nonve

Share-based Compensation (Nonvested share activity) (Details) - Nonvested Shares - Stock Compensation Plan shares in Millions	12 Months Ended
	Jun. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of shares, nonvested at the beginning of the period | shares	4.8
Number of shares, granted | shares	1.8
Number of shares, forfeitures | shares	(1)
Number of shares, vested | shares	(1.9)
Number of shares, nonvested at the end of the period | shares	3.7
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-average grant-date fair value, nonvested at the beginning of the period (in dollars per share) | $ / shares	$ 58.86
Weighted-average grant-date fair value, granted (in dollars per share) | $ / shares	62.82
Weighted-average grant-date fair value, forfeitures (in dollars per share) | $ / shares	61.86
Weighted-average grant-date fair value, vested (in dollars per share) | $ / shares	54.79
Weighted-average grant-date fair value, nonvested at the end of the period (in dollars per share) | $ / shares	$ 62.07

Share-based Compensation (Perfo

Share-based Compensation (Performance award activity) (Details) - Performance Shares - Performance Awards Market Condition shares in Millions	12 Months Ended
	Jun. 30, 2023 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of shares, nonvested at the beginning of the period | shares	0.9
Number of shares, granted | shares	0.4
Number of shares, forfeitures | shares	0.2
Number of shares, vested | shares	(0.4)
Number of shares, nonvested at the end of the period | shares	0.7
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-average grant-date fair value, nonvested at the beginning of the period (in dollars per share) | $ / shares	$ 59.72
Weighted-average grant-date fair value, granted (in dollars per share) | $ / shares	60.72
Weighted-average grant-date fair value, forfeitures (in dollars per share) | $ / shares	64.46
Weighted-average grant-date fair value, vested (in dollars per share) | $ / shares	51.30
Weighted-average grant-date fair value, nonvested at the end of the period (in dollars per share) | $ / shares	$ 64.29

Guarantees (Narrative) (Details

Guarantees (Narrative) (Details) - USD ($)	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021	Jul. 03, 2020
Schedule of Fiscal Years [Line Items]
intellectual property indemnification obligations	$ 0
intellectual property indemnification obligations	0
Standard product warranty accrual	168,000,000	$ 148,000,000	$ 136,000,000	$ 151,000,000
Standard product warranty accrual, period increase (decrease)	$ 20,000,000
Minimum
Schedule of Fiscal Years [Line Items]
Product warranty period term (in years)	1 year
Maximum
Schedule of Fiscal Years [Line Items]
Product warranty period term (in years)	5 years

Guarantees (Product Warranty) (

Guarantees (Product Warranty) (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Movement in Standard Product Warranty Accrual [Roll Forward]
Balance, beginning of period	$ 148	$ 136	$ 151
Warranties issued	55	79	76
Repairs and replacements	(92)	(88)	(81)
Changes in liability for pre-existing warranties, including expirations	57	21	(10)
Balance, end of period	$ 168	$ 148	$ 136

Earnings Per Share (Schedule of

Earnings Per Share (Schedule of computation of basic and diluted net income (loss) per share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Numerator:
Net income	$ (529)	$ 1,649	$ 1,314
Number of shares used in per share calculations:
Total shares for purposes of calculating basic net income per share attributable to Seagate Technology plc	207	220	242
Weighted-average effect of dilutive securities:
Employee equity award plans	0	4	3
Total shares for purpose of calculating diluted net income per share attributable to Seagate Technology plc	207	224	245
Net income per share attributable to Seagate Technology plc ordinary shareholders:
Basic net income per share (in dollars per share)	$ (2.56)	$ 7.50	$ 5.43
Diluted net income per share (in dollars per share)	$ (2.56)	$ 7.36	$ 5.36
Potential common shares excluded from the computation of diluted net income (loss) per share (in shares)	7	0	0

Commitments (Narrative) (Detail

Commitments (Narrative) (Details) $ in Millions	12 Months Ended
	Jun. 30, 2023 USD ($)
Recorded Unconditional Purchase Obligation [Line Items]
Purchase Obligation	$ 68
Recorded Unconditional Purchase Obligation, Order Cancellation Fees	108
Inventories
Recorded Unconditional Purchase Obligation [Line Items]
Unrecorded Unconditional Purchase Obligation	2,800
Unrecorded Unconditional Purchase Obligation, Due within Two Years	297
Unrecorded Unconditional Purchase Obligation, Due within Three Years	991
Unrecorded Unconditional Purchase Obligation, Due within Four Years	981
Unrecorded Unconditional Purchase Obligation, Due within Five Years	489
Capital Addition Purchase Commitments
Recorded Unconditional Purchase Obligation [Line Items]
Unrecorded Unconditional Purchase Obligation	101
Unrecorded Unconditional Purchase Obligation, Due within Two Years	35
Unrecorded Unconditional Purchase Obligation, Due within Three Years	39
Unrecorded Unconditional Purchase Obligation, Due within Four Years	$ 27

Business Segment and Geograph_3

Business Segment and Geographic Information (Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas) (Details) $ in Millions		12 Months Ended
		Jun. 30, 2023 USD ($) numberOfEmployees	Jul. 01, 2022 USD ($)	Jul. 02, 2021 USD ($)
Revenue from external customers and long-lived assets
Revenue	[1]	$ 7,384	$ 11,661	$ 10,681
Long-lived assets	[2]	$ 2,102	$ 2,332	$ 2,275
Number of Reportable Segments | numberOfEmployees		1
Revenue from Contract with Customer Benchmark | Customer Concentration Risk [Member] | One Customer
Revenue from external customers and long-lived assets
Concentration risk, percentage of revenue		10%	10%	11%
Singapore
Revenue from external customers and long-lived assets
Revenue	[1]	$ 3,271	$ 5,322	$ 5,180
Long-lived assets	[2]	460	557	570
United States
Revenue from external customers and long-lived assets
Revenue	[1]	3,053	4,694	3,656
Long-lived assets	[2]	606	679	682
The Netherlands
Revenue from external customers and long-lived assets
Revenue	[1]	1,046	1,627	1,825
Other
Revenue from external customers and long-lived assets
Revenue	[1]	14	18	20
Long-lived assets	[2]	369	426	411
Thailand
Revenue from external customers and long-lived assets
Long-lived assets	[2]	$ 667	$ 670	$ 612
[1]Revenue is attributed to countries based on the bill from location.[2]Revenue is attributed to countries based on the bill from location.

Revenue (Details)

Revenue (Details) - USD ($) $ in Millions	12 Months Ended
	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 7,384	$ 11,661	$ 10,681
Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue	3,285	5,340	5,198
Americas
Disaggregation of Revenue [Line Items]
Revenue	3,053	4,694	3,656
EMEA
Disaggregation of Revenue [Line Items]
Revenue	1,046	1,627	1,827
OEMs
Disaggregation of Revenue [Line Items]
Revenue	5,448	8,742	7,403
Distributors
Disaggregation of Revenue [Line Items]
Revenue	1,119	1,676	1,854
Retailers
Disaggregation of Revenue [Line Items]
Revenue	$ 817	$ 1,243	$ 1,424

Subsequent Events (Details)

Subsequent Events (Details) - $ / shares		12 Months Ended
	Jul. 26, 2023	Jun. 30, 2023	Jul. 01, 2022	Jul. 02, 2021
Subsequent Event [Line Items]
Cash dividends declared per ordinary share (in dollars per share)		$ 2.80	$ 2.77	$ 2.66
Subsequent event
Subsequent Event [Line Items]
Cash dividends declared per ordinary share (in dollars per share)	$ 0.70